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(i)
Abstract
Research into the effects of scopolamine hydrobromide, a post-
synaptic cholinergic receptor blocking drug, upon cognition in
humans has been conducted for at least two decades. In that time.
a distinct pattern of effects has emerged. Within a dose range
of 0.3 to 1.2 mg (oral), scopolamine has been found to impair the
acquisition of new information in verbal and spatial learning
itasks, to reduce stimulus sensitivity'in tests of vigilance and
to impair selective attention. Generally it is thought that
information retrieval, both of newly learned and autobiographical
material, is unaffected by this drug.
A primary reason for research interest in scopolamine is that the
effects have been found to resemble the pattern of impairment
found in advanced age, and particularly in Alzheimer's Disease
Scopolamine model of(AD). This is often referred to as the
dementia'. Coupled with the observation of extensive damage to
CNS cholinergic neurons in AD, the hypothesis has emerged that
acetylcholine activity influences many important cognitive
processes.
Recent theoretical analyses of cognitive loss in AD have proposed
that there is a selective impairment to effortful (i.e. active.
conscious) processes, whereas the more automatic (i.e. reflexive.
unconscious) aspects of cognition remain intact. If the
(ii)
scopolamine model is to remain valid in this perspective, then
it should be possible to show that, in normal humans, the effects
of the drug are specific to effortful cognitive control
processes. This thesis describes six experiments designed to test
this prediction.
It is presented in three parts. In Part I, two experiments
examined the effects of 0.6mg and 0.9mg oral scopolamine upon the
control of attention to targets in visual space. Results
confirmed the prediction that the ability to detect stimuli in
high probability locations on a VDU is impaired, while detection
of stimuli in low probability locations is enhanced. It was
argued that the drug broadened the attentional focus, and that
this is due to a general reduction in cognitive control.
In Part II, two studies sought to find evidence that the drug
impairs the active selection of information from semantic memory.
Here, subjects were not provided with material to learn, but
rather were asked to sustain the retrieval of items from natural
semantic categories for extended periods (8 to 12 min). In the
second study of this pair, subjects were also constrained as to
the type of retrieval strategy they could use. Results failed to
confirm the prediction. The drug had no main or interactive
effects on active control over semantic memory retrieval.
In Part III, two studies tested the prediction that scopolamine
would selectively impair the more difficult, controlled aspects
(iii)
of encoding and retrieval following presentation of verbal
material (i.e. an episodic memory task) in two sensory modalities
(auditory and visual). Subjects were required to recall lists of
words, and to actively group their recall on the basis of the
items' sensory modality. The first study found that the drug
impaired recall, but not recognition, and did not have an effect
on more automatic phenomena such as word priming effects and the
recall advantage for auditory material. In addition, there was
some evidence from statistical interactions that the drug 
impaired subjects' ability to actively cluster the presented
material on the basis of input modality.
The second experiment examined effects of scopolamine upon list
learning and modality clustering when subjects were given five
attempts to recall the same items. This experiment introduced two
levels of task difficulty, by varying the extent to which item
input modality was consistent across learning trials. Pilot
testing (non-drug) revealed that list learning and clustering
ability were significantly impaired in the variable, as compared
to consistent, modality condition. In the full experiment.
scopolamine impaired total recall but not recognition. The drug
did not directly effect subjects' ability to group items on the
basis of modality, and the size of the drug effect on immediate
recall was similar for both the easy (i.e. consistent modality)
and difficult (i.e. variable modality) learning trials. There
were some interactions between drug and task variables which
indicated a weak effect upon attention.
(iv)
Taken together, these six experiments show the following pattern. 
Control over visual attention is impaired by scopolamine, and
this agrees with some previous research. However, this reduction 
in cognitive control appears to be specific, rather than general.
since the attempts to find an effect of the drug on active
control of retrieval from semantic memory and the conscious
organisation of material in episodic memory were unsuccessful.
In theoretical terms, this series of experiments does not support 
the view that anticholinergic drug 'effects are specific to 
effortful processing. It was argued that the pattern of drug
effects observed here is not simply due to low potency of a 0.9mg
oral dose. Numerous previous experiments have observed subtle
effects of scopolamine 0.9mg oral (and lower doses) on various
measures of cognitive function. It was concluded that a low to
moderate dose of oral scopolamine does have selective effects on
different cognitive processes, but that this selectivity is not
related to the amount of cognitive effort involved in the tasks.
This work has identified some important limits to the scopolamine
model of dementia, and extended research with this drug into
several domains of human memory not previously examined. The
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"It is possible that, by careful observation, 
the proper means may be discovered of preserving 
that temperament of the brain which is favourable 
to memory, and of remedying the disorders of that 
temperament. This would be a very noble improvement 
of the medical art"
(Thomas Reid, 1710-1796; cited in 
Hermann and Chaffin, 1988, pl93)
The idea that the brain is involved in human memory may seem
obvious. However, this was not always so. In ancient
writings, there was a belief that human consciousness was a
property of an ethereal soul, and that memory was "... not
a quality of heart or blood or brain or atoms" (Cicero, 106-
43 B.C.; cited in Hermann and Chaffin, 1988, p 80). These
were days before scientific determinism and there was little
understanding of the functions and capacity of the central
nervous system. But early thinkers were not naive when it
came to an appreciation of human cognition: they could see
the complexities of language, memory, attention and
imagination. That these functions were not located in the
brain seemed obvious to Cicero, since "..what can be the
traces of words, of actual objects, what further could be the
enormous space adequate to the representation of such a mass
of material?"
Over time, however, it became clear that human cognition
was housed in the brain. People who survived localised
2
brain damage did not recover their previous level of
functioning, and it appeared that the sick or injured often
lost particular mental functions and not others. In
addition, there was a realisation that consumption of
various plants and drugs, which could only be acting on
physical systems, had distinct cognitive effects.
The plant species henbane (Hyoscyamus niger), deadly
nightshade (Atropa belladonna) and jimson weed (Datura
stramonium) have been known throughout history for their
potent effects on memory (Julien, 1985). In Middle Ages
Europe, they were central to the practice of witchcraft.
where consumption of various brews produced delirium, trance
and 'prophetic imaginings'. Knowledge of the effects of
these preparations on memory was such that Atropa Belladonna
plants were named after the Greek goddess Atropos, who
supposedly "cut the thread of life" (Julien, 1985).
In modern times, two major drugs, atropine and scopolamine
(or hyoscine) have been derived from these plants. In the
early 1900's, scopolamine was used in combination with
morphine to induce mild sedation, or "twilight sleep".
during obstetric surgery (C. Smith, 1984) and atropine is
now commonly used as an adjunct to anaesthetics. These drugs
have distinct physiological effects: they depress
salivation, reduce sweating, dilate the pupils, cause loss
of tone in the urinary bladder and gastrointestinal tract
3
and inhibit the secretion of acid in the stomach (Julien,
1985). At times they have been used during medical
treatments of stomach ulcers, are effective in the
prevention of motion sickness, and have been used in the
treatment of Parkinsonism and to counteract side effects of
anti-psychotic drugs (Abood, 1982).
Primary research interest in these drugs, however, is
because of their effects on memory and cognitive function.
Since the pioneering work on chemical transmission in nerves
/
by Dale, Cannon, Dixon, Elliot, Loewi and Finkelman between
1910 and 1930, which identified the neurotransmitters
acetylcholine and epinephrine (Bowman, Rand and West, 1968),
there have been many attempts to understand the mechanisms
by which psychoactive drugs alter neurotransmitter activity.
It is now known that atropine and scopolamine act by
blocking the activity of acetylcholine at muscarinic
cholinergic receptors (Julien, 1985; Kruk and Pycock, 1983).
Drugs with this action are known collectively as
anticholinergic agents.
It is nearly two decades since the first systematic studies
of the effects of anticholinergic drugs on human memory
were reported (Crow and Grove-White, 1973; Drachman and
Leavitt, 1974; Safer and Allen, 1971). Since then, a
considerable research effort has generated a very complex
pattern of findings, which converges on the view that the
activity of brain acetylcholine (ACh) has a central role
4
in the acquisition of new information into memory
(Kopelman, 1986). In parallel with this work, a great deal 
of information has been gathered from neuropharmacologists 
and neuropathologists which clearly implicates specific
deficits in ACh activity in the onset and course of
dementing diseases, and in particular, Alzheimer's disease
1988).(see Perry, 1988; Ruberg and Agid; 1988; Rossor,
"cholinergicTogether, this research generated the
hypothesis of memory".
The core issue of the central involvement of cholinergic
activity in cognition is not at issue here. Certainly, the
cholinergic hypothesis is firmly established. Rather, this 
thesis is an attempt to superimpose some recent theory
from cognitive psychology onto the diverse body of psycho-
pharmacological and neuropsychological data relevant to
the cholinergic hypothesis, and then to test some 
derivative questions. These issues may be summarised as
follows;
1) Early models of human memory primarily
componential i.e., the acquisition, storage and retrieval
were
of information were described in serial, flow chart form.
and emphasis was placed on the localisation of deficits to
points in the processing sequence (Atkinson and Shiffrin, 
1971; Klatzky, 1975). However, recent years have seen the 
emergence of energetical models (e.g. Craik and Byrd, 
1982; Hockey, Gaillard and Coles, 1986; Sanders, 1983),
5
where neuropsychological impairment is described in terms
to allocate processingof reductions in the ability
resources to the task at hand. These cognitive resource
theories have arisen from the need to interpret
performance on a diverse range 
attention and problem solving within a single conceptual
of tests of memory.
frame. The general question addressed in this study is
whether these resource theory notions can be usefully
applied to the interpretation of cognitive effects of
cholinergic blockade.
2) Cognitive deficits in Alzheimer's disease have recently
been described in terms of resource theory, with the
suggestion that controlled processing is impaired, while 
automatic cognitive operations are spared, at least in 
mild dementia (Jorm, 1986). The question then is whether 
the cognitive effects of cholinergic blockade in normal 
subjects continue to provide an adequate model of dementia
in terms of this new framework.
1.2. Focus of the literature review
This literature review first considers the rationale for
the cholinergic hypothesis of cognitive function. There 
have been many comprehensive reviews of experimental and 
clinical work this area (Bartus et. al., 1982; Coyle et.
al., 1983; Kopelman, 1986; Perry, 1988; Sahakian, 1988;
Warburton, 1987), and the aim here is not to replicate or 
paraphrase this previous work. Rather, evidence for the
6
hypothesis is introduced within an attempt to address one 
question which has continued to intrigue researchers over
Can deficits in brainthe years. This question is:
acetylcholine activity be shown to be associated with
declines in cognitive function in both normal aging and
pathological aging (in particular, Alzheimer's disease)? 
Asked another way, the question becomes: Are the deficits
in cholinergic function in Alzheimer's disease an
exaggeration of entropic processes in normal aging?
The review then introduces theories of cognitive control
and discusses the concepts of automatic and controlled
processing. Next, it considers whether Alzheimer's
dementia can be adequately described in terms of a
specific disruption to controlled processing. This is 
followed by a detailed analysis of whether existing data 
on the effects of scopolamine upon cognitive function in 
normal subjects can be interpreted as a specific 
disruption to active, effortful cognitive control. The 
review then identifies gaps in existing knowledge, and 
thus provides a rationale for the experiments conducted in 
the series.
1.3.1. The Cholinergic hypothesis of memory dysfunction 
(in Aging, in Dementia, or both?)
In the 1970s, there was a general belief that 
cognitive effects of anticholinergic drugs in normal young
the
7
people modelled deficits found in normal aging (see 
Drachman and Sahakian, 1979). Indeed, the original 
publication by Drachman and Leavitt (1974) which found 
similarities between the performance of young people given 
scopolamine and a non-drugged normal aged sample is
probably the most frequently cited work used to preface
studies in this area. It was also believed that declines
in ACh activity observed in brains during normal aging may
have been responsible for mild cognitive deterioration
(Perry et. al., 1977). These parallels between the effects 
of scopolamine and normal aging were included in the same
general model which effects tocompared the drug's
cognitive impairment in Alzheimer's Disease.
On the surface at least, it is possible to regard
Alzheimer's dementia as an exaggeration of cognitive
declines that occur in normal advanced age (Drachman, 
1989; Khachaturian, 1989). Certainly, Alzheimer's disease 
is a condition which primarily afflicts old people, and 
qualitatively, the patterns of cognitive loss have many
similarities, in that short-term memory, attention, motor
speed, learning ability and other functions generally 
decline (Miller, 1977; Moscovitch 1982).
However, it can be argued that to draw a link between the
two organic states is epiphenomenal. It is quite possible 
that the reason for qualitative similarities is that both
the normal elderly and people with Alzheimer's Disease
8
have the costs of brain aging in common, but that, in
Alzheimer's Disease, there is a complex pattern of
cognitive loss, due to particular neuropathology, which is 
superimposed upon an otherwise normally aging nervous
system. The pattern of loss in AD may be additional, but
different to. the patterns observed in normal aging
(Miller, 1977). It might, therefore, be theoretically 
invalid to use the effects of centrally acting drugs which 
alter neurotransmitter activity (such as scopolamine) in 
normal brains as models of cognitive change in both aging
and Alzheimer's Disease.
There is one over-riding concern with the cholinergic
hypothesis, and that is its usefulness. Most of the work
in this field has been driven by the need to understand
pathological changes in dementing illnesses, and to 
thereby gain knowledge of neurochemical mechanisms
underlying cognitive efficiency so that, ultimately, 
effective pharmacological agents might be targeted to 
reverse or minimise this impairment. It is arguable that 
the cholinergic hypothesis is most likely to bear fruit if 
it can be shown that cholinergic neuropathology is a cause 
or correlate of cognitive loss in clinical dementias 
rather than being a non-specific associate of normal aging 
and clinical dementias. If the latter position is 
supported, then research efforts to understand the major 
contributing changes in Alzheimer's Disease might best be 
directed elsewhere.
9
There is a wealth of data on neurochemical changes and
pathology in normal aging and dementia, and many
comprehensive reviews have been published (Creasey and 
Rapoport, 1985; Decker, 1987; Gottfries, 1985; Kubanis and
Zornetzer, 1981; Perry, 1988; Rossor, 1988). The usual
method to establish cholinergic dysfunction is to examine
differences between clinical samples and controls in terms
of various neurochemical markers in cerebrospinal fluid
and ante-mortem and post-mortem brain tissue.(CSF)
Although there are several markers of ACh activity in
human brain (Creasey and Rapoport, 1985; Marquis et. al., 
1985), this discussion is primarily limited to reports of 
levels of cholineacetyltransferase (ChAT), which is an 
enzyme that catalyses the synthesis of ACh (Rossor, 1988). 
Historically, this has been thought 
sensitive indicator of cholinergic pathology (Hohmann et.
to be the most
al., 1988).
1.3.2. Differences in Cholinergic pathology; Early studies 
in this field (McGeer and McGeer, 1975; Perry et. al., 
1977) documented reductions in post-mortem ChAT in the 
cerebral cortex, caudate nucleus and hippocampus in normal 
aging, and Perry (1980) proposed that these were similar 
to, but smaller than, the reductions evident in AD. The
possibility emerged that there is a continuous transition 
from normal aging to Alzheimer's dementia in terms of the
severity of cholinergic dysfunction. It would seem
10
possible, therefore, that reductions in cholinergic
activity might be related to the relatively minor
function which occurs during normaldeterioration of
aging.
In recent years, however, the evidence for reliable and
significant reductions in ChAT during the process of
In a review of 24normal aging has been less compelling.
relevant studies. Decker (1987) found that half of the 
studies reported no relationships between normal aging and 
ChAT activity in the hippocampus and frontal and temporal 
lobes. Of the remaining 12, the significant negative
correlations between age and ChAT ranged from small (e.g. 
-0.85). Decker (1987) suggested-0.42) to very large (e.g.
that in total, existing data show a relatively subtle
decrease in ChAT in normal aging, and that there is
considerable variation in the extent of loss depending
upon the particular brain region under study. In similar 
reviews, Bartus et al (1982) and Creasey and Rapoport 
(1985) uncovered considerable variability between studies 
with the normal elderly, and argued that, when ChAT has 
been found to decline with age, the effects are typically
small.
In contrast to the equivocal data in normal aging, post­
mortem studies of AD brains consistently show marked
reductions in ChAT relative to controls (Bartus et al.
1982; Gottfries et. al., 1983; Rossor et. al., 1982;
11
Francis et. al., 1985) and it seems clear that reduced 
activity is found in all cortical and brain stem regions
that have significant clusters of cholinergic neurones
1988). Studies of the hippocampus in AD (Hyman et(Mann,
al, 1984) indicate that loss of cholinergic neurones is
severe and possibly selective to that disorder.
One important difference between aging and Alzheimer's
Disease is that the former has not reliably been found to
produce degeneration of cholinergic innervation from the 
hippocampus to cortex (Decker, 1987). In a review of this 
field, Kopelman (1986a) found that a majority of studies 
of normally aged brains observe no consistent or
significant reductions in total neuron count and neuron
density in the nucleus basalis of Meynert, which is a
subcortical area providing substantial ACh innervation to
the neocortex (Salamone, 1986). This pattern contrasts 
sharply with the 50 - 70 percent gross cell loss observed
in this and other subcortical areas in Alzheimer's Disease
(Arendt et. al., 1983).
Although the central brain structures appear to be intact 
in normal aging. Decker (1987) suggests that change occurs 
in both the rate of ACh synthesis and the electro- 
physiological response of post-synaptic neurones to ACh, 
which reflects a generalised decline in the optimal level 
of functioning of the cholinergic system, rather than 
significant loss or fractionation of function.
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While studies in Alzheimer's Disease have found that the
extent of ChAT reduction correlates with the severity of
cognitive loss (Perry et. al., 1978; Rossor 1988), it is 
doubtful whether subtle changes in ACh activity in normal 
aging would produce measurable changes in cognitive 
efficiency. Creasey and Rapoport (1985), Decker (1987) and
Perry (1988) suggest that small reductions in ACh would
have little direct impact. given the plasticity and
redundancy of the human brain. Interestingly, Baltes and
Willis (1982) proposed a psychological model relevant to 
this point, where the main change in normal aging is not 
in the level of cognitive functioning, but in the amount
of latent (i.e. mental potential energy) 
available. It is tempting to speculate (as has Squire,
reserve
1987) that this decline is the cost of gradual
neurochemical changes in aging brains, although at present 
there are insufficient data to adequately test the idea.
The distinction between normal aging and Alzheimer's
Disease is most clearly illustrated when the effects of
age within samples of Alzheimer's patients are considered. 
Rossor et. al., (1984) proposed a typology of Alzheimer's 
dementia, whereby an early onset (type I) group (diagnosis 
at less than 79 years) can be distinguished from a late
onset (type II) group (diagnosis at 80 or more years). 
Type I patients have severe deficits in ACh and most major 
neurotransmitters, while Type II patients have a lesser 
degree of cholinergic loss, and relatively normal
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functioning in other neurotransmitters. This suggests that 
cholinergic dysfunction is negatively correlated with age 
in Alzheimer's Disease. In contrast, data from normal aged
subjects indicate that the extent of cholinergic
dysfunction is positively correlated with age (Creasey and
observations1985), although theseRapoport, are
potentially confounded by the possibility that some of the
normal aged samples contain undiagnosed cases of early AD
(Decker, 1987) .
Dissociation of normal aging and Alzheimer's dementia is 
also suggested in data on cognitive loss in these two 
conditions. Kopelman (1985) and Morris and Kopelman (1986)
cite several studies which show that memory test
performance is poorer in younger AD patients, whereas the
reverse is true in normal aging.
To conclude this point, the existing evidence suggests
that it may be best to view cortical and subcortical
cholinergic dysfunction in Alzheimer's Disease as a
neuropathological state which is superimposed upon an 
aging brain, rather than as a continuation or exaggeration 
of normal aging. Neurochemical studies both of people with 
AD and normal aging are likely to reveal some reductions 
in acetylcholine activity (as well as other neuro­
transmitters) . The task facing researchers into the 
etiology of cognitive loss in AD is to disentangle the 
specific Alzheimer pathology from the background of non-
14
specific changes that are normally occurring in advanced
age.
1.3.3. The primacy of cholinergic pathology in AD:
It is widely established that the activity of many major
neurotransmitters is reduced in Alzheimer's disease.
Studies of gamma-aminobutyric acid (GABA), noradrenaline, 
5-hydroxy-tryptamine (5-HT) and somatostatin as well as
other neurotransmitters and neuropeptides. have found
reductions in brain samples in AD (Beal et. al., 1985;
Davis et al, 1988; Gottfries et. al., 1983; Palmer et. al.
1988; Rossor et. al., 1982; Sparks, 1989), and there is 
evidence that these neurochemicals, either directly or via
interaction with ACh, are important in memory and
cognitive function (Introini-Collison and McGaugh, 1988; 
Panksepp, 1986; Squire and Davis, 1981). These studies 
have raised doubts over whether disruption to ACh does 
have primary importance in Alzheimer dementia (Kopelman,
1986a).
Given this complex background of neurochemical
disturbance, research efforts to support the cholinergic 
hypothesis have now become focussed on demonstrating that 
dysfunctions in GABAergic, somatostatinergic,
noradrenergic and other neurochemical systems 
secondary to (i.e. are less extensive, of later onset and 
perhaps more localised) than the marked and diffuse 
disturbance to ACh activity.
are
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Recently, Whitford et. al. (1988) found no evidence of
reduced somatostatin-like immunoreactivity or receptor
binding in post-mortem samples of frontal and temporal 
cortex in AD. This contrasts with observations reported by
Beal et. al., (1985) and Rossor et. al., (1982), but 
agrees with studies by Arai et al, (1984; cited in
Whitford et. al., 1988) and Francis et. al.,(1987). 
Whitford et. al. suggested that, apart from probable
differences in assay procedures and the severity of
disease states in the post-mortem samples used in studies
reporting positive or negative results, it is probable
that the involvement of the somatostatinergic system is
not a primary or consistent feature of AD.
Lowe et. al. (1988) conducted a study in which ACh and
diagnostic
craniotomy and post-mortem samples. They found evidence
GABA concentrations were measured in both
that reductions in GABA content are not apparent in ante­
mortem samples, but only become evident to a significant
degree in brains with severe AD. A similar conclusion has
been reached by Francis et. al. (1987) regarding
somatostatin.
A majority of studies of norepinephrine and dopamine 
(reviewed by Rossor, 1988) indicate relative loss of 
function in AD (but see Palmer et. al., 1988), although 
there is considerable variability in the extent of this 
loss in different brain regions, with some areas showing
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normal levels. In addition, it is not known whether
disruption to these neuronal systems correlates with
dementia severity, although the dopamine deficits might 
help explain parkinsonian features in some AD patients
(Rossor, 1988).
In contrast, many studies have found marked (e.g. greater 
than 50%) reductions in ChAT, indicating significant loss 
of cholinergic neurones, in samples taken from brains even 
at early stages of AD (see Bartus et. al., 1982; Decker, 
1987). In reviewing recent evidence for the primacy of 
cholinergic dysfunction in this disease. Perry (1988) 
suggested that the compensatory mechanisms of the brain 
are such that it is likely that observations of reductions
in neurotransmitter activity of less than 50% are not 
clinically relevant.
The idea that cholinergic deficiency is an important 
neurochemical associate of cognitive loss in AD received 
direct support from studies which show significant 
positive correlations between ChAT levels and cognitive 
function in dementia patients (Perry et al, 1978; Mountjoy
al.et 1986) . Rossor (1988) argued that these
relationships are not causal, and it may simply be that 
cognitive rating scales and ChAT are both good but 
unrelated markers of dementia severity. However, a recent 
report by Kawakatsu et. al. (1990) may be important, in
that there is a clear demonstration that cholinergic
17
activity correlates with dementia severity in AD patients, 
while the activity of other neurotransmitters does not.
Kawakatsu et al (1990) analysed concentrations of the 
acetylcholine metabolite Acetylcholinesterase (AChE) and
the monoamine metabolites homovanillic acid (HVA), 3-
methoxy-4-hydroxy phenylglycol (MHPG) and 5-hydroxy-
indoleacetic acid (5-HIAA) in the CSF of 22 Alzheimer
patients and 32 age matched controls. Assays showed that
AD patients significantly differed from controls in terms
of AChE, HVA and 5-HIAA, though not MHPG, levels (see also
Atack et al, 1988).
There were significant correlations between AChE activity
and three measures of cognitive, motor and emotional
dysfunction from the Gottfries et. al. (1985) dementia
rating scale, and between AChE and scores on another
dementia scale and the Wechsler Adult Intelligence Scale.
In contrast, there was a single significantnot
correlation between any of the monoamine metabolite
concentrations and the five tests of cognitive and motor
function. (These conclusions differ from those of Atack
et. al., 1988, who found no association between AChE and
mental function, although it is noteworthy that Atack et.
al. did not obtain continuous measures of cognitive
performance, and only compared groups rated in terms of 
dementia severity on a 3 point scale).
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Kawakatsu et. al. (1990) acknowledged that the
significance of AChE as a cholinergic marker is a matter
of some debate (see Marquis et. al., 1985). However, they 
cited evidence (from Perry et. al., 1978) which shows that
reduced together with other 
cholinergic markers (such as ChAT) in Alzheimer's Disease, 
and suggest therefore that AChE is probably a sensitive 
measure of cholinergic pathology.
AChE levels tend to be
The most straightforward explanation of the findings from 
Kawakatsu et. al. (1990) is that cognitive performance
declines as a function of reductions in cholinergic
activity in AD, and although there are significant 
reductions in the activity of other neurotransmitters, the
latter are not directly related to cognitive loss (see 
also Rossor et al, 1982; Rossor, 1988). Although it is 
possible that these other neurochemicals either directly 
or interactively contribute to the general loss of
function in some subtle ways, they appear to be
demonstrably less important than acetylcholine.
1.3.4. The current status of the cholinergic hypothesis: 
This review of the neuropathological background to the 
cholinergic hypothesis has been brief and very selective.
has, for example, neglected to consider the effects 
that other changes in demented and aging brains, such as 
senile plaque formation and neurofibrillary tangles, may 
have upon cognitive function (Squire, 1987; Mann, 1988).
It
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The whole complex question of whether cholinergic
dysfunction is a causally related to the numerous other
changes in brain function in Alzheimer's Disease, and how
it might relate to other organic and environmental risk 
factors for the disorder, cannot be adequately addressed
here but the reader is referred to Drachman, (1989),
Iversen et. al. (1988), Henderson (1989) and Price (1986) 
for recent discussions. The problems are extraordinarily 
complex, and it is difficult to draw any conclusions with 
certainty. The best most researchers can do is to grasp 
particular ideas (such as the cholinergic hypothesis) and 
examine their strengths and limitations, but all the while 
acknowledging that there are numerous other pathological 
processes which continue either in parallel or 
interactively throughout the course of Alzheimer Disease.
Within these limitations, some conclusions about the
status of the hypothesis can be offered. First, the loss
of cholinergic function in Alzheimer's Disease is more
severe and widespread than that found in normal aging, and 
it remains unclear whether declines in ACh activity which 
are sometimes found in normal aging have any functional 
significance. Second, recent evidence suggests that, in 
comparison to other neurotransmitters, disruption to ACh 
activity is a primary indicator 
Alzheimer's dementia.
of the severity of
The cholinergic hypothesis of cognitive loss m
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to be supported by-Alzheimer's Disease appears, therefore.
and continued efforts to focusrecent evidence.
pharmacological treatments on this neurotransmitter system 
are justified and provide the most promising approach 
(Kawakatsu et al,1990; Perry 1988).
Insights from clinical neurochemistry and neuropathology
provide only part of the rationale for the cholinergic
hypothesis of memory dysfunction. The other main body of
evidence comes from observations that the cognitive
effects of drugs which disrupt central cholinergic
activity (such as scopolamine) are similar to the 
cognitive dysfunction observed in Alzheimer's dementia.
The remainder of this review examines current theoretical
knowledge of the patterns of cognitive impairment in AD, 
and then considers whether the effects of scopolamine upon
cognition in normal humans can be adequately described in
the same theoretical framework.
1.4. Alzheimer's Dementia: Theoretical approaches to
understanding the cognitive deterioration
In the last fifteen years, there has been a major research
effort to understand the range of cognitive functions
which are impaired or preserved in Alzheimer's Disease.
Given the volume of books and research papers, and the
complexity of the cognitive change in this disorder, it is
not possible to review relevant data and arrive at a
definitive statement about any specific 'locus' of the
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done with some discretedeficit, as perhaps can be
examples of amnesia (c.f. Squire, 1987).
How can the cognitive impairment be described in general
terms? Alzheimer's Disease is characterised by a
progressive decline in cognitive function which follows an
insidious course. It first becomes noticeable when the
person finds increased difficulty in completing complex
tasks, understanding complex conversations, dividing
attention between multiple tasks. and learning new
information. In this "mild" dementia state, there may also
be some problems in word and name finding. In later
stages, there is an inability to accurately recall remote 
autobiographical information, to organise search of one's
own memory, to complete everyday tasks and to carry out
mental calculations. In this "moderate" dementia, there is
also poor orientation to time and place. In the most
severe stages, language and reading skills disintegrate, 
recognition of even familiar people and places is severely 
impaired and basic conscious control over bodily functions 
is lost (Gavrilova, 1989; Granholm and Butters, 1988; 
Kopelman, 1989; Miller, 1977; Reisberg et. al., 1986; 
Semple et. al., 1982; Weingartner et. al, 1981).
While accepting this general description, it is important 
to acknowledge that the course of the cognitive decline is
very variable between individuals: onset of severe loss
may be rapid or slow. it may be associated with other co-
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existing neurological deficits such as Parkinson's Disease
or Multi-infarct states and cognitive function may be
depressed by alterations to mood and personality
(Kopelman, 1985, 1986a).
The complexity of the condition is such that reliable
diagnosis on the basis of cognitive or behavioural
measures alone is very difficult (Jorm, 1986). This has 
implications for clinical research, with perhaps as many 
as 30-40% of 'cases' being originally misdiagnosed (Ron 
et. al., 1979). The reliability of diagnosis before death 
can be improved with ante-mortem biopsy or CSF analysis 
and with new brain imaging technologies (Friedland, 1989; 
Margolin and Ban, 1986; F. Smith, 1989). In recent years 
the pre-death misclassification rate appears to be 
reducing, with figures of around 20%, although this is 
still unacceptably high (Benson, 1989).
A key problem in interpreting clinical neuropsychological 
data in AD is that individual studies vary in the tests 
used and the severity of and types of dementia being 
assessed. In addition, there are few systematic 
longitudinal studies and a paucity of normative data in 
non-demented elderly populations (Henderson, 1989).
The need to examine cognitive impairment in AD within a
theoretical framework becomes obvious when the literature
neuropsychological test performance is reviewed.on
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Recently, Flicker (1988) evaluated the sensitivity of 63 
tests which are commonly used in research, and found that
people with probable AD were impaired on 94% (59) of the
measures. An accurate, but not very useful, conclusion
would be that every cognitive function is (eventually) 
impaired in AD. Clearly, when data are grouped in this
way, much information is lost regarding the rate and
sequence of progression, and little is revealed about the
relative degree of impairment to separable cognitive
functions at various stages of the disorder. According to
Morris and Kopelman (1986), the large clinical data base 
in AD needs to be drawn together and interpreted in terms 
of current cognitive theory. One of the more notable
recent attempts has been put forward by Jorm (1986).
Jorm's (1986) thesis was that the early stages of
Alzheimer's dementia show a selective deficit in
controlled, effortful cognitive operations, while the more 
automatic (over-learned, unconscious) aspects of memory 
remain intact until the final stages of the disorder. Jorm 
suggested that this theoretical position could be useful 
in the design of diagnostic cognitive tests. This approach 
has adopted the cognitive process automaticity metaphor 
from experimental psychology (Hasher and Zacks, 1979; Fisk 
and Schneider, 1984; Shiffrin and Schneider, 1977). Before 
reviewing Jorm's (1986) argument and presenting some more 
recent evidence, the general concepts of cognitive 
automaticity will be briefly described.
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1.5. General concepts of automatic and controlled
information processing:
Since the first documented writings on human cognition.
there has been a realisation that consciousness is a
constructive, rather than a reflexive process (see Hermann 
and Chaffin, 1988, for an interesting selection of ancient
literature). Bartlett (1932) and more recently Baddeley 
(1982) and Handler (1986), have argued that the contents
of awareness are constructed from a mix of stimuli
impinging from the environment and from the unconscious
contents of memory. Awareness, almost by definition, is
the point to which attention is focussed and separated
from the background of other, momentarily irrelevant.
information.
A key element of recent information processing theory is
that a state of awareness has its costs: focussing
attention, searching one's own memory, editing and
organising the retrieval of facts from memory, planning a
sequence of events and the numerous other cognitive
processes of daily life, require the utilisation of a 
limited pool of available "cognitive energy" or 
"resources" (Gopher, 1986; Hasher and Zacks, 1979).
The terms 'automatic' and 'controlled' processes describe
cognitive functions on a continuum. In general, automatic
fast, unconscious. uncontrolled andprocesses are
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involuntary which place little or no demand upon available
mental energy. At the other end of the continuum are
controlled processes, which are slow, conscious, voluntary 
and capacity demanding (Hasher and Zacks, 1979; Jonides 
et. al., 1985; LaBerge, 1981). These terms overlap to some 
degree with other process descriptors, such that some
features of automatic processing are also called
"procedural" or "implicit", while controlled processes are 
termed "declarative" or "explicit" (Handler, 1986). At
present, there is an active debate about whether these
concepts are synonymous with automaticity (Schacter, 1990; 
Roediger, 1990) .
Humans are capable of a magnificent variety of cognitive
skills. When the micro-structure of skills such as
language, fine motor control, verbal learning, problem 
solving and the production of music are examined, it is
clear that most of the separable "bits" of these
operations are conducted without our conscious awareness
(Klatzky, 1984; Neumann, 1984). Indeed, it is impossible 
to imagine how adult humans could function if every 
cognitive operation required conscious awareness. Most of 
what we do occurs without specific intention, but for each 
individual this was not always so. Reading is a good 
example. Most of the basic skills of reading developed in 
childhood in a deliberate, effortful fashion.
While some elements of reading skill are probably acquired
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incidentally due to intellectual and environmental
influences, it remains true that this skill is improved
primarily through practice (Perfetti and Curtis, 1986).
One theoretical mechanism for this is that the initially
conscious activity of reading components of a text becomes 
automatised with practice (Laberge and Samuels, 1974). In 
order to acquire fluent reading skills, it is necessary 
that a person is able to recognise letters and words, and
identify whether a reading unit (word, 
sentence etc) is orthographically regular in that it
phrase.can
follows a conventional visual pattern for an item in the 
particular language. In addition, the person must be able 
to match the visual code to a phonological code (i.e. 
"sound" the word), and ultimately, match the visual code 
with a semantic code (Laberge, 1981; Perfetti and Curtis, 
1986). These and other basic processes require effort when 
a person is beginning to read. However, the need to devote
conscious attention to these component processes 
diminishes with repeated exposure to the stimuli.
Acquired experience in reading and with language leads to 
the formation of abstract schema of semantic associations
in memory (Anderson, 1983; Hunt and Lansman, 1986). To 
comprehend written text we must be able to consciously and 
unconsciously connect elements within these abstract 
schema. The quality of our reading comprehension (our 
expertise) may then be thought of as the extent to which 
we automate the simpler components of reading, and utilise
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our spare mental energy to guide and create higher order
intellectual associations between ideas embedded within
the text. At an early, formative stage of reading poetry
in a second language, we may experience the poetry as the
resonance of sounds, but may be otherwise constrained by
the need to pay attention to the physical attributes of
the words. At later stages, we experience an abstract mix 
of sounds, semantic images and associated emotions as the
words are being processed, without the need to pay
attention to the micro-structure of the written text.
The foregoing analysis summarizes some recent thinking on 
one cognitive skill (Perfetti and Curtis, 1986). These 
ideas are useful in the understanding of the acquisition a 
wide range of cognitive and motor skills, whether we are 
interested in bicycle riding, thesis writing and/or 
balancing on a beam. To function properly, we need a 
broad variety of automated processes that "take over" and 
relieve our conscious working memory of the need to 
allocate mental energy (Shiffrin and Dumais, 1981).
For many years, formal study of neuropsychological
impairment in amnesias and dementias was limited to the
measurement of conscious cognitive functions, such as 
explicit or observable remembering. The recent theoretical 
advances in cognitive psychology have opened up the study 
of memory and cognitive processes to include automatic 
phenomena, and thereby offer more complete insights into
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the nature of cognitive impairment (Gregg, 1986; Hirst and
Volpe, 1984; Reber, 1989).
In the next section, these theoretical concepts are
applied to the analysis of the sequence of cognitive
deterioration in Alzheimer's Disease.
1.6.1. A controlled processing deficit in Alzheimer's
Disease?
It is quite clear that, in late stages of Alzheimer's
dementia, the loss of function is diffuse and is
associated with severe structural changes in the brain
(Moscovitch, 1982). Even if these patients were able to
muster cognitive energy, or are given mnemonic aids to
reduce the processing "load" in particular tasks, the
structural loss is such that energetical factors would
have little or no influence on intellectual ability
(Parasuraman and Nestor, psychological
interest in dementia of the Alzheimer type is at the other
1986) . Most
end of the spectrum, with mild dementia.
Jorm (1986) began his analysis of cognitive impairment in 
early AD by assuming that all major cognitive activities 
have elements of both automatic and controlled processing. 
He then examined relevant studies on various cognitive 
functions, six of which will be reviewed here. These
fields are: (1) Verbal and Performance IQ, (2) Vocabulary,
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(3) Syntactic and semantic knowledge, (4) Reading, 
Naming and (6) Learning. Rather than simply re-phrase 
Jorm's (1986) analysis, this review briefly summarizes his 
position and then adds more recent data where possible.
(5)
(1) Verbal and Performance 10: The general pattern
observed in Alzheimer's dementia is that Performance IQ
declines more than Verbal IQ (see Loring and Largen, 1985; 
Miller, 1977). Jorm (1986) suggested that the verbal
subtests utilise skills that are generally over-learned
and automated (such as vocabulary and general 
information), whereas the performance subtests involve 
tasks that are novel, and hence require active attention 
and problem solving.
Fuld (1984) examined WAIS performance in 33 people with 
probable AD, and 27 people with Multi-Infarct and other
dementias. She found what she described as a
characteristic profile of AD. In 44 % of the Alzheimer
patients (the specificity was 94%), scores on information 
and vocabulary subtests were greater than those for 
similarities and digit span, which in turn were greater 
than digit symbol, block design and object assembly. This 
profile was found in only 4% (1 case ) of the MID/other 
group. Clearly, performance on the novel, 
demanding performance subtests was impaired the most.
attention-
More recently, Tuokko and Crockett (1987) studied a group
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of 74 non-demented elderly people, and found the Fuld
profile in only one case (1.4%). Taken together, these 
data suggest that the AD group, but not people with other
dementias or the normal aged, have a selective deficit in
performing IQ tests which require controlled processing.
(2) Vocabulary; Numerous studies have examined the degree
to which vocabulary is intact in AD (see Miller, 1977).
Consistent with observations from the WAIS, other tests
generally find vocabulary to be very well preserved in 
mild to moderate AD, suggesting preservation of automatic
processing (Jorm, 1986; Weingartner et. al.. 1983).
Performance on the Mill Hill vocabulary scale is often
normal in mild AD (Miller, 1977), and this scale is
to estimate premorbid intelligence insometimes used
clinical samples (Flicker, 1988).
Vocabulary has been found to be impaired in AD relative to 
controls (Flicker et. al., 1987), but the general 
consensus is that the deficit is relatively minor in 
comparison to performance on tests of problem solving, 
learning, remote memory and object naming.
(3) Syntactic and semantic knowledge: Differential effects
of AD on automatic and controlled processing are clearly 
demonstrated when the preservation of syntactic and 
semantic knowledge is examined. Jorm (1986) stated that 
retrieval of semantic knowledge (such as word meaning and
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synonyms), which requires conscious thought, is impaired
to a greater degree than syntactic knowledge, which is
retrieved more automatically.
Bayles (1982: cited in Nebes et. al., 1986) found that if
Alzheimer patients given containingsentencesare
syntactic errors (e.g. "He give me candy") they are not
impaired in their ability to detect and correct such
errors. However, they are impaired in their ability to
detect semantic errors (e.g. lost John's temper")."I
Nebes et. al. (1986) suggested that rules of syntax are 
highly overlearned and are retrieved automatically. In
contrast, the detection and correction of semantic errors
requires deeper cognitive processing.
Kopelman (1986b) gave AD subjects and controls a set of
sentences which varied in the extent to which they were
semantically anomalous, ranging from "The team of workers 
built the bridge" (semantically correct) to "Not in tree
to the ran lake with" (anomalous). The AD patients
exhibited normal memory for the correct sentences, but
were severely impaired on recall of the anomalous
sentences. This suggests that their memory was heavily 
dependent on the presence of strong semantic cues, and
when these cues were absent, they could not consciously
reconstruct the sentences. A similar conclusion based on
different tests was reported by Nebes et. al., 1986.
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It appears that, in early dementia, there is a deficit in 
the effortful process by which people use stored knowledge
of semantic associations in memory and language. However,
automatic access to syntactic rules is not disturbed.
(4) Reading: The reading of high frequency words, which in 
adults is a highly over-learned activity, is intact in 
early stages of Alzheimer's Disease. Jorm (1986) cited 
work from Nelson and O'Connell (1978) which found that AD 
patients had normal reading competence for all materials
except for long or unfamiliar words (such as adventurously 
and chitterling). Jorm suggested that the observed deficit 
may be due to the a requirement to employ a controlled 
phonological recoding strategy on the longer words. In 
contrast, the majority of high frequency words are 
retrieved from memory automatically.
Two recent studies indicate that the ability of AD
patients to read a list of unrelated words is normal.
Using the National Adult Reading Test (NART: Nelson,1982), 
Kopelman and Corn (1988) and Sahakian et. al. (1989) found 
that their samples of AD patients did not differ from 
controls. The preservation is such that reading ability as 
measured by the NART (which also has been found to 
correlate with measures of general intelligence in normal 
subjects) is now commonly to estimate premorbid IQ in 
clinical samples. It should be mentioned, however, that 
there is very little published data on the performance of
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AD patients in reading long texts and prose that might
impose a greater load on limited cognitive resources.
Moscovitch et. al. (1986) found people with clinical
memory disorder to have normal prose reading times, but in 
that study there were only four subjects with probable AD.
(5) Naming: This ability is usually measured by asking
subjects to provide the common name of various objects or 
pictures. Flicker et. al. (1987) found object naming to be 
severely impaired in mild to moderate AD and Flicker
(1988) suggested that poor performance on this task is 
indicative of a semantic memory deficit. Jorm (1986) agued 
that, despite the generally poor naming ability in AD,
several studies indicate that this ability does have
aspects of both automatic and controlled processing, and
that the former is found to be less impaired in AD.
Specifically, the naming of objects with high frequency
names (such as body parts, which would be retrieved
automatically) is impaired to a lesser extent than the 
naming of rare objects.
(6) Learning: A deficit in learning is the major
characteristic of mild AD (Kopelman, 1985; Morris and
Kopelman, 1986). Indeed, it is difficult to find any
studies which do not report impairment in all tests of 
verbal and spatial short-term and long-term recall and 
recognition (see Flicker, 1988; Jorm, 1986; Kopelman and 
Corn, 1988; Sunderland et. al., 1987). In terms of the
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current theoretical position, however, it should be noted
that most conventional tests assess conscious, explicit
memory. Tests such as word and picture free recall do
require active cognitive resources and so impairment could
deficit in the ability to controlbe viewed as a
information processing.
Recent studies have examined procedural learning in AD. 
This is where patients are required to learn a motor skill 
(such as a novel pursuit-rotor task or mirror drawing), or 
are given verbal stimuli designed to 'prime' performance
on later tests, such as word stem completion. Normal
subjects show evidence of learning which is dissociated
from their conscious recollection of the elements of the
task (Schacter, 1987, 1990; Shimamura, 1986). In other
words, learning is largely automatic. A number of studies
have found procedural learning to be normal in Alzheimer's 
Disease. Miller (1975) and Morris et. al. (1983) (both 
cited in Morris and Kopelman, 1986) found word stem
completion to be normal in whereas consciousAD,
recognition was impaired.
More recently. Wens et. al. (1989) analysed the effects of 
priming in lexical decision in AD. In this task, subjects 
are required to decide whether a string of letters forms a
word, and their reaction time is assessed. Prior to the
exposure of the letter strings, subjects were provided 
with either a semantically related word, an unrelated word
35
or a non-word. Wens et al (1989) found that AD patients 
had normal priming effects in lexical decision when
compared to normal controls and the depressed elderly:
that is, they recognised words faster if these words were 
preceded by a semantically related word, and the size of
this advantage was normal.
In addition. Wens et. al. (1989) required subjects to 
decide whether a pseudoword was in fact a word (these are 
orthographically regular, pronounceable non-words). 
Interestingly, people with AD were severely impaired on 
this latter task. Wens et al (1989) suggested that to make 
a decision about a pseudoword, subjects are required to 
conduct conscious, effortful search of their lexicon.
Taken together, the dual observations of Wens et al (1989) 
suggest a disruption to controlled processing in AD, but
preservation of automatic functions. This conclusion has
also been drawn by Nebes et. al. (1986) using similar
tasks.
Important work on the issue of automatic processing in AD 
has been published by Butters et. al. (1990). They found
AD subjects to have normal procedural learning of 
visuomotor skills, but to have impaired verbal priming 
(and this was the converse pattern of impairment found in 
Huntington's Disease). Impaired verbal priming in AD has 
also been found by Salmon et. al. (1988) in a lexical 
decision task. It does seem therefore that automatic
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processing can be impaired in AD, though it is not yet
clear whether this is correlated with global measures of
dementia severity. The problem is complex, as has been 
recently demonstrated by Abbenhuis et. al. (1990), who 
found that AD patients did not differ from aged controls
in the extent of automatic priming, but that both groups
differed from young normal subjects.
In general, studies of learning ability in AD indicate
severe disruption to conscious, effortful functions, and 
relative preservation of learning which occurs without
conscious awareness.
1.6.2. Summary; Information processing in Alzheimer's
Disease: This brief review of research on six cognitive
skills supports the idea that there is a specific
depletion of cognitive resources. and thus effortful
processing, in Alzheimer's Disease. The issue could be
examined in more detail. For example, it is important to
consider selective attention, retrieval from semantic
memory and the ability to use conscious organisational 
strategies in people with AD (see Freed et. al., 1989; 
Hart et. al., 1988; Morris and Kopelman, 1986; Parasuraman 
and Nestor, 1986). These latter three aspects of cognition 
can all be interpreted within the automatic-controlled 
processing framework. The basic concepts are described, 
with relevant research in AD, in the introductions to the 
six experiments presented in this thesis.
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The final section of this literature review examines
evidence for the idea that the effects of scopolamine upon
human memory are limited to controlled processing, and
hence that the drug is an adequate model of impairment in
Alzheimer's Disease.
Does scopolamine primarily effect controlled1.7.
processing?
There is an abundance of published data on the effects of
scopolamine upon human cognition, and there have been many
comprehensive research reviews (Drachman and Sahakian,
1979; Kopelman, 1985; 1986a; 1975;Moss and Deutsch,
Sahakian, 1988; C. Smith, 1984; Warburton, 1987). There
have been several developments and revisions of theory to
account for the effects of this drug.
Deutsch's findings:
The earliest, and most specific, theory of the cognitive 
effects of scopolamine was proposed by Deutsch (1971). It 
was suggested that the cholinergic synapse was the "site 
of memory", and that the strength or permanence of memory
storage was a direct function of an increase in the
excitability of post-synaptic ACh receptors. According to 
Moss and Deutsch (1975), forgetting of new information 
occurs when ACh synaptic excitability decreases over time.
In a careful series of experiments in the late 1960s,
Deutsch and colleagues trained rats in Y-maze
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It was found that memory wasdiscrimination tasks.
disrupted by post-training scopolamine, and improved by
drugs(anticholinesterase 
physostigmine and diisopropyl flurophosphate (DFP)). The
cholinergic agonists
size of the impairment or improvement was found to be
dependent on the age of the memory. When rats were given
scopolamine at 1, 3, 7 and 14 days after training, the
largest disruptive effects of the drug were at 1 and 3
days. At later times, there was virtually no effect (Moss
and Deutsch, 1975).
The cholinergic agonists. on the other hand, were found to
improve memory very little in the first few days after
training, but significantly improved memory up to 28 days 
after training. In fact, physostigmine appeared to restore 
memories which had apparently been totally forgotten by 
control rats (Sahakian, 1988). The key observation in this 
work was that, when cholinergic activity is altered by 
drugs, the extent of change to memory depends upon the
strength of the trace. Increasing ACh synaptic activity
with physostigmine will have little effect if the memory 
is strong, but a large effect if the trace is weak. In the
converse case, reductions of ACh activity with scopolamine 
impair recent (strong) memories, but when the trace is
weak, there is no observable effect. In the latter case.
it is of course very difficult to measure impairment of 
memories which might be at or below the threshold at which 
they can influence behaviour.
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Despite the lead offered by Deutsch's experiments, it
appears that no studies have yet been conducted with
humans to examine whether "trace strength" is a factor in
predicting the magnitude of cholinergic or anticholinergic
drug effects (Sahakian, 1988). Some experiments have
measured the effects of scopolamine administered soon
after training (Ghoneim and Mewaldt, 1977; Petersen, 1977;
Safer and Allen, 1971), but none have repeated the drug 
dose at different points during normal 'forgetting". In
Petersen's (1977) study, recall was tested several times
after training, with final testing at 24 hours. No effect 
of post-training scopolamine was found on retrieval.
However, as C. Smith (1984) observed, the later test 
sessions were conducted well beyond the half-life of 
scopolamine, and so the drug could not have been exerting 
an effect on retrieval.
Drachman & Sahakian's and Warburton's findings:
With further research in the 1970s, it became apparent 
that Deutsch's model of the "cholinergic synapse" was not 
broad enough to account for other cognitive effects of 
cholinergic blockade. There was growing evidence from 
animal studies that the cholinergic system is important in
pre-acquisition processes such 
selective and sustained attention (Cheal, 1981; Warburton, 
1977) as well as learning.
the modulation of as
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argued that effects ofDrachman and Sahakian (1979) 
cholinergic blockade upon acquisition processes (such as
task-relevantthe ability to focus attention on
information) had to be distinguished from effects upon
consolidation and retrieval processes. They suggested.
however, that deficits in both processes could be due to
an effect of the drug on decreasing the signal to noise
ratio. If the noise was increased relative to the signal,
then the organism's ability to separate relevant from
irrelevant material in external sensory space, and their
ability to focus on relevant material stored in memory.
would be reduced. The end products would be both poorer 
acquisition and poorer retrieval.
Warburton (1977) proposed electrophysiologicalan
mechanism which enables the efficient selection of
information. He argued that activity in an ascending 
cholinergic pathway from the reticular formation to the
cortex may serve to modulate electrocortical arousal.
According to Warburton (1977), high levels of cortical 
arousal occlude sensory (or internal) stimuli, which masks 
small (peripheral or irrelevant) stimuli with cortical 
noise. The ascending cholinergic system "... makes the 
final selection of the inputs by masking the smaller ones 
and so determining the response emitted" (p 422). In this 
view, cholinergic blockade by scopolamine reduces the 
ability of the system to mask the less intense signals, 
and hence these irrelevant inputs become part of the
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stimulus subset controlling behaviour. In other words.
scopolamine reduces the organism's ability to discriminate
between signals, and hence reduces control over stimulus
selection.
In parallel with this work on the neuropharmacological
basis of attentional selection, psychological models of
the effects of scopolamine began to appear. Crow and
Grove-White (1973) examined serial position data in free 
recall, and found that scopolamine did not effect memory 
for very recent verbal material, but did impair recall of 
items from "secondary memory" (i.e. items from the 
beginning and middle of word lists). On the basis of this 
and other studies, Crow (1979) proposed that the primary 
effect of scopolamine upon learning was that it disrupted 
the transfer of information from short term memory to long
term memory.
Recently, Warburton (1987) proposed that there are two 
separate cholinergic systems: 
electrocortical arousal and stimulus selection, and
which controlsone
another which enables the transition of information from
immediate to long term memory. This idea in consistent
with obserevations that scopolamine impairs both attention 
and allows for the possibility that someand memory.
deficits in memory are attributable to failures in
attention, but also that learning can be impaired without 
apparent disruption to attention.
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In the late 1970s and early 1980s, research into the 
effects of scopolamine upon human cognition diversified. 
Different studies employed different measures of verbal 
learning and forgetting, and reports appeared showing
attention, semanticeffects upon vigilance, selective
and creative thinking, among othersmemory retrieval
(Caine et. al, 1981; Ghoneim and Mewaldt, 1977; Petersen,
1977; Warburton, 1979; Wesnes and Warbuton, 1984). More
recently, effects of scopolamine upon recall of remote
autobiographical information, procedural learning, working
language. andhallucinationsmemory. sensory
visuoperceptual function have been examined (Flicker et. 
al., 1990; Frith et. al., 1989; Kopelman and Corn, 1988;
Nissen et. al., 1987; Rusted and Warburton, 1988; Troster
et. al., 1989; Warburton et. al., 1985).
Although the recent studies of cholinergic blockade have
been conducted in parallel with developments in 
information processing theory, very few drug studies have 
adopted a particular cognitive model and tested effects 
within that model (Some recent exceptions are Rusted, 1988 
and Rusted and Warburton, 1988). The majority of studies 
have been more pragmatic. In general, they have selected a 
range of neuropsychological tests, and examined dose-
response effects, the comparative effects of various drugs 
or comparisons between the effects of scopolamine and 
clinical data from Alzheimer's Disease patients (c.f. 
Beatty et. al., 1986; Broks et. al., 1988; Meador et. al.,
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1988; Parrot, 1986; Parrot and Wesnes, 1988). No published
studies have specifically compared the effects of
scopolamine upon automatic and controlled cognitive
processes.
Despite this lack of systematic studies, there are
suggestions from a variety of sources that scopolamine
acts to reduce conscious control over cognitive processes, 
while automatic processing remains intact. Kopelman
(1986a) noted that the effects of this drug were largest 
when the cognitive tasks had high "processing load". 
Warburton and Wesnes (1984: cited in Warburton, 1986) 
proposed that the cholinergic system may provide the 
neurochemical basis for the cognitive resources that are 
required for mental effort (although Warburton, 1986, 
proposed a modification of that view, which will be 
discussed later in this thesis). Finally, Dunne and 
Hartley (1985) interpreted findings of scopolamine-induced 
disruption to recall, but no effect upon attention, as 
evidence that effortful processing is selectively 
disrupted, although Sahakian (1988) cautioned that the 
pattern of effects could simply arise due to differences 
in task sensitivity, which were not controlled.
The hypothesis that controlled processing is selectively 
vulnerable to the scopolamine would, if confirmed, have 
limited explanatory power. Other researchers have found it
difficult to distinguish the cognitive effects of
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scopolamine from other, chemically unrelated drugs (Frith 
et. al., 1984; Preston et. al., 1989) and the same 
hypothesis has been proposed to account for the cognitive
effects of the dopamine precursor levodopa (Newman et. al. 
(1984). However, as discussed previously, it might provide 
a useful theoretical approach to examine the "fit" of the
scopolamine model of Alzheimer's Dementia, given Jorm's
(1986) suggestion that controlled processes are primarily 
disrupted in early dementia. To make this comparison, six
areas of function will be briefly examined here, which
correspond to those described earlier with reference to
Alzheimer's Disease (see section 1.6.1. above).
(1) Verbal and Performance 10; In terms of WAIS IQ
profiles, scopolamine reduces scores on the performance
subtests, while the verbal subtests are not significantly 
affected (Drachman and Leavitt, 1974, Flicker et. al., 
1990). This pattern was demonstrated convincingly by Fuld 
(1984), and is directly comparable to data obtained from 
AD patients (see section 1.6.1. above). Fuld found that, 
of 19 young adults given 1.0 mg s.c. scopolamine, 10 (53%) 
had the following pattern: scores on information and
vocabulary were greater than those for similarities and
digit span, which in turn were greater than digit symbol, 
block design and object assembly. Of the control subjects, 
(18%) had this pattern. Clearly, scores on the 




As Sternberg (1984) and Jorm (1986) suggest, verbal
abilities highly automatized, whereas spatialare
reasoning and novel problem solving (which are tapped by 
WAIS performance subtests such as digit symbol and block 
design) require controlled processing. Hence, the drug may
act selectively upon controlled processes.
(2) Vocabulary: There have been few studies which directly 
evaluated the effects of scopolamine upon vocabulary. The 
only relevant data come from observations that performance 
on the Vocabulary subscale of the WAIS is unaffected by 
scopolamine (Flicker, 1988; Fuld, 1984).
(3) Syntactic and Semantic Knowledge: There appear to have 
been no studies which specifically examine drug effects 
upon the comparative preservation of syntactic and 
semantic knowledge. Effects of scopolamine upon verbal 
fluency, which tests retrieval from semantic memory, 
are unclear. Although at least 10 individual studies have
been reported, the results are very conflicting, with six 
reports that scopolamine does impair semantic 
retrieval, and four
memory
reports of no impairment, 
situation is examined in more detail in Chapter 4.
This
At present. existing data do not indicate whether
automatic or controlled aspects of retrieval from semantic 
memory are differentially affected by scopolamine.
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(4) Reading: Two experiments by Kopelman and Corn (1988) 
have found that the ability to read a list of words, from
the NART (Nelson, 1982), is not affected by scopolamine, 
which suggests preservation of this automatic function
under the drug. However, other measures of reading
performance, such as speed or reading under different
conditions of difficulty (e.g. reading physically 
transformed text compared to normal text) have not been 
examined in relation to scopolamine.
(5) Naming: As suggested by Jorm (1986), naming ability
may have elements of both automatic and controlled
processing. Flicker et. al. (1990) found that scopolamine 
had no effect upon object naming, when subjects were 
reguired to give the names of common objects presented on 
a video screen. Further, there was no effect upon a test 
where subjects selected the appropriate names of common
objects from four alternatives. It is likely that the
generation or matching of names to common objects is a 
highly overlearned and automatic process in adults. 
Unfortunately, experiments have examined namingno
performance in tests which might compare automatic versus
effortful search of the lexicon. This could be done by
examining naming ability for common versus rare objects or 
familiar versus unfamiliar public faces.
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(6) Learning:
The single most predictable effect of scopolamine is that
it impairs learning. The drug substantially reduces recall 
of both verbal and non-verbal information (Crow and Grove- 
White, 1973; Flicker et. al., 1990; Mohs and Davis, 1985;
al., 1988: 1989). Of course, learning is not aPreston et.
unitary phenomenon. It involves both active attention and
organisation and more passive, automatic processes. Hasher
and Zacks (1979) consider, for example, that item
attributes such as frequency and temporal and spatial
relations are encoded automatically, but the ability to
use these attributes to organise information during
acquisition and retrieval are conscious. effortful
processes (see also section 1.5. above).
If scopolamine selectively disrupts controlled processing
during learning, then it should be possible to show that
conscious, organisational processes in learning are 
impaired, while more automatic processes are intact.
Rusted and Warburton (1989) found that, when scopolamine- 
treated subjects were given eight trials to learn lists of
ten words, not one subject achieved this criterion. This
was poor in comparison to control subjects, who achievea 
after only four trials. On the face of it, 
scopolamine seems to impair acquisition, which may be due 
to poorer transfer of information from STM to LTM (c.f. 
Crow, 1979 ) .
100% recall
However, recognition testing up to one hour
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later failed to show any effect of scopolamine (see also 
Beatty et. al, 1986, and Dunne and Hartley, 1985). As
Rusted and Warburton pointed out, with additional trials.
scopolamine-treated subjects are able to learn the items 
but are still not able to actively recall them.
One essential difference between free recall and
recognition is that the former places demands on the 
subjects to consciously search their own memory, whereas 
the latter test provides cues which aid conscious 
recollection (Craik and McDowd, 1987). It is of interest 
that scopolamine impairs free, unprompted recall, but when 
subjects are given semantic or acoustic cues to aid 
recall, then the drug effect disappears or is 
substantially reduced (Caine et. al., 1981, Frith et. al., 
1984; but see Kopelman and Corn, 1988). It may be that, 
under scopolamine, information does reach longer term 
storage, but subjects are less able to use knowledge of 
item attributes to efficiently organise their encoding and 
retrieval, and thus have poorer recall.
Molchan et. al. (1990) reported some interesting results 
with scopolamine and recognition memory. In their task, 
subjects were given a list of 12 words, half of which were 
repeated during presentation. In the recognition test, 
subjects had to recognise old words from an aurally 
presented list of 24 items (12 old, 12 new) and make a 
judgement on the number of times recognised words had been
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presented. Scopolamine did not impair recognition of words 
that had been presented twice, but did impair recognition
of words presented once only. This may indicate a
selective drug effect on words with "weak memory traces". 
Another interpretation may be that recognition of twice
presented words was more automatic (due to a word
frequency effect) and hence less vulnerable to the drug.
The issue of a drug effect on automatic processing is
clouded, however, since Molchan et. al. (1990) also found 
that judgements of relative frequency were impaired by 
scopolamine, which on Hasher and Zacks' (1979) criteria 
would indicate an impairment to automatic processing. This 
may be similar to the observation by Richardson et. al. 
(1984) that scopolamine impaired subjects' ability to 
judge the relative recency of verbal material. If recency 
information is automatically encoded (Hasher and Zacks, 
1979), then again scopolamine may impair this process.
Another perspective on this issue comes from studies of
non-conscious, procedural learning. Nissen et. al. (1987) 
and Kopelman and Corn (1988) have found that performance 
in semantic priming tasks, where prior presentations of
stimuli bias performance on later tests without conscious
awareness, is not affected by scopolamine. This contrasts, 
however, with the observation that scopolamine impairs 
non-conscious learning of a visuo-motor tracking task 
(Frith et. al., 1989).
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Overall, it can be confidently stated that the primary 
effect of scopolamine upon learning is to impair the
conscious recall of new information. The amnestic effect
is sometimes attenuated when subjects are given cues to 
aid retrieval. Scopolamine may impair judgements which are
thought to utilise automatically encoded information, 
although the limited data non-conscious learningon
suggest that scopolamine may have little effect, at least
in verbal tasks.
Other cognitive functions:
A number of important studies of the effects of
scopolamine upon vigilance, selective attention, semantic
memory and learning have not been reviewed here. These
works are described in the introductions to the six
experiments.
1.8. Status of the "Scopolamine model" of Alzheimer's
Dementia:
It is clear that there are many similarities between 
cognitive decline in AD and the effects of scopolamine 
administration to young healthy people. The predominant 
failure in both states appears to be in controlled, 
conscious information processing, while (in general) 
automatic processes are least affected. This similarity is 
most noticeable in studies of learning and general 
intellectual function.
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However, there are limitations to this argument. Despite
the wealth of data on scopolamine's effects, much of it
does not fit neatly into this automaticity continuum.
Existing studies which examine the strengths and
weaknesses of the scopolamine model of AD concentrate most
heavily on conscious cognitive processes (c.f. Beatty et.
al., 1986; Broks et. al., 1988; Kopelman, 1986; Preston
et. al., 1989), and there is relatively little information
on procedural learning, reading, vocabulary and other 
cognitive functions which primarily involve automatic
processing. Hence, this literature review may offer
support for the central hypothesis only because there is
systematic
research into the relative vulnerability to scopolamine of 
controlled and automatic processing is necessary.
insufficient contrary evidence. Clearly,
The next chapter describes three areas in which there is 
significant "missing data" and briefly introduces the aims 
of the six experiments reported in this thesis.
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CHAPTER TWO
2.1 Background to the six experiments reported in this
thesis
The preceding literature review found that the scopolamine
model of Alzheimer's Dementia is supported by some recent
data. If cognitive impairment is interpreted in terms of
automaticity theory, it appears that controlled processes 
are selectively disrupted by both AD and scopolamine.
However, this conclusion is tentative. It is based on
retrospective review, where different experiments were
grouped in terms of the presumed demands the various tasks 
place on controlled processing. As well, studies with
scopolamine have been somewhat limited. There are some
areas of cognitive function which are important to the
controlled processing hypothesis, but which have not been
examined in any depth.
The most popular approach in studies of scopolamine is to 
examine effects upon a broad range of generally brief 
standardised tests (c.f. Broks et. al., 1988; Flicker et. 
al., 1990; Parrott and Wesnes, 1987; Preston et. al.,
1988; 1989). There are obvious practical reasons for doing 
so, and the resultant data often are directly comparable 
to clinical work with AD. The general consensus from this 
approach is that the effects of scopolamine offer only a 
limited model of AD (Flicker et. al., 1990).
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However, as Spreen and Tuokko (1982) pointed out, this 
approach does have its limitations. It is very difficult
to interpret results from test batteries within theories
from cognitive psychology. Most measures of attention,
recent memory, semantic memory retrieval, problem solving 
and so on yield very few data points per subject per test.
As such, it is difficult to draw any firm conclusions
about the more strategic, elaborate cognitive processes
involved. These are the first to be impaired by AD (Jorm, 
1986) and it is on these processes that scopolamine might
accurately mimic dementia.
Better resolution on the adequacy of the scopolamine model
may be obtained from experiments which focus in depth on
specific cognitive functions, and then require drug-
treated subjects to complete tasks over long periods and
under different levels of difficulty.
This approach is adopted here. In Part I (chapter 3), two
of scopolamine uponexperiments examined the effects
selective attention, when subjects were tested over
approximately half an hour per session. The design
assessed drug effects upon the detection of targets in 
specific spatial locations, and also upon detection of 
targets within a broader perceptual field. This approach
enables a distinction between two varieties of attention:
vigilance and selective focussing. In addition, it was
intended to show, at a fine level of analysis, that
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scopolamine impairs the efficient allocation of (limited) 
attentional resources to particular spatial locations.
There have been numerous studies of scopolamine and visual
attention (Broks et. al., 1988; Callaway et al, 1985;
Wesnes and Warburton, 1983; 1984; Wesnes and Revell,
1984), but none have specifically examined whether the
effects of this drug upon target detection are uniform
throughout the broader perceptual area.
In Part II (chapter 4), two experiments examined the
effects of scopolamine upon knowledge retrieval. The tasks
used were novel in two ways. First, no previous studies
have examined verbal fluency (retrieval from verbal 
semantic memory) over relatively long periods. In addition
to data on the product of sustained retrieval from natural
semantic categories, information was gathered on several
subtle aspects of conscious memory search, such as the
ability to generate retrieval cues, the number of items
retrieved per cue and the repetition of items and
retrieval cues. In addition, sustained word retrieval was
assessed under two conditions of difficulty.
Second, no previous studies have looked at the effects of
scopolamine upon non-verbal semantic memory. In experiment 
four, a task was devised to assess the efficiency of 
access to non-verbal knowledge. In this latter task, 
subjects were required to retrieve stored knowledge of 
arithmetic operations while solving number series problems
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that varied in difficulty.
If scopolamine impairs efficiency of access to semantic
memory, it was expected that these experiments would
identify effects of the drug upon the active, effortful
operations during retrieval, and hence reveal any subtle 
mechanisms by which the drug impairs retrieval. It might
also show that the more automatic elements of semantic
memory retrieval are intact.
In Part III (chapters 5 and 6), two experiments examined 
scopolamine's effects upon learning. Tasks were developed 
to assess several types of cognitive operations which vary
in terms of the "load" on cognitive resources. In
experiment five, the tests measured semantic priming, 
recognition, recall and the ability to actively cluster
recalled items on the basis of modality of input. In 
experiment six, the ability to consciously organise 
material (by input modality) during learning was examined 
under two levels of task difficulty. The primary aim was 
to show that scopolamine selectively impairs the more 
effortful processes in verbal learning, while automatic 
functions remain intact. Further, it was thought that a 
deficit in conscious organisation might help explain a 
general recall impairment.
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2.2. Organisation of chapters 3, 4, 5, 6 and 7.
Chapters three to six begin with a brief description of
relevant research. This literature has not been discussed
in detail in chapter 1, and individual studies are
reviewed only if they have direct relevance to the
particular experiment, rather than because of general
theoretical relevance. Following this, some background on
tasks is given to illustrate how the measures can be
interpreted in terms of automaticity theory. Then,
specific predictions regarding drug effects are presented. 
Results are presented and then each experiment is 
discussed in turn. There is a general discussion and
integration of the results in Chapter Seven.
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CHAPTER THREE
Does Scopolamine impair control of attention?
3.1. INTRODUCTION: The initial aim of this series of
experiments was to test the idea that cholinergic activity
modulates the efficiency of attentional control in humans.
This extends from an earlier study (Dunne and Hartley, 
1985), which used a dichotic listening task and found that, 
given 0.6mg oral scopolamine, normal young subjects had an
impaired ability to recall words presented to an "attended"
ear, while recall of unattended words increased. It was
argued that cholinergic blockade reduced the degree of
control subjects had over the selection of information for
further cognitive processing.
This idea is similar to Warburton's (1977) view that 
that a brain cholinergic system mediates the selection of 
relevant stimuli from a background of impinging (but 
otherwise task irrelevant) stimuli. Cheal (1981) reached a 
slightly different conclusion, where disruption was thought 
to be, not in the ability of an organism to select task 
relevant stimuli in the short term, but on it's ability to 
maintain attentional focus on these stimuli when the task
"...requires more than a minimal amount of time and effort"
(P181). Whether the locus of the deficit is with selection
per se, or with the maintenance of selection, is difficult 
to determine, since either interpretation would depend upon 
the length of time over which the behaviour was observed.
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What does seem important though, is that data from these
animal studies indicated an effect of cholinergic blockade
on tasks that require active attention, but not when they 
require simple reflexive orientation.
A series of human studies by Wesnes and colleagues (Wesnes
and Warburton, 1983a, 1984; Wesnes and Revell, 1984)
demonstrated that scopolamine impairs vigilance, which they
interpreted as a decline in stimulus sensitivity. In those
experiments, subjects were required to detect sequences of
3 consecutive odd or even digits at a rate of 100 per
minute for long periods (20 to 60 minutes). Absolute 
detection performance declined significantly after the 
drug, and as a function of dose. It is not clear from these
data, however, whether deficits in performance resulted
from changes in the psychophysical threshold for detection.
or because of impaired focussing of attention, since 
subjects had to attend to only one source of information. 
The study by Dunne and Hartley (1985) favours the latter 
view, since sensitivity did not decline overall, but 
stimuli were captured from a broader perceptual "area".
It is possible that deficits in memory so frequently found 
after cholinergic blockade are mediated by a deficit in 
selective attention, in that subjects have a reduced 
ability to efficiently focus on the task or list materials, 
rather than increased forgetting. Kopelman (1986) has 
argued against this view, citing several studies which have
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doses which do not impairfound memory deficits at
attention and vigilance performance. His essential point is
that attentional dysfunction cannot. on it's own, be
invoked as a reasonable explanation for the diverse pattern
of amnestic effects of scopolamine.
In a recent analysis of the effects of scopolamine upon
several varieties of attention. Broks et. al. (1988) found
impairment in sustained attention, but no drug effect on
selective attention. For the latter measure, they used a
task in which subjects were required to name an orange
alphabetical letter superimposed on a green one, and
measured reaction time (RT) following Omg, 0.3mg, 0.6mg and 
1.2mg doses. Scopolamine had no effect on RT, and it was 
concluded that the drug did not impair subjects' ability to
ignore the distractor letter. Broks et. al. (1988) noted
that the lack of a drug effect on selective attention was
inconsistent with the data of Dunne and Hartley (1985), but 
suggested that the disparity may have arisen because of 
differences in the memory demands of the tasks used in the 
two studies. Kopelman (1986) also made the point that the 
dichotic listening task may have been sensitive to drug 
effects because of it's high processing "load". Taken 
together, these analyses point to the need to examine the 
effects of scopolamine on tasks that are more specifically 
designed to assess variation in the allocation of cognitive
resources.
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The most innovative aspect of the previous dichotic
listening study was to measure attention to stimuli that.
according to task demands, were not the primary focus of
attention. This phenomenon was investigated in the
following two experiments, using a visual target detection
task where subjects were required to focus their attention
on spatial locations that varied in terms of the
probability with which a target would appear, with the main
interest being in the subjects' ability to use this
probability bias to guide their search.
3.1.1. Background to the task, experiments one and two
The task adopted here previously has been used both for
studies of cognition in the elderly and theoretical
purposes. A number of alphabetical letters are presented in 
a circular arrangement on a video screen, and the subject 
is required to detect specified target letters on each 
trial. Across trials, the probability of target letter
appearance is biased to several spatial locations, and
measures are taken of the speed and probability of target 
detection at each spatial location.
Rabbitt and Vyas (unpublished, cited in Rabbitt, 1979) used 
a version of this task to test the hypothesis that elderly 
subjects differ from younger controls in the extent to 
which they could use knowledge of relative event 
probabilities in focussing their attention to spatial 
locations. Both young and old subjects recognised and
61
remembered the biases in the display with equal
proficiency, but the young subjects were faster at
detecting letters in high rather than low probability
locations (presumably, according to Rabbitt, because they 
used the knowledge of relative event frequencies to guide
the order in which they scanned the display), while elderly
subjects detected targets no more rapidly at frequent
rather than rare locations. Rabbitt (1979) suggested that 
this reflected an age-related change in the efficiency of
memory-driven (i.e. controlled) selective attention. 
Sanford (1978) reviewed his own series of studies, and
similarly concluded that the elderly are less influenced by
event probabilities than the young.
3.1.2. Selective attention in Alzheimer^ Disease
As was discussed in chapter one, a primary consideration of 
this thesis was to compare the effects of scopolamine with
the deficits observed in Alzheimer's Disease. There is a
considerable body of evidence to show that selective and
sustained attention (vigilance) are significantly impaired 
in AD (Freed et. al., 1990; Grady et. al., 1989; Mohr et. 
al., 1990; Parasuraman and Nestor, 1986). While there have 
been no reports demonstrating impairment in visual 
selective attention using the task devised by Rabbitt 
(1979), there is little doubt that total target detection 
would be lower than controls. In addition, given a poor 
ability to focus attention on high probability locations, 
it is probable that AD patients would respond in a more
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random way, with target detection in both low and high
probability locations being equivalent.
3.1.3. Theoretical studies of selective attention and
visual search: There has been a considerable amount of
research into the cognitive processes that are responsible
for efficient visual search. The principle phenomenon of
interest here is the ability of humans (and primates) to 
shift attention to positions in visual space without any 
overt shift in gaze (Bashinski and Bacharach, 1980; Posner, 
1980; Posner and Presti, 1987). This ability to shift 
attention has been termed, in resource theory notions, the 
"...internal allocation of processing resources from one 
location in the visual field to another" (Jonides, 1983, 
p247). Some studies have attempted to mathematically model 
the optimal allocation of resources (as indexed by 
detection of targets) as a function of the validity of cues 
that direct attention to locations (Erikson and Yeh, 1985) 
or the target location probability biases which a person 
uses to focus attention on particular parts of the visual
field (Shaw, 1978). Shaw (1978, Shaw and Shaw, 1977) varied
the probability of target occurrence in locations in a
circular display, and found more accurate and faster target 
detection in high probability locations. She argued that 
this is an adaptive process that enables an organism to 
search a visual field with optimal efficiency and minimal
resource costs.
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With these characteristics, the visual search task provides
a potentially useful method of assessing the effects of
scopolamine upon the allocation of cognitive resources. If
it is assumed, following Shaw (1978), that practiced
subjects allocate resources in an optimal manner, then we
can examine the vulnerability of this cognitive control 
process to an anticholinergic drug, and most importantly.
measure the cost of suboptimal attentional control (which
should be evident in the change in detection rates and
times for targets in high and low probability locations). 
If subjects have an impaired ability to allocate 
attentional resources following drug administration, then 
detection in low probability locations should more closely 
approximate that found for targets in high probability
locations. Following placebo, of course, the detection
performance for targets in high and low probability 
locations should be more clearly separable. This hypothesis
was tested in experiment one.
A secondary hypothesis was also examined. On the basis of 
the studies by Wesnes and Warburton (1983, 1984), where it 
is thought that scopolamine reduces overall stimulus
sensitivity, it would be predicted that detection 
probability and speed would be reduced for targets in both 
high and low probability spatial locations. However, the 
present proposal that the drug impairs the ability to focus 
attention would predict no change in overall sensitivity, 
but an interaction between drug and target location
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This would be analogous to the drug by ear ofprobability.
attention interaction found in the earlier dichotic
listening experiment by Dunne and Hartley (1985).
3.2. Experiment Ones Pilot study method
3.2.1. Subjects: 10 volunteer female subjects (age range
20-41 years, mean 28.2 years) took part in this phase of
the study.
3.2.2. Apparatus and Test Design; A CBM 64k computer was
programmed to present 12 alphabetical letters (height 
0.5cm) in an 8.5cm diameter circular display on a high
resolution green monitor. For the purposes of target letter
presentation, the 12 locations in the circle were divided
into four quadrants viz., upper and lower left, upper and 
lower right. The task used the 21 English consonants, of 
which 4 were designated as target letters (either BLKY or 
ZRNT). Figure 3.1 below illustrates an example of the 
display, with target letters highlighted.
Subjects sat approximately 50cm from the screen, in an
enclosed cubicle to screen them from extraneous noise and
visual input. In each trial, either none, one, two or three
target letters were presented for 250 milliseconds. The
target location probability bias in the display was
structured so that, on any trial, there was a 50% chance
that one or more targets appeared in predesignated high 
probability quadrants, a 25% chance that one or more
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targets appeared in the low probability quadrants, and a
25% chance that no target letters would appear. Subjects
required to register their detection of at least onewere
target letter by pressing one of two microswitches to
signal Throughout the experiment, the"YES" "NO" .or
sequence of trial types was randomly determined.
Figure 3.1s The visual display in experiment one
J
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note: the words 'high' and 
the testing
'low' were not presented during
3.2.3. Procedure; At the beginning of their session.
subjects were told the nature of the task and the position 
of the high probability locations. They were informed that 
targets "were more likely to appear" in these areas. They 
♦ practised the task for 10 minutes, and after a 2 minute
break, were required to complete 400 trials, with rest
* periods after every 100 trials. The duration of the rest
period was determined by the subjects, and this averaged 30
seconds. The entire test session took an average of 36
'* minutes to complete (range 33-43 minutes) .
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3.3. RESULTS: Experiment One Pilot
Mean detection rates (probability of a hit) and reaction 
times are shown in Table 3.1. A two (location probability) 
by three (number of target letters) repeated measures 
Analysis of Variance revealed significant main effects of
target location probability (F = 17.69; df=l,9; p<.005) and 
Number of Stimuli (F=18.08; df=2,18; pc.OOl), while the
interaction between these two variables was not significant
(F=1.72; df=2,18; ns).
A similar ANOVA on the reaction time data found significant
main effects of location probability (F=13.75; df=l,9;
p<.005) and Number of Stimuli (F=14.81; df=2,18; pc.OOl),
and no interaction between the two (F=1.35; df=2,18; ns).
Table 3.1: Mean detection rates and Reaction Times (in 
milliseconds), experiment one pilot.
High Probability Low Probability
N. stimuli 1 2 3 2 31
Mean p(hit) 
s .d.




819 743 696Mean R.T. 
s .d.
920 884 848
112 117 84 211 209 177
These pretest data suggest that subjects were able to focus 
their attention on the high probability sources of 
information, which is reflected in the increased speed and
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higher rates of detection of target letters in high 
probability locations.
3.4. METHOD: Experiment One
3.4.1. Subjects: 16 subjects (8 male, 8 female; age range
mean 25.6 years) participated 
experiment. All were initially screened for any medical 
contraindications of the drug, and gave informed voluntary
19-36 years. in this
consent. None of the subjects had used scopolamine for at
least one month prior to testing and none had taken part in
the pretest phase of the study.
3.4.2. Scopolamine tablets; Doses of 0.6mg oral Scopolamine 
Hydrobromide (0.3mg tablets x 2) or physically matched 
placebos (2) were administered in a double blind, repeated 
measures design.
3.4.3. Apparatus and Test Design: As in section 3.1.2.
3.4.4. Procedure; Subjects were requested not to eat, or 
drink tea, coffee or other caffeine containing products for
at least two hours prior to each test session. After
entering the laboratory, they were told the nature of the 
task and the positions of the high probability locations. 
In the first session, half of the subjects were given upper 
left, lower right quadrants as their high probability 
locations, with the opposite configuration for the other 8
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subjects, and this order was reversed in the second test
session. The assignment of target letter sets (BLKY or 
ZRNT) were similarly balanced within groups.
Subjects were practised on the task for 10 minutes, and
were then given the tablets, and asked to return to the
laboratory 50 minutes later. They were then required to
complete 400 trials, with rest intervals after every 100,
and on average this session took 34.5 minutes to complete 
(range 31-42 minutes). The two testing sessions for each 
subject took place approximately one week apart, care was 
taken to arrange each individual's sessions two sessions at
the same time of day, and all testing took place between
12-5pm.
3.5 RESULTS
Mean detection rates (p hit) and reaction times are shown 
in Table 3.2. In relation to hit probability, a 2(Drug) by 
2(location probability) by 3(Number of Stimuli) repeated 
measures ANOVA found significant main effects of location
probability (F=114.62; df=l,15; p<.001) and Number of 
Stimuli (F=64.49; df=2,30; p<.001), and no main effect 
Scopolamine The predicted Drug by Location(F<1).
probability interaction failed to reach significance, 
although a trend is apparent (F=3.45; df=l,15; .05<p<.10). 
Figure 3.2 illustrates this trend for an interaction.
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Table 3.2: Mean hit rates and reaction times (in 
milliseconds), experiment one.
High Probability- Low Probability
N. Stimuli 2 3 2 31 1
Scopolamine 0.6mg)
Mean p(hit) .68 
s .d.
.77 .81 .58 .65 .71
.18 .13 .13 .16 .13.15
813 773 727Mean R.T. 
s .d.
930 871 834




.70 .78 .86 .58 .64 .71
.14 .13 .09 .14 .14.15
805 763Mean R.T. 
s .d.
709 947 861 821
102 110111 162 127 136
The mean RTs are illustrated in Figure 3.3. A similar 2x2x3
ANOVA found significant main effects of Location
probability (F=50.13; df=l,15; pc.OOl) and Number of 
Stimuli (F=100.19, df=2,30; p<.001), and no main effect of 
Scopolamine (F<1). However, the RT data offer no evidence 
for an interaction between Drug and Location probability 
(F<1). No other interactions in the p(hit) and RT data 
approached statistical significance.
Figure 3.2: Target hit rates 
experiment one 70
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3.6. DISCUSSION
Despite the fact that the predictions were not supported by
the data, several aspects of the results warrant
discussion. The absence of a drug main effect runs counter
the view, based on earlier data by Wesnes and Warburtonto
(1983a,1984) that Scopolamine reduces stimulus sensitivity. 
While a different task was used here, and the drug dose was
lower, it is interesting that the only effect of the drug
which approached significance was the interaction with
target location probability, while any suggestion of a 
generalised reduction in stimulus sensitivity is absent.
By collapsing across the N. Stim variable, and obtaining 
overall hit rates for high and low probability locations in 
this experiment, we find that, in the drug condition, 
detection of targets in high probability locations declined 
by 2.67% relative to placebo, while detection in low 
probability locations increased by 0.6%.
Of course, these differences between drug and placebo are 
very slight, and may well be spurious. It is possible, 
however, that some changes to the task and experimental 
method could produce statistically significant effects. The 
following modifications were incorporated into the second
experiment;
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Changes to the method: While between subjects1)
variability is not a problem in repeated measures designs.
both the hit rate and RT data in experiment one show
considerable within subjects variability, which may be due
to day to day fluctuations in subjects' efficiency in
performing the task. This within subjects variability can
be examined by obtaining correlations between detection















While four of these correlations are statistically
significant, they are not particularly strong. It appears 
that there is considerable variability in subjects' 
performance across the two testing sessions. It is possible 
that any absolute changes in performance following the drug
may remain undetected because of high overall error
variance. One way of reducing the effects of within
subjects variability is to establish daily baseline 
performance levels, and measure drug effects in terms of 
deviations from these baselines (see Wesnes and Warburton,
1983b).
A further change to the method was introduced by increasing 
the dose of Scopolamine from 0.6mg to 0.9mg, with the
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expectation that any effects of the drug upon attentional
control or stimulus sensitivity will be correspondingly
magnified. Studies by Wesnes and Warburton (1983a,1984) 
have shown that hit rates in single source vigilance tasks
decline as a function of drug dose in the range 0.6 to
1.2mg. In addition, subjects were selected for experiment 2
only if they were non-smokers, since several studies
indicate that nicotine has a direct effect on attention and
vigilance (Hartley, 1973, Wesnes and Revell, 1984) and 
other cognitive tasks (Dunne et. al., 1986), and it would 
not be practical to regulate or control for nicotine intake
prior to or during the experimental sessions and waiting
periods.
2) Changes to the task: Three aspects of the stimulus
presentation were changed in the second study. An attempt 
was made to enhance the separation of high and low 
probability target locations by reducing the number of 
letters in the display from twelve to eight, with clearly 
distinguishable gaps separating the quadrants. The problem 
of near ceiling detection rates (i.e. greater than 90%) was 
addressed by reducing the exposure duration from 250 to 150 
milliseconds, and by eliminating trials with three target 
stimuli. A further change to the procedure was to increase 
the pre-drug practice time from ten to fifteen minutes.
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3.7. Experiment twos Method
3.7.1. Subjects: Twelve female undergraduate non-smokers
(age range 19-40 years; mean 27 years) took part in this 
study with informed voluntary consent.
3.7.2. Scopolamine Tablets: Doses of 0.9 mg scopolamine
hydrobromide (0.3 mg tablets x 3) or physically matched 
placebos (3) were administered in a double blind, repeated
measures design.
3.7.3. Apparatus and Test Design: Two versions of the
test were constructed, one for each testing session. A CBM
64K computer was programmed to present 8 alphabetical
letters (height 0.5 cm) in an 8.5 cm diameter circular
display on a high resolution green monitor. The eight
locations in the circle were divided into four clearly
distinguishable quadrants - upper and lower left, upper and 
lower right (see Figure 3.4. below).
English consonants, of which 4 were designated as target
The task used the 21
letters in any one session. Two sets of targets were used
(BLKY and ZRNT), one for each session, in order to limit 
any practice effects over the study.
Three types of trials were arranged for presentation. 
First, either one or two target letters occurred with a 
probability of 0.5 in predesignated (high probability) 
diagonally opposite quadrants. Second, either one or two 
target letters appeared in the remaining two quadrants with
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a probability of 0.25. The remaining 25% of trials
In successive trials, thecontained no target letters.
sequence of trial type and the selection of target and non­
target letters were arranged randomly.
Figure 3.4s Visual display in experiment two (with example 






Subjects were seated approximately 50 cm from the screen.
On each trial, subjects were required to fixate on a + sign
which was presented in the middle of the screen for one
Immediately following this, the circular display 
was presented for 150 msecs.
second.
Subjects then responded by
pressing either of two microswitches marked 'Yes' or 'No'
to signify whether they detected a target in the display. 
Once this response was registered, the next trial began.
3.7.4. Procedure: Subjects were requested not to eat, or 
drink tea, coffee or other caffeine-containing products for
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two hours prior to testing, 
subjects were told the nature of the task and the position
Upon entering the laboratory.
of the high probability locations. They then practiced the
task for 15 minutes. After 10 minutes rest, they completed
160 trials to establish their daily baseline performance
(which took an average of 14.6 minutes, range 13.2 to 15.6
min). Subjects were then given the tablets and swallowed
Exactly 50 minutes later, they returnedthem with water.
and began the testing session, which consisted of 320
trials and took an average of 28.7 minutes (range 25.7 to 
36.0 min). The two testing sessions for each subject took 
place approximately two weeks apart.
The order of testing was internally balanced so that
subjects were equally likely to receive drug or placebo on
the first or second session, and either of the two subsets
of target letters in each session. Target letters and the 
location of high probability areas were consistent across 
practice, baseline and testing phases in each session.
3.8. Results
3.8.1. Pre-drug Baseline: Mean detection rates
(probability of a hit) 
performance in each test session are shown in Table 3.3
and reaction times for baseline
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Table 3.3s Mean p(hit) and Reaction Times in baseline target 
detection, experiment two
Test session 1 Test session 2
High Prob. Low Prob. High Prob. Low Prob.
N. Stim. 1 2 21 1 2 1 2
P(hit)
s .d.
.683 .853 .400 .614





616 568 787 791 







A 2 x 2 x 2 Analysis of Variance of baseline performance 
(session sequence x location probability x number of 
stimuli) revealed that subjects detected significantly 
more targets in high probability than low probability 
locations (F (1,11) = 24.68, p< .001), and that detection 
was significantly higher when two rather than one stimuli
were presented (F (1,11) = 61.16, p < .001). There was
no main effect of session sequence (F < 1) which, in
reference to Table 3.3., indicates that the additional
practice and task familiarity at session two did not 
significantly influence performance.
With regard to Reaction Time, a similar 2x2x2 ANOVA
revealed that correct detections were faster in high
probability than low probability locations (F (1,11) = 
13.82, p<.01), and RT was faster when two stimuli were 
presented rather than one (F(l,ll) =6.38, p < .05).
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There was, again, no main effect of session sequence (F <
!)• No interactions in baseline hit rate and RT
approached significance.
The above analyses suggest that the task is a sensitive
measure of attentional processing capacity allocation (as
described by Shaw, 1978) since detection in high
probability locations was higher and faster than in low
probability locations.
3.8.2. Analysis of the drug effects
Mean target detection performance and Reaction times are
shown in Table 3.4. These were converted to deviation
from baseline (difference) scores, which are shown in
Table 3.5.
A2x2x2x2 ANOVA (Drug x location probability x number 
of stimuli x time) showed a significant interaction between 
drug state and location probability (F (1,11) =10.88, p < 
.01) which, in reference to Figure 3.5., indicates that 
scopolamine increased detection of targets in low 
probability locations, while detection in high probability 
locations decreased. The opposite trend is apparent in the 
placebo condition. Since no significant effects of the N. 
Stim variable were found, it has been removed in order to
simplify the graph.
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Table 3.4: Mean Hit Rates and Reaction Times, experiment two 
(raw data)
High Probability Low Probability
S Baseline 1st Half 2nd Half Baseline 1st Half 2nd Half
1 2 2 21 1 1 2 1 2 21
Drug Condition
P(H) .68 .87 .66 .83 .65 .85 .40 .59 .55 .64 .55 .68
s.d. .15 .10 .20 .10 .19 .09 .21 .22 .21 .23 .19 .19
RT 657 589 679 609 671 615 782 760 786 719 780 729
s.d. 143 100 179 136 153 176 304 245 227 186 303 173
Placebo condition
P(H) .64 .84 .64 .81 .67 .88 .43 .63 .41 .60 .44 .58
s.d. .14 .08 .11 .12 .13 .07 .20 .25 .30 .25 .25 .27
RT 654 575 682 632 632 595 803 794 735 659 650 693
s.d. 153 135 232 251 141 187 283 301 208 229 191 236
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Table 3.4s Mean difference from baseline: p(hit) and
experiment two
RT,
High Probability- Low Probability
N Stim. 1 Stim. 2 Stim. 1 Stim. 2 Stim.
Time T2T1 T1 T2 T2 T2T1 T1
Placebo condition
p(hit) +.01 +.03 -.04 +.04 -.02 + .01 -.03 -.04
s .d. .11 .13 .10 .09 .17 .19 .20 .22
RT(ms) +27 +11 +57 +20 -67 -153 -135 -100
s.d. 184 123 177 156 227 290 281 191
Scopolamine 0.9mg condition
p(hit) -.02 -.03 -.04 -.01 +.15 + .15 + .04 + .09
s.d. .08 .12 .07 .04 .08.11 .11 .10
RT(ms) +22 +15 +21 +34 +4 +3 -41 -33
s .d. 95 147 126 161 260 416 152 236
Figure 3.5: Deviation from baseline 
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There was also a significant main effect of scopolamine (F 
= 5.52, p < .05) which, in reference to Table 3.4.,(1/11)
indicates that hit rate increased under the drug in
absolute terms. This effect is mainly attributable to a
post-baseline increase in the detection of targets in low
probability locations, which increased by 11% compared to a
decline of only 3% for detection in high probability
locations. No main or interactive effects involving the
time variable were significant.
A similar ANOVA on difference from baseline RT failed.
however, to demonstrate any drug main or interactive
effects. The only significant effect was for location
probability (F (1,11) = 7.97, p < .05) which, in reference 
to Table 3.4., indicates that post-baseline RT decreased 
for detection in low probability spatial locations, while 
high probability location detection RT increased.
3.9. Discussion
The results of experiment two support the prediction that
scopolamine would facilitate target detection in low
probability spatial locations, while impairing detection in 
high probability locations. If Shaw and Shaw (1977) are 
correct in their assertion that the probability of a
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correct detection at a given spatial location depends upon
the allocation of attentional processing capacity to that
location, then the present data suggest that scopolamine
acts to impair the optimal allocation of attentional
capacity.
While the studies by Wesnes and Warburton (1983a; 1984) 
suggest that scopolamine produces overall declines in
stimulus sensitivity, it is possible that their drug effect 
reflects the same phenomenon, since Parasuraman (1984) has 
argued that sensitivity decrements in vigilance tasks occur 
because subjects have an impaired ability to utilise short 
term memory processing resources in the control of 
attention. One interpretation of the present results is 
that scopolamine exerts its effect upon subjects ability to 
utilise knowledge of relative frequency (i.e., the 
probability bias in the display) in allocating attentional
resources.
It is of interest that detection of targets did not vary as 
a function of time on task. If, following Cheal (1981), the 
drug impairs the ability to maintain focus over long 
periods rather than influence the ability to selectively 
attend per se, then it would have been expected that the 
drug's effect would be greater in the second half of the 
test session. However, it is difficult to use the present 
results to disconfirm Cheal's position, since her data were
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derived from scopolamine-treated gerbils who participated
in testing over relatively longer periods.
One apparent anomaly in the results was the finding of an
overall increase in detection under scopolamine. Figure 1
reveals that the largest post-baseline increase is in low
locationprobability detection under the drug,
(approximately 11%) while high probability location 
detection declined only 3%. It may be that, even though
scopolamine reduced subjects' control over the allocation
of attentional capacity and subsequently increased
detection of low probability location stimuli, there were
still sufficient resources available to enable detection of
stimuli in high probability locations at a near optimum
level.
It is important to consider that. in any study of the
effects of scopolamine upon attention, the performance
changes may be to some extent due to a reduction in visual
acuity that follows systemic antimuscarinic administration.
Scopolamine 0.9 mg is known to produce pupillary dilation 
(mydriasis) and loss of accommodation (Innes and Nickerson, 
While this may have occurred in the present study, 
it would not explain the increase on target detection in 
low probability spatial locations, since a decrease in
1970).
visual acuity would presumably not interact with the 
physical location of stimuli in visual space.
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Summary: Experiments One and Two: These experiments go some
way toward confirming the hypothesis that cholinergic
blockade impairs the efficient allocation of cognitive
resources in selective attention tasks (see also Dunne and
Hartley, 1985). In terms of the cholinergic model of
Alzheimer's Disease, this appears consistent with the
general view of disruption to controlled processing (or 
energetic supply) in that disorder (Jorm, 1986; Parasuraman 
and Nestor, 1986).
However, there are at least two caveats here. First, the
finding that the drug impairs the ability to focus 
attention, and hence leads people to capture information 
from a broader perceptual field, does not preclude 
generalised effects of scopolamine upon a range of
attention and speeded information processing tasks (see, 
e.g. Broks et al, 1988; Kopelman and Corn, 1988; Parrot,
1986). It may well be that the drug simply impairs 
performance on most tasks that demand active attention. One
way of stating this is to say that scopolamine has its 
strongest effect in tasks with a high processing load 
(Rusted and Warburton, 1988; Kopelman and Corn, 1988). 
Another, less theoretically appealing, way is to say that 
it impairs performance when the tasks are "hard". The
latter statement is not very helpful, since this is a non­
specific indicator of the effects of most psychoactive 
drugs.
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A second caveat, which is important if we are to attempt to
validate the scopolamine model of Alzheimer's dementia, is
that we can simply say that cholinergic blockade impairs
selective attention, and that selective attention is
impaired in AD. The "fit" of the psychopharmacological
model may be best examined in tasks which have various
subcomponents, some of which are impaired in AD, while
other aspects remain intact. The study of attention using
target detection tasks may well be too limiting, because
virtually all neuropsychological studies find impairment to
all measures of attention in Alzheimer's Disease.
An adequate test of the cholinergic hypothesis should
include the study of drug effects upon performance in
controlled processing tasks that do not involve the
acquisition of new information or sensory perception, since
tasks in which the to-be-remembered or to-be-perceived
information is externally provided do not allow one to 
clearly disentangle the major competing hypotheses. 
Specifically, impairment in both the ability to maintain
attentional focus on high probability ofsources
information and the ability to recall lists of words could
equally be interpreted as a depletion of cognitive 
resources (i.e. the ability to focus on the primary source 
of information, regardless of the nature of the task) or as 
an impairment to episodic memory (memory for the words or 
high probability locations and set of target items). In the 
previous experiments, if subjects had impaired recall of
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the set of target letters and had an impaired ability to 
learn and remember the probability bias in the display, 
then the observed pattern of drug effects could simply 
reflect a more random pattern of responding throughout the
task.
One way to circumvent this problem is to examine effects of
Scopolamine in normal subjects using a task that has both 
automatic and effortful components, but which does not rely 
on the memory for experimenter provided events. These 
criteria are fulfilled by the Continuous Response Task: it 
is essentially a test of controlled retrieval from semantic
memory, and is in many ways analogous to verbal fluency
tasks that have been extensively used in the analysis of
cognitive impairment in Alzheimer's Disease. Two
experiments are described in Chapter Four.
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CHAPTER FOUR
Is there a link between cholinergic dysfunction and
impaired retrieval from semantic memory?
4.1. Introduction
4.1.1. Semantic memory: Some memory tasks require recall of
information which has been learned and which has a distinct
temporal or autobiographical context. On other occasions,
we are required to retrieve facts or general knowledge from
memory, and this information often is retrieved without any
collateral information on when or where it was learned. The
former type is called "episodic memory" or "memory for
events", while the latter type is known as "semantic
memory", "knowledge memory or "memory for facts" (Baddeley, 
1990; Gregg, 1986; Tulving, 1983). This distinction in 
memory "systems" has received a great deal of attention in 
cognitive psychology and clinical neuropsychology. At one 
level, it has been useful to classify subtypes of memory 
and memory impairment. It should be acknowledged, however, 
that there is a much debate over whether semantic memory is 
a separable "system", and indeed, what it actually means to 
dissociate subtypes of memory (Hintzman, 1990; McKoon and 
Ratcliff, 1986; McKoon et. al., 1986; Tulving, 1983).
Tulving's (1972) original paper defined semantic memory as 
".. a mental thesaurus, organised knowledge a person 
possesses about words and other verbal symbols, their 
meaning and referents, about relations among them and about
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rules, formulas, and algorithms for the manipulation of 
these symbols, concepts and relations" (p380). Subsequent 
research has explored various conscious and non-conscious 
aspects of this system: theories of automatic spreading
activation, associative connections in semantic networks
and conscious search of associative memory have been
proposed (see Baddeley, 1990, for a review). In this 
chapter, the aim is to examine semantic memory from a
relatively limited perspective: studies are reviewed only
if they usefully distinguish between automatic and
controlled processing during information retrieval.
4.1.2. Alzheimer's Disease and semantic memory:
Despite the general profile of global intellectual
impairment in AD, there is clear evidence that some
semantic memory functions remain intact, at least until the
final stages of the disease. Nebes et. al. (1984) found
that Alzheimer's Disease patients exhibit normal
performance on some relatively 'automatic' tests that do 
not require active memory processes. AD patients were
equivalent to controls in the benefit they derived from
semantically associated primes in word naming performance, 
showed a normal increase in the gradient linking 
probability of letter string recall as the letter strings 
approached orthographically regular English, and a 
similarly normal gradient linking word string recall as the 
word strings approached conventional semantic and syntactic 
regularity. These findings of intact automatic processes
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were in contrast to a clear deficit in the AD patients'
ability to search their semantic memory and retrieve items 
that can be consciously associated in a meaningful way.
Weingartner et. al. (1981) provided further evidence of 
intact speech and articulation in AD, and found that, while
these patients maintain a relatively rich spontaneous
vocabulary, they are severely impaired in making semantic 
judgements (e.g. in selecting appropriate words to complete 
experimenter provided sentences) and have difficulty in 
completing reconstructive semantic memory tasks, such as 
reporting the order of every-day events and actions. In a 
recent review, Morris and Kopelman (1986) suggested that 
these observations reflect preservation of the over-learned 
(i.e. automatic) aspects of knowledge retrieval, while 
semantic memory functions requiring active search and 
retrieval strategies (i.e. effortful processes) are 
impaired.
Kopelman (1986b) found that recall of sentences by AD 
patients (in comparison to healthy controls, depressed and 
Korsakoffs patients) was severely impaired when the
semantically anomalous. Presumably, 
sentences are remembered with less effort when they make 
sense, but as the meaning disappears, recall would depend 
more on active rehearsal of unrelated strings of words, 
which is usually found to be disrupted in AD.
sentences were
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The majority of studies of semantic memory in dementia have
used verbal fluency tasks, where the standard method is to
ask subjects to generate, for one minute, as many words as 
they can that belong to semantic categories (e.g. animals) 
or begin with a specified letter, such as F, A or S. There
is clear evidence that AD patients are impaired in this
test (Appell et. al, 1982; Martin and Fedio, 1983; Rosen,
1980; Weingartner et. al., 1981), although there is some
disagreement as to whether the deficit is greater for
retrieval from semantic or alphabetic categories (Hart et. 
al., 1988). A detailed analysis of this task by Beatty et.
(1986) found that, as well as producing fewer items, 
AD subjects show a tendency to repeat previously retrieved
al.,
items. These re-retrievals were classified as perseverative 
and are thought to be the verbal fluency analog oferrors,
increased prior list intrusions which are often found in
list learning tasks.
Several studies have addressed the important issue of the
use of retrieval strategies in semantic memory tasks.
Martin and Fedio (1983) found that demented subjects did
not differ from controls in their ability to give
appropriate category names for groups of related items, but 
when they were asked to name different items that could be
found in a supermarket, not only did they produce fewer 
items, they drew items from fewer semantic categories and.
when a category was accessed, fewer items were retrieved
from within it. This pattern of intact category naming but
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impaired ability to generate concept attributes and
associates has also been reported by Flicker et al. (1987).
Rosen (1980) asked groups of mild and moderate to severe AD 
patients and normal elderly controls to produce animal
names for 60 seconds, and then to retrieve items beginning
with C, F and L over 3 trials. As expected, the AD group
produced fewer items overall, but Rosen found that when
items were classified as being either "clearest cases" from
a category or as members of a category "subset", then a
distinction between AD and controls in terms of how they
searched semantic memory became evident. When clearest
(which those retrieved immediately andcases were
automatically) were considered, subjects with mild dementia 
were not impaired. However, they showed little evidence of 
spontaneous entrance into subsets in the later stages of 
the task. Those with moderate to severe AD were impaired on 
both measures, and showed virtually no evidence of entrance
into semantic subsets.
These more detailed studies of the components of verbal
fluency suggest that the retrieval deficit in AD may be
described as an impaired ability to use conscious search
processes to capture information into awareness, rather 
than in terms of a structural disorganisation of semantic 
networks. In relation to the central theory of this thesis, 
if we extend the anticholinergic model of AD to semantic 
memory, then it should be possible to detect similarities
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between AD and the pattern of impairment following
scopolamine in normal subjects.
4.1.3. Anticholinergic drugs and verbal fluency
A search of the literature on the cognitive effects of
anticholinergics revealed thirteen publications that have
included conventional measures of verbal fluency. Nine
stated that retrieval of alphabetic and/or semantic
category exemplars was impaired. However, a close analysis
of the individual studies reveals that, in fact, only six
experiments were conducted. Four reports by Sunderland et. 
al. (1985a,1985b,1986,1987) all originate from a single 
study. Here, Sunderland et. al. examined the effects of 3 
doses of scopolamine IV upon performance in a 90 second 
verbal fluency task in 10 Alzheimer's Disease patients and 
10 healthy elderly matched controls. In this challenge 
design, they found a dose-dependent impairment in the AD 
group, and a significant reduction in item output by normal 
controls at the highest dose (0.5mg). Individual reports of 
these effects appeared for the full 20 subjects (Sunderland 
et. al., 1987), for the 10 AD patients alone (Sunderland
control subjects alone 
(Sunderland et. al. (1986), and for the 10 AD plus 7 of the 
10 controls (Sunderland et. al., 1985b).
et. al. 1985a), for the 10
Drachman and Leavitt (1974) examined retrieval from 
familiar semantic categories with 20 subjects given 1.Omg 
subcutaneous scopolamine. Relative to placebo, retrieval
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was reduced by approx. 15% at 20 seconds, and approx. 20%
(1981)at 60 seconds in a one minute task. Caine et. al.
conducted a study with 7 subjects, who received between
0.6 to 0.8 mg scopolamine IM. The drug diminished output of
andsemantically related words after 30 seconds.
semantically unrelated words (letter cue) after 75 seconds
of a 2 minute retrieval trial. In the final 15 seconds.
scopolamine reduced semantically related retrieval by 50%
relative to placebo, while the corresponding reduction for 
unrelated words was approx. 25%. Newhouse et. al., (1988) 
tested 9 depressed elderly subjects with 3 doses of
scopolamine, and found retrieval from both natural and
alphabetical categories to be impaired.
In some experiments, retrieval from letter categories, but 
not natural categories is impaired (Molchan et. al., 1990) 
while Troster et. al., (1989) found impairment in natural 
but not alphabetical category retrieval.
In contrast, three studies with young normal subjects 
reported no effect of the drug. Beatty et. al. (1986) 
tested 6 subjects in several one minute trials following 
0.5mg scopolamine IM. No impairment was found on measures 
of item production and repetition, and they reported a non­
significant trend for output to be higher in the drug 
condition for both alphabetic and semantic category trials. 
Kopelman and Corn (1988) 
responses to the letters F,A and S for one minute following
asked 40 subjects to give
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infusion of 0.4mg scopolamine, and found no significant
effect of the drug on total item output. In addition.
Preston et. al. (1988) found verbal fluency following 
letter stimuli was unaffected by either scopolamine or the 
cholinesterase-inhibitor Physostigmine.
In a recent study relevant to this issue, Curran et al.
(1988) examined the cognitive effects of four
antidepressant drugs (Amitriptyline, Trazodone, Viloxazine 
and Protriptyline) with, they claim, were dose-matched for 
antidepressant efficacy but differed in terms of the
sedative and anticholinergic effects. They used an
independent groups design, with 10 subjects in each of 9 
conditions (8 groups taking active drugs of various types 
and doses, and 1 placebo group). The agents with the most 
pronounced anticholinergic effects (Amitriptyline and 
Trazodone) were found to produce significantly greater 
impairment on a range of tests of recall, recognition 
reaction time and attention. However, none of the drugs 
significantly impaired retrieval from semantic memory in a 
90 second category retrieval task.
At present, then, the question of whether scopolamine 
impairs retrieval from semantic memory remains open. Apart 
from the fact that methodological factors, such as drug 
dose, route of administration and task retrieval time
varied considerably among studies, 4 of the 10 experiments
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mentioned above collected data from 10 or less subjects.
Another limitation of the existing data is that no analyses
have been conducted on the more elaborate, strategic
aspects of knowledge retrieval, which might reveal
something about the locus of the effects of scopolamine on 
the cognitive operations required for efficient sustained
search of semantic memory. All previous experiments have
limited retrieval time to between one to two minutes. It is
arguable that items are retrieved almost automatically for
the first minute in semantic retrieval tasks (Herrmann and 
Pearle, 1981), and that conscious, effortful processes, 
including attention, become more important in the later 
stages of sustained memory search.
Clearly, our understanding of the effects of scopolamine 
upon semantic memory would be enhanced by studies of 
retrieval over relatively long periods.
4.1.4. Controlled and automatic processing in sustained
retrieval from semantic memory
While research in cognitive psychology has placed a great 
deal of emphasis on understanding the role of effortful 
processing in episodic memory tasks (e.g. sustained 
vigilance, attention and the use of encoding strategies in 
the "depth of processing" framework), the application of 
cognitive resource theory to semantic memory has progressed 
more slowly. Millsap and Meredith (1987) attributed this to 
the difficulties involved in testing such theories, since
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"... the input to short term memory can be experimentally
manipulated, while the input to semantic memory cannot."
(P39)
One semantic memory task that has a long history in
psychology, and has recently been examined within the
controlled processing framework. is the Continuous
Retrieval task. Here, subjects attempt to recall as many
exemplars of a single semantic category as possible over a
long period (e.g. 12 minutes). Retrieval of items is rapid 
initially, and slows down over time, but may continues 
indefinitely. Over groups of subjects, cumulative output is 
accurately described by a smooth, negatively accelerating 
function, although individual curves are heavily scalloped.
due to the retrieval after the first few minutes of
clusters of closely associated items, followed by little or 
no output while subjects are searching for more clusters or 
retrieval cues (Graesser and Handler, 1978; Gruenewald and 
Lockhead, 1980) .
Performance in this task has elements of both automatic and
controlled retrieval. Hermann and Pearle (1981) suggest
that the early stages of the continuous recall process
consist of automatic, "reflex" recall: when subjects are 
given a category cue they immediately access the most 
dominant items in that category. Retrieval after the first 
few minutes involves a more complex process, which they
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termed "reasoned" recall, which involves active search for
possible retrieval cues, checks to see whether each cue had
been previously retrieved, and if so, whether some items
associated with that cue were not retrieved earlier. If the
retrieval cue is new, then subjects automatically retrieve
items from within it (see also Raaijmakers and Shiffrin's 
(1981) model of search of associative memory).
It is not possible, however, to precisely estimate, using
mathematical models of continuous recall, the times at
which subjects will change from automatic to effortful
retrieval, since output varies as a function of the size of
the category (Hermann and Murray, 1979) and because
retrieval cues for each subject are to some extent
idiosyncratic (Gronlund and Shriffrin, 1986),
Most experiments with this task have collected data only on 
item output and inter-item retrieval times, although it is 
possible, using the "thinking out loud" procedure (Walker 
and Kintsch, 1985), to gain information on the temporal 
patterns of retrieval cue generation and repetition. In 
this variant of the task, subjects are required to give 
verbal descriptions of their memory search for 12 minutes 
per category. As well as reporting items and cues, subjects 
are asked to report any information that comes into
awareness. Although there is some doubt as to whether 
people can give accurate verbal reports of ongoing mental 
processes (Nisbett and Wilson, 1977), this technique does
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at least offer one way to examine patterns of cognitive
operations in sustained memory search. Some recent
experiments clearly describe the output of this process,
but the task has not previously been used to examine the
effects of drugs which alter cognitive function.
4.1.5. Predictions
If the effects of scopolamine upon semantic memory 
retrieval are similar to the pattern of impairment found in
senile dementia, then the drug would be expected to reduce
total item output overall, and particularly in the later
stages of memory search (Rosen, 1980; Weingartner et. al 
1981), reduce the number of self-generated retrieval cues 
(Rosen, 1980) with the expectation of a drug by time 
interaction, increase item and retrieval cue repetition 
(Beatty et. al., 1986) and reduce the number of items 
retrieved per cue (Martin and Fedio, 1983). Such a pattern 
of effects would suggest a reduction in control over 
cognitive processes, particularly if the drug was found to 
have little or no effect upon 'automatic' item and cue 
retrieval in the first few minutes (ie. drug by time 
interactions should be observed).
• t
4.2. Methods Experiment Three
4.2.1. Subjects 14 subjects (7 males, 7 females; mean age 
26 years; range 18-37 years) participated in the study.
All were initially screened for medical conditions which
are contraindicated for the drug, and all gave full
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None of the subjects wereinformed voluntary consent.
currently taking other medications, and none had used 
scopolamine for at least a -month prior to testing. They
caffeine-containingwere asked not to eat, or drink
products for 2 hours prior to drug administration and in 
the period before testing commenced.
4.2.2. Scopolamine Tablets Doses of 0.9 mg Scopolamine
Hydrobromide (0.3 mg tablets x 3) or physically matched 
placebos (3) were administered in a double blind, repeated
measures design.
4.2.3. Continuous Retrieval Task:
In each session, subjects were given the names of one small
and one large natural category from a group of 4 selected 
for the Battig and Montague (1969) norms. Two large (Toys, 
Birds) and two small (Non-Alcoholic Beverages, Crimes) 
categories were selected, with category size being judged 
from Battig and Montague's frequency of response data. The 
large categories had, respectively, 48 and 46 items with a 
frequency of 10 or more, while the small categories had 31 
and 32 items of 10+ frequency.
In the two trials in each session, subjects were given the 
category name and were instructed to 'think out loud' when
naming members for 12 minutes. They were encouraged to say 
everything that came into awareness, and in particular to 
state the cues or retrieval strategies they were using in
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order to access items. They were told to speak freely, and
not to worry about repeating items and cues or the
The verbalproduction of proper English sentences, 
protocols were tape recorded, and later transcribed with
marks at the end of every 10 second interval. In
accordance with the scoring system of Walker and Kintsch
(1985), responses on the verbal protocols were assigned to 
five different scoring units. The protocols were broken
down into basic idea units which were usually a single
clause or a single word. An example of the scoring method
is shown in the following excerpt from one subject's
protocol or retrieval of Non-Alcoholic Beverages.
"... Now I'm thinking of things I have at home (C), 
milk (I)/•.tea (I), coffee (I).../ oh. Now I'm
thinking of the pub ...grapefruit juice (I)/ 
orange juice (I)/ ...ginger ale (I), soda water 
(I)/... what I normally drink on a regular basis
(C)
(C)... water (I), herbal teas (C), like camomile (I), 
rosehip (I), peppermint (I)/... occasional goats milk 
(I), skim milk (I)... / ... I've gone a blank (M) ... 
/ ... don't know what to think (M) ... I need a drink 
(G) ... / ... urn, what else ... decaffeinated coffee 
(I) .../"
The five categories are items 
statements or cues (C), metastatements (M), unrelated or 
general statements (G) and descriptive statements (D) (such
retrieval related(I).
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tonic water ...yeah, that tastes really awful 
Using this scoring system, graphs of the cumulative
as
output functions for items. retrieval cues. item
repetitions and cue repetitions can be obtained.
Testing was conducted on an individual4.2.4. Procedure:
basis. In each session, subjects were given the tablets
and returned to the laboratory 50 minutes later. They were
then given the task instructions, and practised the task
for two three minute intervals by retrieving names from
other natural categories (vehicles, parts of a building, 
vegetables and natural earth formations). They then began 
the first 12 minute trial, and when finished, paused for 
approximately two minutes before the second trial began. 
In each trial, subjects were informed of the category name 
immediately before retrieval began, thus preventing any
The experimenter sat opposite and 
remained quiet except to urge subjects to "keep trying' if 
a pause of more than 40 seconds occurred. The two testing 
sessions took place one week apart, and all testing was 
conducted between 12 and 4 p.m.
rehearsal effects.
4.3. Results
Table 4.1 contains means and standard deviations for the
four principal measures of retrieval, averaged over the two 
trials per session. The cumulative output functions 
illustrated in figures 4.1 and 4.2 show item and cue
retrieval and repetition.
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Item retrieval (Fig. 4.1) is represented by the typical 
smooth negatively accelerated function found in most verbal
fluency tasks. These group curves do not, however, reflect
the individual retrieval functions, which tend to be
heavily scalloped, presumably due to search time and the
intermittent retrieval of clusters of closely associated
items. A 2 x 12 (Drug x Time) repeated measures ANOVA on
these item retrieval data found a significant main effect
of Time (F(ll,143) = 64.66; p<.001), no main effect of 
Scopolamine (F(l,13) = 0.54; n.s.) and no interaction 
between Drug and Retrieval Time (f(ll,143) = 1.05; n.s.).
Table 4.1: Item and Cue retrieval and repetition
Time (minutes)
1 2 3 4 5 6 7 8 9 10 11 12
ITEM RETRIEVAL
Scopolamine 0.9mg
X 11.3 8.5 6.5 5.3 4.3 3.3 2.8 2.9 3.6 2.9 2.6 2.4
sd 3.1 2.1 2.1 2.4 1.6 2.3 2.0 2.3 2.4 2.1 1.6 1.8
Placebo
X 10.4 7.9 6.2 4.9 3.6 4.4 3.2 3.7 3.3 2.8 1.5 1.6









0.7 0.4 0.5 0.5 1.0 0.6
0.9 0.7 0.6 0.5 1.4 0.8
0.6 0.4 0.5 0.5




0.2 0.2 0.6 0.4 0.3 0.1 







X 2.1 1.5 1.0
sd 0.9 0.4 0.9
1.3 1.0 0.9 0.9 0.7 






X 2.4 1.3 1.0
sd 1.0 1.0 0.8
1.1 1.0 0.6 0.5 0.9 







X 0.1 0.2 0.3 0.1 0.3 0.5 0.3 0.4
sd 0.3 0.3 0.6 0.3 0.3 0.6 0.4 0.3
0.4 0.4 0.6 0.5
0.6 0.6 0.70.3
Placebo
X 0.0 0.3 0.4 0.3 0.3 0.3 0.4 0.3
sd 0.0 0.4 0.5 0.4 0.4 0.3 0.7 0.5
0.3 0.5 0.2 0.4
0.7 0.8 0.4 0.7
10S




Figure 4.2:Mean item and cue repetition
Cumulative frequency
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With regard to retrieval cue generation, there was a
significant main effect of Time (F(ll,143) = 12.42; 
p<.001), but the main effect of scopolamine (F < 1) and the
interaction between the drug and Time (F(ll,143)
1.14;n.s.) were not statistically significant.
Analysis of variance in item output over the first 120 sec
(at 10 sec intervals) was conducted so that a more direct
comparison could be made between this study and those of
Caine et al (1981) and Beatty et al (1986). The 2 x 12
ANOVA revealed a significant main effect of time (F(ll,143)
= 5.01; p.001), no main 
1.38; n.s.), and no 
time (F(ll,143) = 0.71, n.s.).
effect of Scopolamine (F(l,13))
interaction between drug and retrieval
Item and cue repetition are shown in Figure 4.2. The main 
effect of time (F(ll,143) = 1.19; n.s.), and the drug by
time interaction (F(ll,143) 
significant. However, the drug significantly increased the
1.46; n.s.) were not
number of items that were repeated during retrieval 
(F(l,13) = 7.63; p<.025). This drug main effect was not 
evident in the cue repetition data (F(l,13) = .06; n.s.). 
That ANOVA showed a small main effect of time (F(ll,143) = 
1.92; p < .05) and no drug x time interaction (F(ll,143) = 
.88; n.s.).
Another measure of interest is the number of items
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retrieved per cue, which would presumably reflect the
ability to 'capture' items following cuesubjects'
It is derived by dividing the total itemgeneration.
retrieval (new items and repetitions) by total cue
retrieval (new cues and repetitions). In the drug
condition, subjects retrieved on mean of 3.84 items per
cue, compared to a mean of 5.00 in the placebo condition.
This difference was not, however, statistically significant
( t(13) = 1.01; n.s.).
The data from the remaining 3 protocol categories were 
analysed, with no drug effects being found on any measure
(See Table 4.2).
Table 4.2: Mean production of Metastatements, Descriptive 







Metastatement 7.04 (6.27) 0.43 (n.s.)
Descriptive 1.397.32 (4.64) (n.s.)
General 2.07 (1.67) 1.09 (n.s.)
n.b. standard deviations are in parentheses.
4.4. Discussion: Experiment three
This analysis clearly shows that scopolamine had no effect
upon item retrieval. The output functions illustrated in
Fig. 4.1 show very similar retrieval rates at all points in 
time during sustained search. In particular, the pattern
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of item output following drug and placebo in the first 2
minutes is in direct contrast to the large effects found in
semantic category search reported by Caine et al., (1981), 
Drachman and Leavitt (1974) and Troster et. al., (1989), 
but is consistent with Beatty et. al. (1986), Kopelman and 
Corn (1988) and Preston et. al. (1988).
Scopolamine significantly increased item repetition. In the 
final six minutes of retrieval, repetitions accounted for 
20.7% of item retrieval in the drug condition and 8% in the
placebo condition. The question of why the drug would 
effect item repetitions but not gross item output must be 
raised. One explanation would be that scopolamine's effects 
are limited to information acquisition (Frith et. al., 
1984), and while item output is a direct measure of 
semantic memory retrieval, item repetition is primarily a 
function of episodic memory failure (with the assumption 
that once an item has been retrieved it becomes an episode, 
and repetition reflects poor recall of a previous event).
A difficulty for this interpretation arises because no drug 
effect was found on retrieval cue repetitions, which would 
presumably have a similar episodic quality. It is 
conceivable, though, that individual items are less
memorable than retrieval cues since (as can be seen in 
they outnumber cues by more than 4 to 1, and 
probability of recall diminishes with increased set size. 
This would account for the relatively greater vulnerability
Table 4.1)
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of individual items to scopolamine.
The observations that scopolamine did not reduce the
generation of new retrieval cues or the number of items
retrieved per cue are in contrast to the impairment found
on these measures in mild senile dementia (Martin & Fedio,
1983; Martin et al., 1985). Both measures would reflect
the efficiency of active memory search: the former as a
of spontaneous implementation of retrievalmeasure
strategies and the latter as a measure of 'capture'
following activation of semantic units or clusters of
related items.
In theoretical terms, this lack of a distinct effect of
scopolamine on various measures of semantic memory
retrieval poses difficulties for the idea that the drug
selectively impairs controlled (effortful) processes rather 
than automatic cognitive processes. On the one hand, it 
could be argued that retrieval of information from semantic
memory is a relatively automated operation, so no drug 
effect would be consistent with predictions. This may be 
true of most verbal fluency tasks in normal subjects which 
test retrieval for brief periods. However, this sustained 
retrieval task was originally chosen because of it's 
inherent difficulty or, more formally, because performance 
in sustained search is constrained by limited processing 
capacity (Graesser and Mandler, 1978). Anecdotal evidence 
for this criterion was gained during testing, as most
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subjects repeatedly expressed difficulty in sustaining
search within each category.
One possibility not ruled out by experiment three is that
the drug does reduce the extent to which subjects can
spontaneously generate retrieval cues, but that intact
people have a sufficiently large variety of potentially
useful idiosyncratic cues to guide retrieval in free
emission tasks (Gronlund and Shiffrin, 1986) which enable 
them to compensate for reduced efficiency in the drug
condition.
This issue was addressed in experiment four. In one
condition, an attempt was made to control the availability
of associative cues by requiring subjects to adopt only one 
retrieval strategy (by cycling through letters of the 
alphabet as aids to retrieval from natural categories). In 
the other condition, the free emission procedure was
employed.
The hypothesis is that, if scopolamine does impair 
controlled retrieval from semantic memory, then this should 
be apparent in a task which restricts cue availability, and 
thus requires subjects to impose more order on their search 
(i.e. focus on a single strategy, edit out items retrieved 
that do not match the nominated strategy etc.). In 
contrast, free retrieval should be relatively less 
vulnerable to impairment by the drug. Hart et. al. (1988)
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have argued that greater impairment of alphabetically- 
guided retrieval than free retrieval in Alzheimer's Disease
patients may be due to the fact that the former retrieval
strategy requires more cognitive control, and that in AD 
patients there is a generalised loss of control over all
cognitive processes. In terms of the anticholinergic model 
then, a drug by retrieval strategy interaction would be
predicted.
A non-verbal semantic memory task was introduced in
experiment four. The subjects were required to solve number 
series problems of varying complexity, with measurements of
accuracy and problem solving speed being obtained. As with 
verbal retrieval, this task does not require the learning 
of new information, and performance would presumably 
reflect the efficiency of access to computational 
algorithms stored in semantic memory (Tulving, 1983).
4.5. Methods Experiment Four
4.5.1. Subjects: 16 volunteer subjects (8 males, 8 females; 
mean age 24.4 years; range 18-33) participated in the 
study. As in previous experiments, all Ss were initially 
screened for health contraindications and concurrent drug
use. They were asked to abstain from food and caffeine
containing products for 2 hours prior to drug
administration. None of the subjects had participated in
earlier studies in this series. During recruitment.
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potential subjects were asked about their typing ability, 
and were excluded if they did not claim to be proficient in
typing more than 30 words per minute on a conventional
keyboard.
4.5.2. Scopolamine tablets; Doses of 0.9mg Scopolamine
Hydrobromide (0.3mg tablets X 3) or physically matched 
placebos (3) were administered in a double blind, repeated 
measures design.
4.5.3. Experimental Tasks
4.5.3. (i) Continuous Retrieval Task; In each session.
subjects were asked to retrieve, for 8 minutes, items from
categories selected from the Battig and Montague (1969) 
norms. 8 categories (4 footed animals, Sports, Fruits and 
vegetables. Non-alcoholic beverages. Cities of the world. 
Vehicles, Toys, Birds) were used in this study, with four 
for each subject's test session. The order of presentation 
of the categories was controlled by an 8 x 8 Balanced Latin 
Square design. Across 16 Ss, this produced a matrix where 
8 pairs of different category presentation sequences were 
obtained. For each pair, one presentation sequence was then 
assigned to Drug first/Placebo second test order, with the 
opposite for the other member of the sequence pair. This 
arrangement would have randomly distributed any variability 
in item retrieval that was due to order effects or the size
of individual semantic categories.
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In each session then, Ss were asked to retrieve instances
from four categories (four trials). In each trial, 
seated at the computer keyboard, were shown a category name
Ss were
on the VDU, and were required to begin typing as many
category instances as possible in the next 8 minutes. A 
millisecond timer in a CBM 64k computer recorded the entry
of the first letter of each word, and a record of inter­
word retrieval time was obtained by subtracting first 
letter entry times from consecutive words. Elapsed time, in 
minutes and seconds, in each trial was constantly displayed
at the top of the screen, and words were erased from the
screen at the start of each new entry.
In each session, two of the four categories were assigned 
to the Alphabetical strategy. In these trials, subjects 
were first prompted with the letter 'A' and typed in as 
many words as they could starting with that letter. Ss then 
pressed a nominated key to signal that they could retrieve 
no more words, and the program moved to the 'B' prompt, and 
so on. The program allowed Ss to cycle through the alphabet 
a maximum of three times, although pretesting with six 
subjects found that none did this in the 8 minutes.
In the two free retrieval trials, Ss were given the
category name, and were asked to retrieve words in any 
order using any strategy they desired, with the proviso 
did not intentionally use an alphabetical 
strategy to aid retrieval(Gronlund and Shiffrin, 1986). The
that they
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order of presentation of the alphabetical and free
retrieval trials was randomised across subjects and
categories, to the effect that it was equally probable that 
any particular category occurred in either strategy 
condition, and that any sequential effects due to retrieval
strategy order across the task were randomly distributed
across subjects.
4.5.3. (ii) Arithmetic Task
In this task, Ss were asked to solve 50 logical number 
series problems. In each trial, a two digit number (from 10 
90) appeared on the left hand side of the screen 
followed, at one second intervals, by four more numbers
across the screen, with a question mark adjacent to the 
fifth number, e.g..
10 14 19 25 32 ?/ t I I
Ss were required to press a microswitch to signal that they 
had generated the sixth number (answer) of the series, and 
following this, to type that number on the keyboard. The 
program then went on to the next series.
Four types of number problems were employed:
(1) Simple Addition - Where the series increased by a
constant value between 2 and 8. On any trial, a series
could begin with any number between 10 and 45, e.g.
37,40,43,46,49 ?
(2) Complex Addition - Where the series increased by a
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constant (between 2 - 8), plus a compounding value of 1,2
or 3, e.g. 37,40,45,52,61 ? (Here the series increased by a
constant of 3 with a compound addition of 2).
(3) Simple Subtraction - Where the series decreased by a
constant between 2 and 8. On any trial, a series could
begin with any number between 55 and 90, e.g.
67,59,51,43,35 ?
(4) Complex Subtraction - Where the series decreased by a
constant (between 2 - 8), plus a compounding value of 1,2 
or 3, e.g. 67,59,50,40,39 ? (Here the series decreased by a 
constant of 8 with a compound subtraction of 1)
The computer program ensured maximum randomization within
this task. Type of problem was randomly selected for each 
trial, and within a trial, the values of the first number
in the series, the constant and in complex trials, the 
compound number, were randomly selected. As such, there
were no sequential dependencies or 'problem blocking' 
effects that might assist Ss in responding from trial to
trial.
4.5.4. Procedure
Testing was conducted on an individual basis. In each
session, Ss were given the tablets, and returned to the 
laboratory 30 minutes later. First, they were given 50 
practice trials on the number series task, which took 
approximately 10 minutes, and performed two practice trials
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on the continuous retrieval task (one Alphabetical and one 
Free strategy) for 5 minutes each. Practice trials in each 
session used two of four practice categories (Pieces of 
furniture, colours, weapons, occupations or professions).
Formal testing commenced approximately 50 minutes after
drug administration. Ss began with a word retrieval task
for 8 minutes using a CBM 64k computer, and then completed 
50 number series problems on a different CBM. The two tasks
alternated until 4 Continuous Retrieval Tasks (CRT) and 3
number series (NS) blocks had been completed. With 32 min 
for CRT and approximately 30 min for NS, the formal test
phase took just over one hour to complete. Ss were alone in 
the testing room, with the experimenter entering only to 
reset the computers after each segment of the session.
4.6. Results
4.6.1. Continuous Retrieval Task
Scoring: The three independent variables in this task were 
Drug Condition, Type of Retrieval Strategy and Time (8 min 
per trial). Raw data were collated for analysis in the 
following ways:
1) The numbers of items retrieved per minute in each of 
the two alphabetical strategy and two free strategy trials 
were summed, and average retrieval per minute per strategy 
was obtained.
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2) The mean Inter-item Retrieval Time (IRT) per minute in 
each trial was converted into average IRT per minute per
strategy.
3) In the alphabetical strategy trials, items that were
retrieved out of the specified sequence (i.e. those that
did not correspond to the currently displayed letter) were 
summed per minute, and were converted into proportions of
total retrieval for that minute (see also Gronlund and
Shriffrin, 1986). The data thus obtained reflect the
probability of incorrect alphabetic retrieval.
4) The numbers of item repetitions per minute were
scored. Since very few items were repeated overall.
analysis was conducted only on total repetitions per 
subject per strategy, collapsed across the time variable.
Analyses: Table 4.3 shows mean item retrieval by drug
condition, strategy and time. When these figures are
converted into cumulative frequencies we see, in Figure
4.3, that more items are retrieved in the free strategy
and, while free retrieval follows the negatively 
accelerating function found in the experiment in the 
previous chapter, item retrieval in the alphabetic strategy 
appears to be more linear. Figure 4.2 does not, however, 
suggest any main or interactive effects of Scopolamine.
These trends were confirmed in a 2x2x8 repeated measures 
There were significant main effects of retrievalANOVA.
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strategy (F=77.12; df=l,15; p<.001) and time (F=35.77;
df=7,105? p<.001), and a significant interaction between
strategy and time (F=18.42; df=7,105; p<.001). Free
retrieval appears to be approaching asymptote by the 7th or
8th minute, while alphabetic retrieval appears to be
accumulating at a relatively constant rate.
There was no significant main effect of Scopolamine (F <
1), and, contrary to predictions, no interaction between
the drug and retrieval strategy (F < 1). Both the drug by 
time and drug by strategy by time interactions were not 
significant
A similar pattern of effects was observed in the IRT data
(see Figure 4.4 and Table 4.2). There were significant main 
effects of strategy (F=29.23; df=1.15; pc.OOl) and Time 
(F=20.67; df=7,105; p<.001). IRT was faster in the free 
condition, and overall, IRT became longer with time spent 
retrieving. In this case, though, the interaction between 
strategy and time was not significant (F=1.96; df=7,105; 
N.S.). Again, there were no significant main or interaction 
effects involving the drug.
in
Table 4.3: Continuous retrieval by strategy: Mean number of 
items and Inter-item Retrieval Times
Time (minutes)




3.6 3.7 2.93.5 3.0 3.2 2.7 3.3X
sd 1.21.3 1.2 1.0 1.3 1.3 1.31.1
Free Strategy 
8.9 6.6 3.25.6 4.8 4.1 3.6 3.7X
sd 2.2 1.6 1.2 1.3 1.8 1.8 1.71.5
Placebo
Alphabetical Strategy
3.6 3.4 3.1 3.1 2.5X 3.3 3.0 3.0
sd 0.9 0.8 1.4 1.3 0.81.5 1.4 1.3
Free Strategy 
8.4 6.0 3.3X 7.1 5.6 4.2 4.2 3.8
sd 2.5 1.4 1.4 1.5 1.3 1.4 1.8 1.7

















sd 1.6 2.5 3.3 9.6 6.8 7.3
Placebo
Alphabetical Strategy







10.3sd 4.6 6.1 9.6 8.5
Free Strategy





10.8sd 1.5 3.7 1.9 4.3 7.2
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Figure 4.3: Item retrieval by strategy 
cumulative retrieval
Cumulative retrieval
Figure 4.4: Item retrieval by strategy













With regard to proportions of items retrieved out of
alphabetical sequence, a 2(Drug) x 8(time) repeated
measures ANOVA found that retrieval out of sequence
increased with time (F=2.29; df=7/105; p<.05), but no main 
effect of Scopolamine (F < 1) and no significant 
interaction between drug and time (F=1.49; df=7,105; N.S.).
Figure 4.5 shows that there is a considerable degree of
variability in this measure, but in general the trend
conforms to that reported by Gronlund and Shriffrin (1986).
Contrary to predictions and the findings of the previous
study, the analysis of item repetitions found no 
significant effects of either the drug or time (F < 1). As 
Table 4.2 shows, subjects rarely repeated items in this 
version of the Continuous Response Task.
Figure 4.5: Alphabetical trials 'errors’ 
Retrieval out of specified sequence
Proportion of total recall
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4.6.2. Arithmetic Task
Scoring: The two independent variables in this task were
Drug Condition and Type of Arithmetic Problem. Raw data 
were collated for analysis in two ways:
1) Mean response time data in each of the three blocks of
trials were converted into average response times per
problem type.
2) The proportions of trials in which an error was
reported in each block of trials were converted to errors
a proportion of total responses to each problem type in 
this task. Given 150 trials for each subject, this gives an
as
average of 37.5 trials per problem type in each testing
session.
Analysis: Mean response time for each problem type is shown
in Figure 4.6. The time taken to reach solution to each
problem increases with task difficulty, but no drug effect 
is apparent. A 2(Drug) x 4(Problem Type) repeated measures 
ANOVA found a significant main effect of Problem Type 
(F=54.15; df=3,42; pc.OOl) but no main or interactive 
effects of the drug (F < 1).
Figure 4.7 shows the mean proportions of errors in this 
task. Errors appear to increase as a function of task 
difficulty, and a 2x4 ANOVA found this effect to be 
significant (F=13.39; 
response time data, however, the drug did not have any 
significant main or interactive effects (F < 1).
df=3,42; p<.001). As with the
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Figure 4.7: Arithmetic Task Errors
Mean Proportion of Errors




4.7. Discussion: experiment four
Clearly, the absence of any drug effects in this experiment
does not support the hypothesis that Scopolamine impairs
controlled information retrieval from semantic memory. In
the computer-based continuous retrieval task, the absence
of a main effect of the drug replicates the outcome of the 
previous study, and the finding that scopolamine does not 
have a focal effect upon retrieval when subjects were 
constrained by the strategy they could use suggests that
the null results reported in chapter 5 are not simply due 
to subjects having a sufficiently large pool of available
strategies to compensate for any disruptive effects of the
drug.
The general patterns in item retrieval found here
correspond closely to those reported by Gronlund and 
Shriffrin (1986), in that item production was constrained 
by the requirement to use the alphabetical strategy and 
that subjects have increasing difficulty following the 
alphabetical strategy with time on task. Hart et. al. 
(1988) consider that retrieval in the alphabetical 
condition requires more cognitive effort than does free 
retrieval. The absence of a drug effect here suggests that 
it does not differentially impair the ability to maintain 
focus on a single strategy over time, and that it does not 
selectively effect effortful retrieval.
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in experiment four do notThe item repetition data
itemreplicate results reported previously. However,
repetitions in this study accounted for a very small
proportion of total retrieval ( <1% ), and as such there
was insufficient data generated to adequately test for a
drug effect. It may be that the use of typed responses in
experiment four makes the individual items more
discriminable, and hence less vulnerable to disruption.
since subjects must not only generate the items but to some
extent focus on their physical structure (spelling), which 
presumably is not necessary in spoken output.
One innovative aspect of experiment four was the inclusion
of a non-verbal semantic memory task, and the manipulation 
of level of difficulty within this task. The aim here was
to introduce different levels of cognitive "load", and
hence to examine whether the drug and problem difficulty
interact in a another task that does not require the
learning of new information.
Reaction time studies of cognitive
(Ashcraft,1982; Geary and Widaman, 1987) have identified 
that numerical facility, which is usually studied with 
addition problems, is subserved by the ability to retrieve 
basic arithmetic facts and knowledge of logical operations 
from long term memory. Of course, performance in number 
series problems of the type used in this study is to some 
extent dependent upon episodic memory as well, i.e. recall
arithmetic
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of the early elements of the series. An attempt was made to
limit the episodic memory component in this task by
displaying the full number series untilcontinuously
subjects signalled completion.
The results indicated that both response time and
probability of error varied as a function of task
difficulty, and it is interesting that the order of this 
(i.e. Complex Subtraction > Complex Addition > Simple 
Subtraction > Simple Addition) is consistent with a levels 
of difficulty model outlined by Resnick and Ford (1981).
While the absence of a main effect of the drug on this
aspect of semantic memory is consistent with the pattern
observed in the two continuous retrieval tasks, it is
perhaps more revealing that there was no significant 
interaction between scopolamine and task difficulty on 
performance in the number series problems. If only simple 
arithmetic problems had been used, then an absence of a 
drug effect could suggest that basic (and presumably 
automatic) numerical facility i^ not vulnerable to drug 
effects in intact adults. However, anecdotal reports from 
subjects indicated that they 
difficult, and this is perhaps reflected by the high error 
rate and long response times (up to an average 9 seconds) 
seen in the complex trials. The failure to find a drug 
effect on difficult trials does not indicate that task
found this task to be
difficulty does not interact with the drug: rather, it
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suggests that the task should have an episodic memory
component before these effects can be observed.
4.8. Summary: Experiments three and four
The absence on an effect of scopolamine upon retrieval from
semantic memory is notable for a number of reasons. This is
only study to have examined in depth a range of both
quantitative and qualitative measures of sustained retrieval.
and it is significant that the only drug effect observed
(item repetition in experiment three) can be interpreted in
terms of impairment to episodic memory.
It is worth considering whether the null results here can be
attributed to a lack of experimental power. Taken together.
these two experiments represent data from 30 subjects. If a
minimum sample size was to be calculated on the basis of
previously reported effect sizes (c.f. Caine et al. 1981;
Drachman and Leavitt, 1974), then it would be possible to
detect effects with fewer than 16 subjects (Bird and Hall,
1986).
A problem with this analysis of power is that the dose and
route of scopolamine administration in the present studies
differ from those of Caine et. al. (0.6 to 0.8mg
intramuscular) and Drachman and Leavitt (l.Omg subcutaneous). 
Clearly, calculations of minimum sample size on the basis of
published effect sizes require parity in terms of drug dose.
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At one level, it is possible to argue that the absence of a 
drug effect in this study is simply due to the fact that the
dose was too low to exert significant cognitive effects. Oral
administration of centrally acting drugs leads to
considerably lower potency than that which is achieved
through parenteral routes (Bowman et. al., 1968), and so it
should be predicted that 0.9mg oral scopolamine will have
fewer effects than, say, 0.9mg subcutaneous scopolamine, and
possibly, that the former dose will have no effects at all.
/
A weakness of this argument, however, is that numerous
studies have found oral doses of 0.9mg scopolamine (and 
lower, such as 0.6mg oral) to significantly impair other
cognitive functions. For instance, Warburton and colleagues 
(Warburton et. al, 1985; Wesnes and Warburton, 1983; 1984)
have found 0.6mg oral to impair attention and increase
experimentally-induced hallucinations. Parrott (1986), Broks 
et. al. (1988) and Dunne and Hartley (1985) have similarly 
found a dose as low as 0.6mg oral to impair performance on
attention, recall and speeded classification tasks and to
slow reaction time.
The primary conclusion, then, from experiments three and four 
is that scopolamine does not impair semantic memory at a dose 
which has repeatedly been found to impair other cognitive 
functions. Hence, the present results are unlikely to occur 
because of low drug sensitivity. Rather, the data point to an
USol.
interesting dissociation, where drug effects at low to
moderate doses are task specific. This observation has
recently been confirmed by Lines, Preston, Broks and Dawson
(1991) using 0.6 and 1.2 mg oral scopolamine and an
independent study by the author (Raphael, Dunne, Statham,
Kemp and Kelly, 1991, manuscript in preparation) using 0.43mg
subcutaneous scopolamine, where semantic memory retrieval was
not impaired in experiments where significant effects were
found on several other cognitive tasks.
In theoretical terms, it is clear from experiments three and
/
four that scopolamine does not selectively effect effortful
information processing during semantic memory retrieval. In
terms of the scopolamine model of dementia, the data suggest
that. for healthy normal subjects at least, the model may
have severe limitations.
The next step in this series of experiments is to examine the
integrity of the central hypothesis when effects of
scopolamine upon a range of measures of human learning are
observed. From other studies, there appears to be little
doubt that scopolamine impairs learning and memory (Crow, 
1979; Kopelman, 1986). The aim of experiment five was to 
introduce tasks which vary in terms of their requirement for 
conscious, effortful information processing (from minimal to 
high), in an attempt to isolate the point where the drug may 
begin to impair performance.
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CHAPTER FIVE
Does scopolamine selectively impair effortful processes in
episodic memory?
5.1.1. Introduction
In chapter one, it was argued that episodic memory tasks
which require conscious processing impaired byare
scopolamine, whereas more automatic memory processes remain
intact. While many learning and memory experiments have
used multiple tasks to assess the drug's effects (c.f.
Broks et al, 1988; Parrot, 1986; Preston et al, 1988), to
date none have specifically chosen tasks which sample
different points hypothetical continuum ofon a
automaticity.
Experiment five was conducted to evaluate the drug's
effects upon four measures of verbal learning that sample 
different points on this continuum. A word completion task 
was included as a measure of non-conscious or procedural
memory, and is regarded as a task which requires only (or 
predominantly) automatic processing. Recognition memory was 
assessed, and while this is a conscious function, it is 
thought to require fewer processing resources than recall 
(Craik and McDowd, 1987). Recall performance was measured, 
and nested within this was an assessment of the extent to
which subjects could consciously cluster or organise the 
retrieval of items on the basis of input modality. A brief
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background to each measure, and experimental predictions.
are given below.
5.1.2. Background to the tasks used in Experiment Five
(1) Word Completion task
A common methodology here is to demonstrate repetition
priming, which is where a subject is given a set of 3-
letter stems (e.g. BEA ) or word fragments (e.g. 
after exposure to words in recall or recognition lists. The
B_A_H)
subject is asked to complete each stem or fragment "with
the first word that comes to mind", and half of the items
are derived from previously presented words, while the
other half are from distractor words. The usual outcome is
that subjects show significantly greater than chance 
completion of repeated stems, and this is independent of 
whether the words have been consciously remembered during 
explicit memory tests.
There is some support for the view that repetition priming 
reflects the operation of a separate memory system (Squire, 
1986). However, Moscovitch et. al. (1986) have questioned 
whether memory systems are really separable, and argued 
that performance may be seen as a function of the task 
demand characteristics. The question of whether priming 
phenomena reflect a separate memory system is complex, and 
has recently been examined in detail by Roediger (1990).
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Important to the present study, however is the generally
accepted view that word completion performance is 
example of automatic ("implicit" or "procedural") memory
an
(Schacter, 1987; 1990; Squire et. al. 1985).
Studies of people with Alzheimer's disease have not reached
consensus on whether implicit memory is intact (see section
1.6.1. for a detailed review). Briefly, it is generally 
agreed that non-conscious memory functions such as word 
priming and the learning of procedural skills are preserved
relative to the large deficits observed with conscious
cognitive functions in this disease.
Only three studies have been published which examine the 
effects of scopolamine upon procedural memory (Frith et. 
al., 1989; Kopelman and Corn, 1988; Nissen et. al., 1987), 
and these were reviewed in section 1.7. Scopolamine had no
effect on procedural memory in two of these three
experiments, but the issue requires further research.
Recognition Task.
There has been a considerable amount of research on
recognition memory, which can only be briefly described 
here. In terms of resource theory. Hasher and Zacks (1979) 
suggested that recognition was a more automatic task than
recall in the sense that it involved less conscious
reconstruction of the to-be-remembered event. Craik and
132
McDowd (1987) used a dual task methodology to determine the 
relative vulnerability of memory tasks to secondary task
interference. Free recall was impaired by the secondary
recognition. Craik andtask to a greater extent than was
McDowd argued that recognition involves less self-initiated
activity and fewer processing resources than recall. While
recognition is of course a conscious memory process, it may
be positioned a "step lower" than recall on the gradient of
cognitive control required for efficient memory
performance.
Studies of recognition in people with Alzheimer's disease 
almost invariably, a performance deficit relative tofind.
controls (see Morris and Kopelman, 1986). With regard to
scopolamine, however, the data are less consistent. Frith
et. al. (1984) and Richardson, et. al. (1984) found that 
the drug significantly impaired 
recognition, whereas Beatty et. al. (1986), Dunne and




The recall of lists of words, numbers or ideas is the most 
common metric of cognitive performance both in studies of 
the effects of scopolamine and cognitive loss in AD. The 
most widely held view is that impaired performance on tests 
of episodic memory is due to disruption to acquisition
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processes (Kopelman, 1986). As discussed in section 1.7. 
though, this position is open to debate, and the specific
question of whether the learning deficits are due to 
impaired attention and/or organisational processes during
acquisition and retrieval requires further investigation.
In the present experiment, an attempt was made to measure
both recall performance and efficiency in conscious
organisation of to-be-remembered material. with the
following variables being examined;
1) The ability to cluster retrieval by modality of input. 
This is essentially a test of the ability to organise newly 
acquired information in memory. While no previous studies 
have examined effects of scopolamine upon such a measure, 
the task itself is relatively well understood. When words 
in a list are either read or heard by subjects, there is 
usually some evidence of spontaneous clustering in free 
retrieval (Hintzman et. al., 1972;, Nilsson, 1973). This 
clustering effect is magnified when subjects are 
specifically instructed to organise retrieval by modality, 
and is found to improve with practice (Nilsson, 1973). 
Given these observations, clustering of items in recall can 
be thought of as an effortful process, on the basis of 
accepted criteria outlined to distinguish between effortful 
and automatic processes (Hasher and Zacks, 1979),
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There are several measures currently is use to quantify the
extent of item clustering in recall (Frankel and Cole,
1971; Robertson and Ellis, 1987; Roenker et al, 1971).
While there are some differences in computations, most
methods are similar, in that they calculate a ratio based
on the sum of consecutive items in the various categories
(runs) divided by the maximum possible number of intra­
category repetitions. This experiment used the Adjusted
Ratio of Clustering (Roenker et al, 1971) so that
comparison could be made to the human memory data of
Nilsson (1973) .
2) Control over retrieval in the presence of an alternative 
clustering scheme. Organisation by modality was assessed as 
in 1 above, but in this case the lists contained words from
semantic clusters as well. Each list was comprised of two 
of strongly associated words (e.g. sports and 
colours), half of which were presented aurally and half 
visually. It was thought that subjects would have more 
difficulty clustering by modality in the presence of an 
alternative (and possibly distracting) potential clustering 
scheme, and that scopolamine would have a greater effect on 
modality clustering in these more difficult trials.
groups
3) Total recall. Overall recall performance on each trial 
was examined independently of clustering.
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Summary of the experimental variables: While there are many 
possible dependent measures here, the primary focus of 
interest was on the effects of scopolamine upon word
D
completion, total recognition score, total recall score, 
and clustering by modality scores. The primary theoretical
consideration was that these four measures reflect
cognitive activity at different points of the automatic-
controlled processing continuum.
5.1.3. Predictions: On the basis of previous research, it
was predicted that scopolamine would significantly impair 
total recall, and, perhaps, recognition. If scopolamine 
does not impair automatic processing, then repetition 
priming in word completion and other non-conscious aspects 
of memory (such as the recall advantage for auditory 
material) should remain unaffected. In contrast, the
measure of modality clustering, which is a conscious.
effortful process, should show a significant degree of
impairment.
5.2. Method: experiment five
5.2.1. Subjects: 16 volunteer subjects (8 females, 8 males; 
mean age 25.1 years, range 18-37 years) participated in the 
study with informed consent. As in previous experiments, 
they were screened for medical contraindications and
concurrent drug use. They were asked to abstain from food 
and caffeine-containing products for at least two hours
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prior to testing, and none had consumed scopolamine for at
least one month before the experiment.
5.2.2. Scopolamine Tablets; Doses of 0.9mg Scopolamine
Hydrobromide (0.3mg tablets X 3) or physically matched 
placebos (3) were administered in a double blind repeated 
measures design.
5.2.3. EXPERIMENTAL TASKS
5.2.3. (i) Recall Test: In each of the 8 recall trials in
each session. 6 words were read by subjects on a VDU and
these were randomly interspersed with 6 words spoken by the 
experimenter through headphones. Subjects were required to
recall, immediately, as many words as possible from the 
preceding list. In addition, they were instructed to group 
words together according to whether they saw or heard them.
Subjects were told that they were free to recall these
groups or clusters in any order (i.e. visual before
auditory, or vice versa), 
down the page on a response sheet.
but that they must list the words
In all. 24 lists of words were constructed for this phase
of the experiment. On each test day, subjects were given 
practice trials with 4 semantically unrelated lists of 
words , and in the test session, 4 lists of unrelated words 
followed by 4 lists of semantically related words. Lists
were constructed in the following manner:
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of 24 categories from the1) 12 words were taken from each 
Battig and Montague (1969) norms (see Table 5.1)
Table 5.1: Natural categories from which words were 















Parts of the body 










2) Each of the 16 semantically unrelated lists were
constructed by taking, from the set of 192 available items,
1 word from each of 12 separate categories. After the lists
constructed, each checked for unexpectedwere was
associations e.g. if "sailor" taken fromwas
occupations/professions and "ocean" from natural earth
formations, then this was judged to be an unwanted
association, and one of the items was replaced with a word 
from another list. The final 16 lists were then randomly 
assigned to either the practice(8) or test(8) phases. 
Within each list, each word was randomly assigned for 
auditory or visual presentation, with the constraint that 
no more than three words occurred consecutively in the same 
modality.
3) Each of the 8 semantically related lists was formed by 
taking 6 words from a Battig and Montague category and
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mixing them with 6 words from another category. Again,
after all lists were created a check was done to eliminate
unwanted associations. Within each list, each word was
assigned to auditory or visual presentation in a semi­
random manner, with the constraints that there should be
equal numbers of auditory and visual words from each of the
two semantic categories and that there should be no more
than three consecutive items in the same modality.
All lists of words and their corresponding mode of
presentation are shown in appendix 5.1. Control over
sequential order effects was gained by using an 8 x 8 
balanced latin square design to create an arrangement where
no list followed another more than once. After this design
was applied across the three subgroups of word lists (i.e. 
practice, unrelated test, related test) each sequential 
list order was equiprobable.
5.2.3. (ii) Delayed Recognition Test: In each session, 
subjects were presented with one list of 28 words at a rate
of one item per 1.5 seconds. 14 words were visually
presented on a VDU, while 14 were spoken by E through 
headphones. After all words were presented, Ss were 
required to count backwards from 100 by 9's, 8's 7's etc
for one minute. After this, they were given a four page
response booklet containing 42 words (see appendix 5.1). 
For each word, subjects were required to judge the word as
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or "Old", and then make a judgement about whether"New"
they had seen or heard the word in the earlier list.
This recognition task was constructed from an original pool
84 words. These were a minimum of four letters in lengthof
and had no more than three syllables, and the first three
letters of each (the "stem") were shared in common with at 
least 10 other words in a standard dictionary (see the word 
completion task below). From this group, two thirds (56)
were randomly designated as target words while the
remainder (28) served as semantically unrelated distractors 
in the later recognition test. Once this was done, a group 
of 28 words that had strong semantic associations (Keppel 
and Strand, 1970) with 28 of the recognition list words was
semantically relatedobtained. and these served as
distractors in the recognition test.
Following this, half of the words in each list type were 
assigned to one of two test forms (A or B, one for each 
session). The final outcome of this process was that, in 
each test session, subjects were shown an original list, 
and after the intervening subtraction task, completed a 
response booklet with 14 of the original target items, 14 
semantically related distractors and 14 unrelated
distractors which were mixed together randomly. Care was 
taken to ensure internal balancing of presentation modality 
in the response booklet to the effect that half of the
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aurally.target words had been visually. and half
presented, and further that half of the semantically
related distractors were associated with words that had
while the other halfbeen visually presented. were
associates of aurally presented words. None of the words
used in this recognition test had appeared in the recall
lists, and the order of presentation of test forms A and B
was randomised across subjects.
5.2.3. (iii) Word Completion Task: In this task, subjects
were required to complete a word from a three letter stem.
to TYPist. A response booklet givenTYPe.g.
immediately after the recognition test contained 56 stems.
and subjects were asked " to complete each item with the 
first word that comes to mind ", with the proviso that they 
avoided the use of proper nouns and colloquialisms.
The task was constructed by taking the three letter stems 
of the 28 items originally presented in the recognition 
list and randomly mixing them with 28 distractor stems in
the response booklet (see appendix 5.1). Each stem chosen
could be used to complete no less than 10 words in a
standard dictionary (Shimamura, 1986). Internal balancing 
ensured that, of the 28 previously presented words, 14 had 
been given visually and 14 aurally and of these, half had 
been presented twice (once in the recognition list, and 
once in the recognition response booklet) while the other
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half had been presented once only (in the recognition 
list). Care was taken to ensure that none of the target or
distractor items shared common stems with items in the
recall lists, although subsequent to the experiment it was 9
discovered that three word stems did not reach this
criterion (all were found to have been used as distractor
stems).
5.2.4. Apparatus
Words were visually presented on a Sanyo colour monitor
controlled by CBM64k while auditorycomputer.a
presentation occurred through TEAC headphones with voice 
relayed via a microphone attached to a Sanyo cassette 
recorder set on pause. Synchronisation of aural and visual 
stimuli was controlled by the computer program. For visual 
items, Ss were shown a word in block letters 0.8cm high in 
the centre of the screen for 1.0 seconds followed by a 
pause of 1.5 seconds. During auditory presentation, a 
sign appeared on the screen simultaneous with the spoken 
word. The E was prompted to speak the auditory words into 
the microphone when the items appeared on another monitor 
controlled by a different CBM64k computer. The onset of the 
two concurrently running programs was controlled by E with 
a microswitch linked to the two computers. Subjects sat 
diagonally opposite from E in a semi-enclosed booth approx 




On each test day subjects entered the laboratory and were
given four practice recall trials. This was done mainly to
familiarise the subjects with the modality clustering
requirement and to inform them, in the first session, of
the nature and sequence of testing to be conducted in the
experiment. After practice, Ss were given the pills, which 
they swallowed with water, and were asked to return exactly
50 minutes later. On return, Ss completed the 8 recall
trials, paused for 2 minutes, were shown the 28 item
recognition list, counted backwards for one minute, and
then completed the recognition and word completion
booklets. Each session took approx. 30 minutes to complete
and sessions occurred on average one week apart. All
testing took place between 12 - 4pm, and as 




Scoring: Data were collated for analysis in two ways; 
words recalled were grouped separately in relation to 
whether the word was originally seen or heard by the 
subject, whether it was from a semantically related or 
unrelated list, and in terms of the list number (1-4) in 
each of two blocks of four lists, 2) errors of intrusion 
were summed across trials.
1)
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Table 5.2s Recall and Adjusted Ratio of Clustering (ARC) 
means: experiment five
"Unrelated" lists "Related" Lists



















































































































N.B. Aud - Words heard by the subjects 
Vis = Words seen by the subjects
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Analysis; Table 5.2 shows mean item recall in relation to
each independent variable. A 2(drug) by 2(presentation 
modality) by 2(list semantic relatedness) by 4(trials) 
repeated measures ANOVA found significant main effects of
semantic relatedness (F=14.03; df=l,15; p<.005) and
modality (F=15.50; df=l,15; p<.005), and no significant
effect of trials (F=1.01; df=3,45; n. s . ) . A recall
advantage for semantically related lists can be clearly 
seen in Table 5.2. The significant advantage for words that
were heard, rather than seen, is illustrated in Figure 5.1
Scopolamine significantly impaired total recall (F=6.22, 
df=l,15; p<.025). The interaction between scopolamine and 
list semantic relatedness was not significant (F<1), in 
that there was no greater effect of the drug on recall from 
semantically unrelated or related lists, and none of the
two, three or four way interactions were significant.
The incidence of intrusion errors is shown in Figure 5.2,
and it appears that they occur more frequently in recall 
from unrelated lists of words, and that the drug produces
more intrusions. A 2X2 repeated measures ANOVA found the
main effect of semantic relatedness to be significant
(F=6.53; df=1,15; p<.025). There was a non-significant
trend for a drug effect 
interaction between the two variables (F<1).
(F=3.35; df=l,15; .05<p<.10) and no
Figure 5.1: Recall Performance
145N recalled
Figure 5.2: Intrusions during recall
Number
n.b. Numbers are totala acroaa subjects
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5.3.2.: Clustering by Modality
Scoring: The extent to which subjects could follow the
requirement to group recalled items according to
presentation modality was assessed by calculating ARC 
values for each trial (A detailed description of the 
computational method, with examples, is provided in
appendix 5.2).
Analysis: Mean ARC scores are shown in Table 5.2. Modality
clustering trials and list relatedness isacross
illustrated in Figure 5.3. Contrary to predictions, there 
was no significant main effect of scopolamine (F<1). The
main effect of list semantic relatedness notwas
significant (F<1). Clearly, the presence of an alternative 
clustering scheme (i.e. the possibility of grouping words
on the basis of semantic category) did not effect the
ability of subjects to cluster words on the basis of input
modality.
An effect of the drug upon modality clustering was observed 
in the two way interaction between Scopolamine and Trials. 
While the main effect of trials failed to reach
significance (F=2.77; df=3,45; .05<p<.10), there was a
significant interaction between drug and trials (F=4.39; 
df=3,45; p<.01). 
fairly complex pattern. At trial 1 (in each block of four
With reference to figure 5.3, we find a
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trials) ARC scores are higher in the drug condition, at
trial 2 no difference is discernible between drug and
placebo, and then, at trials 3 and 4, ARC values are
considerably lower in the drug condition. Placebo ARC
scores appear relatively constant across trials whereas
there is an almost linear reduction from trials 1 to 4 in
each block under scopolamine.
5.3.3: Recognition
Scoring: The measures obtained here were; 1) The number of 
words that were correctly judged to have been presented in 
earlier lists, 2) The numbers of false positive judgements 
to both semantically related and semantically unrelated 
distractors and 3) The proportions of correctly recognised 
words which also had correct modality judgements.
Analysis: Recognition judgements are illustrated in Figure 
5.4. Recognition accuracy was close to 80%, and scopolamine 
did not have a significant effect on this measure (F < 1). 
With regard to false positives, a 2(drug) by 2(related vs 
unrelated distractors) ANOVA found that false positives 
occurred more often when the distractor was semantically 
related rather than unrelated to an earlier list item
(F=14.12; df=l,15; p<.001). Scopolamine did not effect the 
number of false positives (F=1.40; df=l,15; n.s.) and there 
was no significant interaction between the drug and 
semantic relatedness (F<1).
Figure 5.3: Clustering by Modality 
ARC scores from recall lists 148
Mean ARC score
Figure 5.4: Recognition Performance
Proportion of total
Correct Related-Diet Unrelated-Dlst 
Correct or false recognition
ScopolaminePlacebo
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The ability of subjects to correctly judge the input
modality of correctly recognised words is shown in Figure
5.5. Correct modality judgement occurred on 70.0% of items.
A 2X2 ANOVA found no main effect of scopolamine upon
correct modality judgement (F<1), and no difference between 
the accuracy of judgements of words that were previously
seen or heard (F<1), and no interaction between drug and
presentation modality (F<1).













Modality identification for semantically related false 
positives should also be noted (see Figure 5.5). Subjects 
correctly judged the modality of the old list words which
were semantically related to the distractor on 65.15% of
responses in the drug condition, and 64.81% in the placebo
condition. This level of identification is above that which
would be expected by chance (i.e. 50%). When subjects
'guessed' the input modality of unrelated distractors, they
were equally likely to judge that the word was presented 
visually (54%) and aurally (46%), which would be expected 
on the basis of chance guessing.
5.3.4: Word Stem Completion
Scoring; Subjects found little difficulty with this task, 
with response sheets revealing that stems could not be
completed on only 4 of the 1792 individual responses
required throughout the experiment. Data were collated in
the following ways; 1) Numbers of responses which matched a 
word that had previously been presented once in the test
session, 2) Same responses where the word had been
presented twice (once in the recall list, and again in the 
recognition list), and 3) Numbers of responses to 
distractor stems which matched a word previously chosen by 
the experimenter but not shown in earlier lists. Word
matching criteria were strict, in that plurals and
contractions and words in a different tense were not scored
as a match.
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Figure 5.6a shows that the probability of wordAnalysis:
stem completion was higher for "old" list words than the
(F=53.00;chance completion of a distractor word stem
df=l,15; p<.001). There appears to be a trend for poorer
stem completion in the drug condition, but this was not
statistically significant (F=3.42; df=l,15; n.s.).
Figure 5.6b shows completion of words by each modality and
number of presentations. Half of the prime words had been 
presented once only in the initial list, whereas half had
been presented twice (initial list and visually in the 
recognition test). Analysis of Variance found that stems 
completed frequently after two priorwere more
presentations (F=103.09; df=l,15; pc.OOl) and when the word 
was visually, rather than aurally, presented in the earlier
recall list (F=5.45; df=l,15; p<.05). In this analysis.
data from distractor stem completion were not included.
Again, scopolamine did not significantly impair word
completion performance (F=2.94; df=l,15; n.s.) and no 
significant 2 way interactions (F<1) or 3 way interaction 
(F=1.31; df=l,15; n.s.) were significant.
5.4. Discussion: experiment five
This experiment found some support for the prediction that
effortful cognitive 
processes, although the conclusions are limited by a number
scopolamine selectively impairs
Figure 5.6a: Word Completion Task 












Figure 5.6b: Word Completion Task 














of factors. After discussing the general pattern of
effects, several methodological limitations of this
experiment are described.
The drug did not significantly impair word completion 
performance, which replicates an observation by Kopelman 
and Corn (1988) and makes this the third study to find that
automatic or 'procedural' memory phenomena are very
resistant to disruption by scopolamine (see also Nissen et
al, 1987). In addition, the absence of an effect on
recognition memory confirms 
Rusted and Warburton (1989) that this measure of conscious 
or 'declarative' memory, which requires less cognitive 
effort than recall (Craik and McDowd, 1987), is sometimes 
resistant to cholinergic blockade.
a previous observation by
The impairment of immediate recall confirms many previous 
findings (Crow, 1979; Ghoneim and Mewaldt, 1977; Kopelman 
and Corn, 1988), and is the single most predictable effect 
of this drug. To the extent that recall requires more 
controlled cognitive resources than recognition (Craik and 
McDowd, 1987), then the hypothesis of a selective drug 
effect upon effortful processing is supported. However, the 
primary aim of this experiment, which was to identify an 
effect of scopolamine upon subjects' ability to organise 
list words on the basis of modality of input, achieved
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limited success.
Two points should be noted in discussing the Adjusted Ratio
of Clustering scores. First, the recall data showed the
expected advantage for auditory over visual information, 
and this 'modality effect' did not interact with the drug.
Second, in the recognition test, scopolamine did not impair
correct recognition of the mode of item input. Taken 
together, these findings suggest the drug does not impair
memory for modality. and therefore that modality
information was potentially available to subjects while 
attempting to cluster items both during acquisition and 
retrieval. Kirsner (1974) has shown that modality 
information persists over very long intervals, with above 
chance accuracy for more than one hour. In addition, it is 
interesting that, in this experiment, subjects had above 
chance recognition of modality for items which were only 
semantically related to the "old" words in the recognition 
test. The modality information appears to be available even 
when there is imperfect recognition of the actual item.
Scopolamine did not impair modality clustering. On the face 
of it, then, the predicted effect on organisation in recall 
was not found. However, the significant drug by trials 
interaction in modality ARC scores suggests that a drug 
effect on clustering cannot be discounted altogether.
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It is difficult to explain why the drug would interact with
trials in the ARC data. In Figure 5.3, there is an apparent 
clustering advantage under the drug in the first trial of
each block of four, no difference in the second, and then a
reduction in trials three and four. It should be noted that
subjects were reminded to cluster retrieval by modality at
the beginning of the session and after the fourth trial on
unrelated lists (before the semantically related lists). 
The most straightforward explanation of declining ARC
scores in trials three and four of each block is that
subjects in the drug condition simply forgot about the 
clustering requirement, and changed to a more conventional
pattern of recall. This may be unlikely, since subjects
were practiced before each session, and while no formal
measure was taken, it is doubtful that they would have
forgotten this element of the recall task. In addition.
that proposition does not explain the relative clustering 
advantage under the drug in trial one.
5.4.1: Methodological limitations:
There are several difficulties with the research design and
test materials in experiment five which may have interfered 
with the attempt to find effects of scopolamine upon 
conscious memory organisation.
5.4.1. (i) Research design issues
It was hoped that this experiment would find that
156
scopolamine impaired recall and clustering. It might then
have been possible to suggest that at least some of the
recall impairment was due to poor conscious organisation of 
the words during acquisition and/or retrieval.
From experiment five it is not directly apparent whether 
recall impairment by scopolamine co-varies with an effect
of the drug on clustering. This would seem unlikely.
however, since the observed drug by trials interaction in
modality ARC scores was not found in the recall data, and
the main effect on ARC scores was not significant.
One way to determine a relationship between modality
clustering and recall would be to introduce a condition
where recall and clustering were attempted under two levels 
of task difficulty. In experiment five, the list semantic 
relatedness variable was introduced so that subjects would 
be attempting to cluster words by modality in the presence 
of an alternative (and perhaps dominant) clustering scheme. 
It was expected that subjects would find it more difficult 
to cluster words on the basis of input modality during 
semantically related lists. If, theoretically, scopolamine 
was to have a greater effect on clustering in difficult 
trials, then the largest drug effect on modality ARC scores 
would be in the semantically related lists.
However, the semantic relatedness factor was a very weak
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experimental manipulation, and is possibly a confounding 
variable. Clustering by modality was not affected by list 
semantic relatedness, and this should have been established
in a pilot study. In addition. semantic relatedness
confounds the issue. If the aim was to show that the drug
affected clustering in difficult trials and this perhaps 
causes poor recall, then any chance of this happening may 
be negated by the fact that semantic relatedness actually
improves recall. Such an effect should have been predicted 
from previous research (Wickens, 1972) .
5.4.1 (ii) Further problems
The 16 word lists in experiment five contained a great deal
of "experimental noise". That is, the requirement to
compile a list of so many words reduced experimental
control over the attributes of the stimuli, such as
frequency. imageability, syllabic structure and word
length, all of which to some extent influence the
probability that individual items will be recalled (Paivio, 
1976; Wickens, 1972). While the impact of these factors on 
recall variability may have been reduced by randomising 
presentation across subjects, it remains probable that the 
stimulus materials themselves contributed to high overall 
error variance in the data.
In the next study, word lists were refined and new
procedures adopted to enable greater resolution on the
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cognitive control under investigation.process
Specifically, a limited number of words were selected, and
these were closely matched in terms of frequency in the
printed language, imagery and the physical structure of the
words. These materials were then presented in a five-trial
list learning procedure: the same lists were repeated five
times, with words presented in the same temporal order. In
this way, it is possible to measure clustering by modality
across lists which do not differ on the basis of stimulus
characteristics.
Another possible limitation of experiment five was that
subjects gave written responses, and this may have 
influenced the measurement of clustering. Although subjects 
were asked to write their responses down a page in the same 
order in which they were retrieved, examination of the
response sheets indicated that this instruction may not 
have been followed in every case. Some subjects left spaces 
on the response sheets to separate auditory and visual 
words, and it appeared that several subjects placed items 
in these spatial groupings, instead of writing retrieval 
consecutively. The end product, of course, is that the ARC 
scores for these subjects would not be valid. In experiment 
six, the order of retrieval was tape-recorded, and
therefore it was not possible for subjects to selectively 
group the output after retrieval. In his original 
Nilsson (1973)
paper.
obtained written records of output, but he
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did not address the issue of whether this threatened the
validity of the ARC scores, or if so, how he overcame it.
The next chapter describes a study which simplifies the 
questions asked by experiment five. The design of 
experiment six has one focus: to directly assess effects of 




Can it be clearly demonstrated that scopolamine impairs
active organisation in memory?
6.1: Introduction:
The previous experiment offered some support for the idea
that effortful processes in memory are disrupted by
scopolamine, while more automatic processes remain intact. 
However, that study did not add much to existing knowledge.
but simply confirmed previous findings that word stem
completion and recognition are less vulnerable to the drug
than is immediate recall. The attempt to show that 
scopolamine impairs active clustering of items on the basis 
of input modality provided data which were only suggestive
of an effect, and the issue was clouded by several
methodological factors.
One important question in the study of anticholinergics and 
memory is this: Can it be clearly demonstrated that the 
drug's effect on recall is linked to an impairment of 
conscious organisation of new information in memory? In 
conventional studies of the effects of scopolamine, it is 
often found that the drug impairs new learning, but that 
recognition is impaired to a significantly lesser degree 
(Flicker et. al., 1990; Rusted and Warburton, 1989). It may 
be that some information is admitted into longer term 
storage, but the drug impairs organisation at encoding
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(Kopelman, 1986). In this view, stored information is less
accessible in attempts to recall because the subject has 
been less efficient is using mnemonic strategies to
organise the material in a meaningful way. Recognition is
less affected by scopolamine, and this may be due to the
fact that recognition does require consciousnot
reconstruction of the material (Craik and McDowd, 1987),
and hence is less dependent on the extent to which the
information was organised during learning.
But what is the nature of this scopolamine-induced 
"disorganisation"? Frith et. al. (1984) suggested that 
when words in lists are semantically related, the 
disruptive effects of the drug on recall were minimised. It
is possible that subjects use semantic relationships as a
mnemonic scheme to overcome a drug effect. However, Rusted
and Warburton (1989) found that semantic relatedness did 
not protect against the scopolamine deficit. Of course, 
when subjects attempt to remember long lists of words, they
use a variety of schemes to group items in memory.
including grouping on the basis of temporal order, spatial
arrangement and input sensory modality, as well as 
idiosyncratic mnemonic associations (Nilsson, 1973; 
Tulving, 1983; Glenberg and Swanson, 1986). Clearly, the 
drug might be affecting recall by disrupting subjects' 
ability to use any or all of these organisational schemes.
The question of reduced organisation during encoding or
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storage under scopolamine has not yet been directly tested.
Most previous studies have been based on what might be
called "passive" data: passive in the sense that subjects
have not been specifically required to organise information
that is to be learned. Inferences about processing
requirements are usually made on the basis of stimulus
attributes such as word list semantic relatedness, imagery
or concreteness, temporal relationships between items and
so on (see Caine et. al., 1981; Frith et. al., 1984;
Richardson et al., 1984), but in most cases it is not clear 
whether subjects were actually doing what was inferred. The*
aim of experiment six was to introduce a multi-trial verbal
learning task where subjects are required to actively 
organise their recall on the basis of encoding context. In 
addition, there were two levels of difficulty in this task.
which are described below.
When items are presented in exactly the same way across 
successive trials, total recall increases. One way of 
interpreting this learning is to say that repeated 
presentations increase the level of activation of the item 
in memory (Klatzky, 1975; 1984). However, if the encoding 
context varies across learning trials, successive 
representations of items are not reinforced completely, and 
words therefore have lower activation. Items with high 
activation (trace strength) are accessed more quickly and 
more completely than are items with low activation (Huppert 
and Piercy, 1978).
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In this experiment, subjects were asked to recall words
under two conditions. In one block of five learning trials.
successive lists were presented in which the words,
temporal order and modality were exactly the same
(Consistent condition). In the other condition, five 
successive lists were given where the words and temporal
order were the same, but the modality of presentation
varied across trials (Variable condition). Subjects were
required to cluster words on the basis of input modality.
Predictions
Since the words and temporal order are the same on all
successive trials. it was expected that the primary
difference between the consistent and variable conditions
would be that memory for modality would be weaker in the
variable trials, and therefore that subjects would have a 
reduced ability to organise words on the basis of modality.
To the extent that subjects use modality in organising
recall, it was expected that total recall would also be
poorer on variable trials.
In theoretical terms, clustering in the consistent 
condition would be more automatic, while in the variable 
condition (where modality information is weaker), subjects 
would have to exert more cognitive effort in the 
organisation of word lists. Hence, it was predicted that 
the drug would impair clustering ability and recall most in 
the variable modality trials.
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The validity of the predictions regarding the internal
attributes of the task were examined in a pilot study,
which did not include drug as a variable.
Experiment Six Pilot study
6.2. Method.
6.2.1s Subjects: Ten volunteer subjects (7 female, 3 male; 
means age 19.8; range 17-27) participated in the pilot.
6.2.2: Test Materials;
6.2.2 (i) Recall tests; Ajii pool of
constructed (see Appendix 6.1). These words were all low to 
medium frequency in the printed English language, with 
Kucera-Francis values of less than 100 per million (Kucera 
and Francis, 1967). All words had imagery values of less 
than 5.0 on a 7 point scale using norms from Paivio, Yuille 
and Madigan (1968) and Abernethy (1989). In addition, they 
were between 4-8 letters in length and had either one or
128 words was
two syllables.
Five lists of 16 words were constructed for the experiment: 
one for practice and four for testing, with the latter 
group being divided into two test forms (A and B) . All 
words were randomly assigned to lists, and analysis of the 
frequency and imagery values revealed that the lists did 
not differ significantly on these measures.
*
Five practice trials were given, using the same list on
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each trial. In each successive presentation, the same words
appeared in the same temporal order and the same modality 
(consistent modality condition). Subjects were instructed
to immediately recall as many words as possible. In
addition, they were asked to try to cluster the words as
much as possible in terms of whether they saw or heard
them, but they were to report any words that came to mind
even if they were unsure of the modality or if the word
appeared out of the appropriate cluster.
the test session, subjects were assigned to test form AIn
or B, and given five learning trials in the consistent
modality condition, with recall after each trial. Following 
this, they were given five trials with a different list in
the variable modality condition. In these trials, the same 
words appeared in the same temporal order, but the modality 
of presentation varied across trials. The pattern of
variation across trials is shown in Table 6.1. The
presentation was balanced to the extent that, horizontally, 
no word appeared in the same modality on more than two 
consecutive trials and each word was presented either twice 
or three times in each modality. It can also be seen in 
Table 6.1 that, vertically, no more than three words 
appeared in the same modality consecutively.
6.2.2 (ii) Recognition tests; The remainder of the words
from the original pool were used as distractors in the 
recognition test. Here, subjects were given a 3 page
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Table 6.1: Modality of presentation for words in the 
Variable Modality condition. Test forms A and B.
Presentation Modality
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A A V A V
V V A A V
V A A V A
A A V A V
A V V A V
n.b.: A = Auditory, V = Visual
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booklet containing 32 words and were asked to indicate
whether they recognised each word from an earlier list (see 
appendix 6.1). All target words (N=16) were taken from the 
consistent modality word list. In addition, subjects were
required to indicate whether each "old" word had been seen
or heard in earlier trials.
6.2.3: Apparatus: Visual stimuli (words 0.8cm high) were
shown to Ss for 1.5 sec on a CBM colour monitor, with
presentation timing controlled by the internal clock of a
CBM-64 computer. The inter-stimulus interval was 1.5 sec.
Auditory stimuli were spoken by E, 
presentation to E controlled by a program running on a CBM-
with timing of
62 system and relayed to S via a Yamaha TC-320 Cassette
Deck to Bell and Howell headphones. Subjects' spoken
responses were recorded on a Technics Dual Cassette Deck.
6.2.4: Procedure:
Subjects were tested on an individual basis. They were 
given the practice list, and instructed to recall as many 
words as possible by speaking into a microphone as soon as 
the final word was presented. This was followed by the 
consistent modality condition, 
modality condition. Test form (A or B) was counterbalanced
the recognition 
administered. The entire test session took approximately 40 
min.
and then the variable
subjects. Finally,across test was
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6.3: Results (pilot study)
6.3.1: Recall Performance: Mean recall performance as a 
function of modality of presentation and modality
consistency condition is shown in Table 6.2. A 2(Modality 
consistency) by 2(sensory modality) by 5(trials) repeated
measures ANOVA found that recall in the consistent
condition was significantly higher than in the variable
condition (F=5.22; df=l,9; p<.05). There was a significant 
effect of trials (F=41.22; df=4,36; p<.001), indicating
that recall increased over the block of trials, while the
interaction between trials and modality consistency
approached significance (F=2.53, df=4,36;.05<p<.01).
Subjects recalled significantly more auditory than visual 
words (F=8.45; df=l,9; p<.025), and there was a significant 
interaction between trials and input modality (F=3.33; 
df=4,36; p<.025). This interaction is shown in Figure 6.1, 
where the slope of the increase for visual items is greater 
than that for auditory items.
This analysis clearly indicates that recall is diminished 
when the encoding context (modality) is varied across 
trials. In addition, it confirms the relative superiority 
of auditory over visual information in immediate recall.
6.3.2: Clustering by Modality: Mean ARC scores as a 
function of trials and modality consistency are shown in 
Table 6.3. A 2 by 2 repeated measures ANOVA found no main
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Table 6-2: Recall as a function of modality consistency 
across learning trials
Mean recall 
Trial 2 Trial 3Trial 1 Trial 4 Trial 5
A V A V A V A V A V
Consistent Modality Condition
X 5.3 2.2 5.4 5.2 6.2 6.1
sd 1.6 1.4 1.7 1.6 1.5 1.5
6.8 6.6 6.9 7.0
1.2 1.2 1.3 0.8
Variable Modality Condition
X 4.0 3.2 5.2 4.6 5.5 4.6





Note: A = Auditory Presentation, V = Visual Presentation






Table 6.3: Adjusted Ratio of Clustering scores 
function of modality consistency across trials.
as a
ARC Scores
Trial 1 Trial 2 Trial 3 Trial 4 Trial 5
C V C VC VC V C V
.69 .75 .82 .61 .86 .42 .88 .66 .86 .52X
sd .42 .36 .34 .40 .32 .33 .29 .39 .29 .13
Note: C = Consistent and V = Variable
i















effect of trials (p<l)/ but did find a significant main 
effect of Modality Consistency (F=7.06; df=l,9; p<.05).
As with the recall data, the interaction between trials and
modality consistency approached significance (F=2.62; 
df=4,36, .05<p<.01; critical value at .05 = 2.63) . In
Figure 6.2, we see that ARC scores increased over trials in
the consistent condition, but decreased in the variable
condition.
These data confirm the original hypothesis that clustering 
would be impaired when contextual information varies across
trials, and show the expected increase in clustering when
the contextual information is consistent.
6.3.3. Recognition performance: Recognition of the words
was nearly perfect, with hit rates of 95% for both auditory 
and visual words. For words that were correctly recognised, 
the probability of correct modality identification was 0.95 
for auditory and 0.927 for visual words. Given the absence 
of variability in these measures, no statistical analysis 
was conducted.
6.4s Discussion (pilot, experiment 6)
This pilot testing achieved several aims. First, it
revealed that the list learning task produces an increase
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in recall across trials, and this occurs in both the
consistent and variable modality conditions. Second, it
shows that output is reduced by approximately 17% on the
final learning trial when the contextual information varies
Third, the Adjusted Ratio of Clustering 
(ARC) data show that clustering is reduced in the variable 
modality condition (by approximately 40% on the fifth 
trial) in comparison to the consistent modality condition, 
but that clustering is still well above zero in the
across trials.
variable condition.
The poorer ARC and recall scores on variable trials would
suggest that this condition is difficult. This was
supported by feedback from subjects, who reported that it 
took considerably more effort and concentration to actively 
group items on variable trials.
The recognition data show that there is nearly perfect 
identification of presentation modality from consistent 
lists up to 10 minutes after the words were perceived by 
the subjects. While there are some problems with the 
recognition data, since performance is near ceiling, they 
at least suggest that modality information is potentially 
available to subjects when they are attempting to organise 
words in memory. This agrees with previous studies 
which find modality information to be relatively well 
preserved for an hour or more after testing (Broadbent et. 
al., 1980; Kirsner, 1974).
the
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Additional measures in experiment six
A number of new measures and design factors were included
in this experiment. First, a between groups, rather than
repeated measures, design was used. This was primarily done 
several "surprise" tests of long term recall couldso that
be included. Each subject first completed 
baseline) tests of recall and recognition, was then given 
scopolamine or placebo, and
pre-drug (or
then completed a repeat
session. After this, they were given unexpected tests of
their recall and recognition of material learned before the
drug.
One strength of this design is that direct effects of 
scopolamine upon retrieval (albeit long term recall) can be 
assessed, and so therefore any effects of the drug on 
learning and organisation of new material can be compared
to its effects on retrieval.
Between groups designs (rather than repeated measures 
experiments) are usually not favoured in psychopharmacology 
because, despite random assignment of subjects to 
conditions, it remains possible that high error variance is 
caused by differences between groups. In this study, 
however, subjects' pre-drug performance was used as a 
covariate in the determination of drug effects, which acts 
to reduce between subjects variability (Lehmann, 1986; 
Tabachnick and Fidell, 1989).
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Predictions regarding the effects of scopolamine upon these
measures
If scopolamine directly impairs active organisation
(controlled processing) of words in memory, then this 
should be revealed in experiment six. A number of specific
effects were predicted;
1) The drug would significantly reduce ARC scores
2) With ARC scores, there would be a significant 
interaction between Drug and Modality Consistency, such
that clustering would be impaired to a relatively greater 
degree in variable modality trials.
3) The drug would significantly impair immediate recall, 
but not recall of material learned prior to the drug 
(Ghoneim and Mewaldt, 1975; Rusted and Warburton, 1989).
4) With recall, there would be a significant interaction 
between Drug and Modality Consistency, in that recall would 




6.5.1: Subjects: Forty eight subjects (32 females, 16 
males; mean age 23.5, range 17-42 years) participated on a 
voluntary basis. None of the subjects had participated in 
the pilot study, and all gave full informed voluntary 
consent. None of the subjects were currently taking any
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other prescribed medication, and none reported consumption
of scopolamine for at least a month prior to testing.
6.5.2: Scopolamine tablets: Doses of 0.9mg Scopolamine
hydrobromide (0.3mg X 3) or physically matched placebos (3)
were administered in a double blind design.
6.5.3: Sequence of tests:
(i) Pre-drug session: This experiment used a Pre 
between subjects design, with each subject being assigned 
to either drug or placebo. In each pre-drug (baseline) 
session, subjects were given five practice recall trials 
where modality information was consistent across trials.
Post
These were followed by two blocks of five trials, with one
block each in the consistent and variable modality
conditions. The order of presentation of consistent and
variable blocks was randomised across subjects, so that 
received variable trials followed by consistenthalf
trials, while the other half received the opposite
sequence. In addition, test form (Word lists A or B) was 
counterbalanced across pre/post testing, subjects and drug
condition.
After the third recall block. subjects were given one 
recognition test, which tested recognition for words in the 
consistent modality condition.
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(ii) Post Drug session: No practice was given in the second 
session. Subjects completed two blocks of recall trials 
(one consistent modality, one variable modality), with both 
test form and modality consistency counterbalanced. These 
trials were followed by a recognition test for words in the
consistent modality lists. After this, subjects were given 
several surprise tests of long term memory. First, they
were asked to recall, in any order, words from the first
session (long term free recall). Subjects were then given a 
long term cued recall test. In this test, the experimenter 
said the first two words that subjects heard or saw in each 
of the three lists provided in session one (including 
practice), and subjects were asked to state any words that 
they recalled with the aid of these prompts. Finally, 
subjects were given a test booklet to examine their
recognition of words which appeared in the practice trials.
6.5.4: Experimental Materials 
(i) Immediate Recall Tests: 
experiment were identical to those used in the pilot study 
(See section 6.2.2. and appendix 6.1). The requirements of 
the recall test were explained to subjects at the beginning 
of the practice. They were told that the most important 
task was to recall as many words as possible. While doing 
this, they should attempt to group the words according to 
whether they heard or saw them. However, they were asked to 
report any list words that came into awareness, even if 
they did not remember the modality or if the items were
The word lists used in this
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apparently out of sequence. Subjects were free to decide
the order of report (i.e. whether the auditory or visual 
words were recalled first).
The experimenter and subjects discussed the task
requirements throughout the practice session, and subjects
reminded of the requirements at the beginning of eachwere
block of trials.
(ii) Recognition tests: The word lists used here to assess 
recognition of items from the consistent modality condition
in test forms A and B were identical to those used in the
pilot study. In addition, a new recognition booklet was 
prepared which included all words used in the practice list 
and 16 semantically unrelated words of equivalent imagery 
and frequency which were used as distractors (appendix 6.1)
6.5.5: Apparatus: The equipment used was the same as 
described for the pilot study (see section 6.2.3).
6.5.6: Procedure: Subjects were randomly assigned to 
receive either the drug or placebo. The first session, 
consisting of three blocks of recall trials (one practice 
and two test) and a recognition test, took an average of 35 
min to complete. After subjects took the pills, they left 
the laboratory and returned 45 min later. The post drug 
session lasted approximately 35 min. Testing was conducted 
on an individual basis.
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6.6: Results
6.6.1: Analytical strategy: A variety of different analyses 
were carried out in this experiment. The primary method 
used to analyse the effects of scopolamine upon recall.
clustering and recognition was a mixed design Multivariate
Analysis of Covariance (Tabachnick and Fidell, 1989). In 
the recall analysis, there was one between groups factor
two levels) and three within groups 
factors (Modality Consistency - two levels, input modality 
(auditory/visual) - two levels, and Trials - five levels). 
Pre-drug (baseline) measures were included as covariates.
(Drug condition
in order to reduce the effects of between groups
variability. Analyses of recognition and clustering scores
used variants of this model, t tests were conducted to test
the effects of the drug on the surprise long term recall 
and recognition tests and Pearson correlations examined the 
relationships between modality clustering scores and recall
on individual trials.
The analyses were conducted on data from 47 subjects. 
Baseline data from one subject (drug condition) was lost 
due to a technical malfunction during recording which was 
not detected until after completion of the study, and so
all data from this person were excluded from further
analysis.
6.6.2: Immediate recall
Table 6.4 shows mean item recall in relation to each
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independent variable for both baseline and post-drug tests.
Analysis of covariance found that total recall was
significantly reduced by scopolamine (F=10.13, df=l/44;
p=.003). There was a significant main effect of trials
(F=19.33; df=4/179; p=.000), with the increase in recall
across trials clearly illustrated in Figure 6.3. For ease
of interpretation. Figure 6.3 
of Input Modality (i.e. whether a word was seen or heard by 
subjects). That variable is considered in the next section.
does not include the effects
The main effect of Modality Consistency on recall was not 
significant (F < 1.0) and this contrasts with the pattern 
the pilot study. However,observed in there was a
significant interaction between Trials and Modality
Consistency (F=7.44; df=4,179; p=.000). Figure 6.3 shows 
this interaction as a steeper increase in learning in the 
consistent as compared to the variable modality trials.
This experiment did not find a significant interaction 
between Scopolamine and Modality Consistency (F=1.20; 
df=l,44; p=.278). As can be seen in Figure 6.3, the drug 
effect appears to be of a similar magnitude in both the
consistent and variable conditions. In addition, the drug 
did not interact significantly with (F=1.37;trials
df=4,179; p=.245) and the three way interaction between
Drug, Modality Consistency and Trials was not significant
(F=1.00; df=4,179; p=.411).
ISOTable 6.4s Mean word recall, Drug and Placebo
SCOPOLAMINE 0.9mg
Trial 1 Trial 2 Trial 3 Trial 4 Trial 5
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n.b: Aud = auditory presentation; Vis = visual presentation
Figure 6.3: Scopolamine, Modality 
Consistency and Immediate Recall
Trial number
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Figure 6.4: Scopolamine and Imm. Recall 
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6.6.3: The "modality effect" in recall:
Recall was significantly greater for words that were heard.
rather than seen, by subjects (F=17.83; df=l,44; p=.000). 
The two and three way interactions involving Scopolamine,
Trials and Input Modality revealed an interesting pattern.
The two way interaction between Drug and Input Modality was
not significant (F=1.28; df=l,44; p=.631), indicating that 
the recall impairment by the drug was equivalent for both 
auditory and visual words. However, the two way interaction 
between Trials and Input Modality was significant (F=11.18; 
df=4,179; p=.000), which in reference to Figure 6.4, shows 
that the size of the "modality effect" (recall advantage 
for auditory words) diminished in later trials. Note that 
the means in Figure 6.4 are collapsed across the Modality 
Consistency variable for ease of interpretation.
There was a significant three way interaction between 
Scopolamine, Input Modality and Trials (F=2.66; df=4,179; 
p=.034). As can be seen in Figure 6.4, the drug and placebo 
recall lines do not differ appreciably for auditory words 
in the first three trials and only become separated in 
trials 4 and 5. In contrast, the recall of visual words
appears to be impaired by Scopolamine on each trial, with 
the drug and placebo recall lines being relatively parallel
across the session. The four way interaction between
Scopolamine, Modality Consistency, Trials and Input 
Modality was not significant (F < 1).
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6.6.4: Clustering Recall by Input Modality
Adjusted Ratio of Clustering (ARC) scores were calculated 
for each trial, with the means shown in Table 6.5. Analysis
of covariance found that scopolamine did not have a 
significant effect on ARC scores (F < 1.0). There was a 
significant main effect of Modality Consistency (F=24.48; 
df=l,44; p=.000), which in reference to Figure 6.5 is seen 
in higher ARC scores in the Consistent Modality condition. 
The main effect of trials was significant (F=3.55; 
df=4,179; p=.008), and this can be seen in relatively lower 
mean ARC scores in later learning trials.
Figure 6.5 illustrates an interaction between Scopolamine 
and Modality Consistency, and this was statistically
significant (F=5.58; df=l,44; p=.023). Clustering on the
basis of input modality is poorer with the drug in 
consistent modality trials. but relatively better in
variable modality trials. While an interaction between the 
drug and modality consistency predicted in thiswas
experiment, the observed interaction is the converse of
expectations. This is discussed in detail later.
VBH-
Table 6.5s Adjusted Ratio of Clustering (ARC) scores. Drug 
and Placebo.
SCOPOLAMINE 0.9mg












































































































Figure 6.5: Scopolamine and Clustering 
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Learning Trial
Consistent - * Variable
There was a significant interaction between Trials and
Modality Consistency (F=5.57; df=4/179; p=.000). This is
similar to that observed in the pilot study, and in
reference to Figure 6.5, emerges because ARC scores decline
across trials when input modality is variable, but remain
high in the consistent modality trials.
6.6.5: Relationships between recall scores and clustering
ability on each trial
Correlations between ARC scores and recall scores on each
trial were examined, with the Pearson correlation matrix
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shown in Table 6.6. On consistent modality trials, none of
the correlations were statistically significant. However, 
on variable modality trials, there were significant
negative correlations between the two measures on Trials
One, Two and Four. Higher ARC scores in the variable
condition are associated with poorer recall, while
clustering and recall scores in consistent modality trials
appear to be independent.
It is notable from Table 6.6, however, that the size and
direction of these correlations are similar in the Drug and 
Placebo conditions (with the exception of Trial 3). It 
appears that better clustering is related to poorer recall
when modality information is variable across trials, but
this effect does not vary as a function of the drug.
6.6.6: Intrusion errors and repetition of items in
immediate free recall.
Errors and repetitions in the list learning tasks, averaged
across the five trials in each block, are shown in Table
6.7. On the whole, subjects made relatively few errors, and 
the data appear to be very variable from baseline to post­
drug testing. Partially repeated measures analysis of 
covariance found that the main effect of Scopolamine was 
not significant (F=1.60; df=l,44; p=.291) and there was no 
significant difference between consistent and variable
modality trials (F < 1).
m
Table 6.6: Correlations between total recall and ARC scores 
on each trial.
CONSISTENT MODALITY LEARNING CONDITION
ARC SCORES
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Note: * p < .05; “ p < .01; p < .001.





















































Although means in Table 6.7 suggest that subjects made more
word repetitions than intrusions, this difference was not 
statistically significant (F < 1).The interaction between
the Drug and Modality Consistency conditions also was not
significant (F < 1).
6.6.7: Recognition of items and input modality
Table 6.8 shows correct word recognition and correct 
identification of input modality for words presented in the 
consistent modality trials. Recognition of items was close
to ceiling, but there is an apparent trend for poorer
recognition in the drug condition (with a reduction of 
post-test recognition under scopolamine of approximately 
10%). A one way analysis of covariance found that the main 
effect of Scopolamine was not significant (F=1.918; 
df=l,44; p=.173). A similar analysis revealed that the drug 
did not significantly effect the ability of subjects to 
correctly identify the input modality of items (F < 1).
The effect of Scopolamine upon long term recognition of 
items and input modality was examined by comparing delayed 
recognition of practice items. After a delay of 
approximately 90 min, subjects' average correct recognition 
of items was 77.4% in the drug and 82.6% in the placebo 
conditions. A t test found that this difference was not, 
however, statistically significant (p=.318). The ability to
\^o
Table 6.8: Recognition of words in consistent modality 














































n.b: Numbers are proportions of totals
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recognise the input modality of practice items was well
preserved after this delay, with 74.8% (Drug) and 70.2% 
(Placebo) correct modality judgements. Again, the 
difference was not statistically significant (p=0.483).
Subjects made relatively few recognition errors (false
alarms), with means of less that 1.0 in each of the three
There were no significant differences betweentests.
Scopolamine and Placebo conditions on this measure.
6.6.8. Recall of words learned prior to the drug
The post-drug free and cued recall of words which had been 
presented in the pre-drug baseline session were examined, 
with mean recall data presented in Table 6.9. Free recall 
was always tested prior to cued recall, and the data refer 
only to new items on each recall attempt. Hence, if an word 
which was retrieved in the free recall trial was repeated 
in the cued recall trial, it was not scored as an item in
cued recall.
A 2(Drug) by 2(Modality consistency) by 2(Type of Recall -
free or cued) ANOVA found that subjects recalled
significantly more words in the free condition (F=24.30; 
df=l,45; p=.000), although this may be attributable to the 
fact that "repetitions" in cued recall were not included in 
the analysis. The main effect of modality consistency was 
significant (F=39.37; df=l,45; p=.000), in that subjects
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recalled more items from the consistent modality trials 
than the variable modality trials. The interaction between 
Type of Recall and Modality Consistency was also 
significant (F=12.02; df=l,45; p=.001). From Table 6.9, we 
see that the bias toward relatively greater recall of words 
from consistent modality lists was greater in free, as 
opposed to cued, recall.
Table 6.9s Recall of words learned before the drug session
FREE RECALL CUED RECALL














































Scopolamine did not have a significant effect on recall of
words presented prior to the drug session (F=2.05; df=l,45; 
p=.159)/ and no two or three way interactions involving the 
drug reached statistical significance. Similarly, there was
no effect of the drug on the long term recall of practice
items (t=1.38; df=45; p=.179).
6.7: Discussion
The pattern of results can be summarised as follows:
Scopolamine impaired the immediate recall of words
learned after the drug, but did not impair recall of words 
learned in the pre-drug session and had no significant
effects upon item recognition and the correct
identification of sensory modality, either in the short or 
longer term. Contrary to predictions, the drug did not 
differentially disadvantage recall of material learned in 
the more difficult, variable modality condition. However, 
scopolamine did interact with input modality and trials, to 
the extent that recall of words which were seen, rather 
than heard, was disrupted by the drug to a relatively 
greater degree in early learning trials.
Scopolamine did not directly impair subjects' ability to 
cluster items on the basis of input modality, although with 
ARC scores there was a significant interaction between 
scopolamine and modality consistency.
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This profile of effects has some implications for current
discussion about the effects of scopolamine upon learning
and memory. Before these are discussed, some comments on
the memory tasks are relevant.
• The memory tasks were devised to test subjects' ability to
actively organise information under two levels of task
difficulty, and then to determine the extent to which the
drug directly influences memory and conscious organisation. 
The Modality Consistency variable had a clear effect upon
subjects' ability to cluster words. When each trial
contained the same words in the same temporal order and
sensory modality, clustering was superior to the condition 
where input modality varied across trials.
After the pilot study, where both recall and clustering
were lower in the variable modality condition, it was
assumed that the poorer recall was caused by poorer
clustering, and therefore that the relatively better recall 
on consistent trials was due to better organisation on the
basis of modality. However, this was not the case. With
only 10 subjects in the pilot, 
calculate meaningful correlations between recall and ARC
it was not possible to
scores. When these were done for the 47 subjects in the
full experiment, no positive association was found between
and recall scores in consistent trials, and mostlyARC
negative correlations were found in variable trials. It is
possible that the requirement to cluster on the basis of
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modality acts as a competing task (during difficult trials) 
which ultimately impairs recall.
Despite this unexpected finding, data from this experiment
are of theoretical interest.
6.7.1. Scopolamine and Recall
The absence of a significant interaction between
Scopolamine and Modality Consistency in recall poses 
difficulty for the central theory of this thesis. The most
consistent observation in experiments five and six was that 
the drug impaired recall, and it can be clearly seen in 
Figure 6.3 that the magnitude of this effect does not vary 
when the learning task is made more effortful. Clearly, a 
larger drug effect on recall should have been observed in
variable trials.
This lack of specificity of the drug is also apparent in 
the negative correlations between recall and clustering in 
the variable modality conditions there is no systematic 
difference between the drug and placebo conditions in the 
size or direction of correlations, suggesting that the 
degree of interference between clustering and recall found 
in variable trials in experiment six is no greater under 
the drug.
This line of reasoning does not preclude an effect of 
Scopolamine upon conscious organisation. In fact, the
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significant interaction between the drug and modality
consistency in ARC scores (Figure 6.5) indicates some 
influence. It does, however, suggest that the drug induced
recall deficit is probably not attributable to an effect on 
conscious organisation of the material during either
encoding or storage.
6.7.2. Scopolamine and Clustering
With regard to ARC scores, an interaction between
scopolamine and modality consistency was predicted. 
However, it had been expected that the drug would have a
greater effect upon clustering in the variable condition.
rather than in the consistent condition, on the grounds
that clustering in the former situation is more effortful.
and thus more vulnerable to disruption by the drug. In
fact, the opposite pattern emerged.
It is possible that the enhanced clustering in variable 
modality trials in the drug condition is due to an 
impairment to the ability to shift attention to the
components of the task. Subjects were specifically
requested to recall as many words as possible, and 
secondarily, to group the words on the basis of modality. 
The correlations in the variable modality data, as well as 
subjective feedback from subjects, suggests that at some 
point there was a trade-off between recalling the items in 
any order or grouping them. It may be that, when attempting 
to recall and cluster items during variable modality trials
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in the drug condition, subjects could not do both tasks.
and paid more attention to the grouping task. This would
then produce higher ARC scores. In the consistent modality
lists, both recall and ARC scores were high and this trade­
off was possibly not an issue, and thus the small reduction
in ARC scores might reflect a weak drug effect on general 
cognitive efficiency.
6.7.3. Drug and task factors as predictors of cognitive
performance
At this point we should consider the relative importance of 
the drug variable alone, and of the drug by modality 
consistency interaction, in explaining overall clustering 
performance. While the main effect of scopolamine was not 
significant, the interaction was. In addition, the Modality 
Consistency and Trials factors were significant. However, 
which of these is most strongly related to subjects' 
ability to group words on the basis of input modality? To 
answer this question, intra class coefficients of
correlation (RI) were calculated (Lehmann, 1986). This 
measure determines the proportion of the variance in the
dependent measure (recall) due to the independent 
variable(s) or their interactions.
Scopolamine alone accounted for only 1.97% of the variance 
in ARC scores, while the drug by modality consistency 
interaction explained 8.88% of the variance. These values 
should be compared to those for Modality Consistency
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(33.33%) and Trials (5.15%). Clearly, the drug did not
exert a direct influence on ARC scores, and the interaction
between scopolamine and modality consistency explains
relatively little of the variance in ARC scores.
Predictors of recall performance can be examined as well.
The significant three way interaction between Scopolamine,
Input Modality and Trials also suggests that the drug had
some effect upon the manner in which subjects organised
their recall. One strong feature in this task was that
recall is superior for auditory as compared to visual 
stimuli. The three way interaction suggests that the drug 
impaired memory for visual words to a greater degree early 
in the learning task. This may arise because subjects in
the drug condition have an impaired ability to
simultaneously hold in memory words from both modalities in 
early trials, and therefore focus primarily on the dominant 
(auditory) lists to the detriment of visual item recall. In 
later learning trials, when a sufficient number of words
were available for recall,• subjects may have begun to 
switch attention between the two list modalities, which may 
in turn produce a more uniform impairment of recall of both 
auditory and visual words.
Calculation of the intra-class coefficients of correlation
revealed that scopolamine alone accounted for 16.26% of the
variance in recall, while the drug by trials by input 
modality interaction accounted for only 3.43% of the
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variance in recall. Clearly then, the interaction, which as
discussed above may be due to attentional or strategic
factors, explains about 5 times less of the variability in
recall than does the drug alone.
6.7.4. Recognition, and the fate of information learned
prior to the drug.
As has been found in previous studies (Dunne and Hartley, 
1985; Rusted and Warburton 1989), scopolamine did not 
effect recognition, although it should be noted that 
performance in the recognition test was at ceiling, and 
therefore the task lacks sensitivity. The primary value of 
the recognition data is that they show that the items and 
knowledge of their input modality were potentially 
available for immediate free recall in both drug and 
placebo. Delayed recognition of practice items (up to 90 
rain after initial exposure) was well above chance, and 
information about input modality was generally intact, with 
better than 70% accuracy, over this period (see also 
Kirsner, 1974). No other scopolamine studies have examined 
effects upon recognition of sensory modality, although 
Kopelman and Corn found that scopolamine did not effect 
memory for the temporal order of remote memories. Taken
together, these studies indicate that the drug does not 
influence memory for the encoding context of events, 
whether they are learned before or after the drug.
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This study found no effect of scopolamine upon recall of
information learned prior to the drug, which confirms many
previous findings (Ghoneim and Mewaldt, 1975; Petersen, 
1977; Rusted and Warburton, 1989) and thus supports the 
general view that scopolamine does not effect retrieval of 
existing episodic information in memory (Kopelman, 1986a)
6.7.5. Conclusion (experiments five and six)
These two studies of the effects of scopolamine upon a
range of measures of verbal learning and conscious
organisation in memory do not support to the idea that the 
drug selectively impairs effortful cognitive processes. The 
more automatic memory phenomena such as semantic priming in
word completion and immediate and delayed recognition were
not impaired, while immediate recall, which is more
effortful, was impaired. However, this dissociation is not
sufficient to argue that controlled processes are
differentially sensitive. Such a position would have been
supported in experiment six if the magnitude of the drug 
effect on recall was greater in the difficult, variable
modality trials, but this theoretically important
interaction was absent.
Clearly, the drug had no direct effect upon subjects' 
ability to actively cluster items in memory, either in
"easy" or "difficult" task conditions. In addition, where
the drug did interact with various aspects of the tasks.
the evidence suggests that the effects are small and almost
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incidental to the larger effects observed in recall scores.
the6.7.6. How are these conclusions relevant to
scopolamine model of dementia?
The research designs and measures used in experiments five
and six are not directly analogous to studies in 
Alzheimer's disease, thereby limiting their comparability.
However, the data are of general interest to discussions
about the source of the primary memory deficit in amnesia
and dementia.
A number of studies have attempted to quantify
relationships between loss of contextual information and
poor learning and retrieval in amnesia. Huppert and Piercy
(1976, 1978) found patients with Korsakoff's amnesia to
have impaired ability to either encode the temporal context 
of items or to use temporal information as an aid to 
retrieval (see also Mayes et. al., 1985). With regard to 
memory for modality, Pickering et. al. (1989) found that 
amnesics have impaired encoding of collateral sensory 
information, and therefore suggested that one cause of the 
primary learning deficit is that amnesics cannot use the 
encoding context as a memory aid.
Kopelman (1987; Kopelman and Corn,1988) has argued that one 
causative factor in poor 
that contextual
memory in Alzheimer's dementia is 
information is not available. or at least
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be integrated with semantic information, andcannot
therefore that recall is essentially context-free. This is
perhaps most clearly illustrated in spontaneous
confabulation of remote memories in AD, where past events
are recalled in an apparently unrelated fashion, with 
temporally and spatially remote ideas converging in 
generally incoherent speech (this is sometimes a problem in 
thesis writing as well). A similar argument has been 
proposed by Granholm and Butters (1988) where it was found 
that the recall deficit in Alzheimer's patients is related
to their inability to encode incidental or "weak"
associative information.
If the scopolamine model of dementia is to be upheld, then 
it should be possible to show that the learning or 
retrieval of contextual information is impaired by the 
drug. However, the current studies found no effect on input 
modality recognition, and most importantly, that efficient 
clustering on the basis of modality (which requires memory 
for sensory modality) is not disrupted by cholinergic
blockade.
Three studies have examined effects of scopolamine upon 
memory for temporal context (which is generally impaired in 
dementia). Caine et. al. (1981) and Richardson et al (1984) 
found that scopolamine impaired the ability to discriminate 
between auditory tones separated by 300 milliseconds, and 
between word lists separated by 30 seconds, suggesting some
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disruption to knowledge of temporal relationships. However,
analysis of the effects of this drug on the frequency of
temporal context errors in the Huppert-Piercy recall test 
by Kopelman and Corn (1988) found no significant effect on 
subjects' ability to identify which of two presentations, 
separated by 24 hours, contained the target items.
Given the paucity of existing data, it is not possible at 
this stage to say whether scopolamine does or does not 
reliably impair memory for context. However, the absence of
direct effect in experiments five and six does at least
suggest that any impairment to this attribute of memory may 
be smaller in magnitude than that found for recall, and 
also perhaps be causally independent of the primary memory 
deficit. In this respect, the existing data may point to a 
further limitation of the scopolamine model of dementia. It 
would seem important for future studies to more closely 
examine the "Contextual Memory Deficit" hypothesis of 
amnesia in Alzheimer's disease, and to directly compare 
performance on corresponding measures when scopolamine is 




This chapter presents an overview of the results of the six
experiments in this series. It then comments on the current
status of the scopolamine model of Alzheimer's dementia.
Some weaknesses and strengths of this thesis are discussed
and finally, some suggestions are made for further research
7.1. Overview of the findings
Experiment two demonstrated that scopolamine impairs the
ability to focus visual attention on specific spatial 
locations. This provided an interesting extension to an 
earlier study by Dunne and Hartley (1985) where scopolamine 
impaired selective attention to auditory stimuli. These two
studies assessed the processing of information presented in 
a broader perceptual area, and it was found that the drug 
actually increased the 'capture' of background information.
As stated in Chapter Three, if we adopt Shaw and Shaw's 
(1977) idea that the probability of stimulus detection at 
different spatial locations depends upon the conscious 
allocation of (limited) processing capacity to those 
locations, then the most straightforward explanation of the 
drug effect in experiment two is that scopolamine 
selectively effects the allocation of cognitive resources.
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This adds clarity to studies showing that the drug impairs
vigilance in single source target detection tasks (Wesnes
and Warburton, 1983; 1984). These latter effects may be due 
to poorer resource allocation (focussing of attention) or
overall declines in stimulus sensitivity. Data from
experiment two, and Dunne and Hartley (1985) suggest that 
stimulus sensitivity does not decline overall, since the
processing of processing of peripheral information is
enhanced.
Experiments three to six examined whether the hypothesis of
a scopolamine-induced controlled processing deficit in 
attention could be generalised to other aspects of 
cognition. Unfortunately, there is no clear evidence for a
generalised effect of the drug.
The two studies of sustained search of semantic memory
could not detect any drug effect on various quantitative 
and qualitative aspects of retrieval of existing knowledge. 
The only significant effect was on item repetition 
(experiment three) and this was interpreted as a deficit in 
memory for recent events. Previous evidence regarding 
effects of cholinergic blockade on semantic memory is very 
conflicting. Despite numerous studies, an intriguing 
situation has developed where equal numbers of experiments 
have found either impairment or no impairment. Further, 
when drug effects on verbal fluency are found, there is 
disagreement as to whether the deficit arises in retrieval
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from alphabetical or natural semantic categories. It is
difficult to reconcile these data, since most studies used
comparable tasks and drug doses.
Warburton (1987) has identified three 
chemical systems which are important in cognition. There 
are two cholinergic systems thought to be responsible for
separate neuro-
a) stimulus selection and b) consolidation of information 
in longer term memory. In addition, there is an adrenergic
system which may be responsible for 'associative
elaborations' in long term memory. Frith et. al. (1985)
found that clonidine (a pre- and post-synaptic 
noradrenaline alpha receptor agonist, which in low doses 
actually reduces noradrenaline turnover), impaired
retrieval from semantic memory, but had no effect on free
recall. This is a very interesting dissociation, since no
studies with drugs that reduce cholinergic activity have 
found impaired semantic memory and intact episodic memory: 
in fact, at least four experiments show the reverse
pattern.
There are other strands of evidence to suggest that an
adrenergic system is responsible for elaboration of
information in semantic memory. Warburton (1987) cited
studies from Weingartner et al 
laboratory which show that catecholamine agonists enhance
(1980) and his own
memory for semantically processed words, and this effect is 
independent of changes to attention. It appears that
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increased noradrenaline release produces relatively greater
in recall of words with weak semanticimprovement
post-storage semanticassociations, suggesting that
encoding was being improved. It should be noted here that
cholinergic blockade does not produce differential effects
upon the learning of words which differ in terms of
(See Rusted andstrength of semantic associations
Warburton, 1989, but also Frith et. al., 1984 for a
contrary view).
While most of the above studies have looked at semantic
processing during learning, the adrenergic model could be
extended to processes involved in sustained retrieval. An
adrenergic system may be responsible for the ability to
access clusters of semantic associations, and then to
retrieve items from within those clusters. Certainly, this
issue requires further investigation.
It is possible, then, that the absence of effects of
scopolamine upon semantic memory retrieval in experiments 
three and four is due to the fact that cholinergic systems 
have very little direct involvement in semantic memory. If
this is the case, the lack of an interaction between
scopolamine and semantic retrieval difficulty (in
experiment four) may not, by itself, produce evidence for
against cholinergic 
processing. It may simply be that semantic memory is an 
inappropriate domain in which to test the hypothesis.
involvement in controlledor
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There is little doubt that cholinergic activity has an
1986a).important influence on episodic memory (Kopelman,
Experiments five and six directly assessed whether
controlled processing in episodic memory tasks are
differentially effected by scopolamine. The pattern of
effects suggests that active, conscious organisation of new
information is not directly impaired by cholinergic
blockade. This is not to suggest that scopolamine cannot
produce changes to general processing efficiency in
addition to poorer learning, since there were two
interesting interactions involving the drug. However, it 
was argued that the primary effect of the drug is upon new 
learning, and there are some minor, and perhaps 
independent, effects upon attention or cognitive 
flexibility during the tasks.
7.3 Status of the scopolamine model of AD
During the time in which this series of experiments was 
conducted, there have been numerous published reports 
showing severe limitations to the scopolamine model of 
Alzheimer's dementia. There are two levels of analysis 
here. First, scopolamine's effects in healthy young 
subjects can be compared to neuropsychological performance 
in AD patients. Second, the whole idea of single 
neurotransmitter models of amnesia can be questioned. These 
issues are briefly reviewed below.
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(1) Mismatches in neuropsychological profiles: Both
cholinergic blockade and AD produce impaired vigilance.
selective attention, psychomotor speed and new learning.
and both cause deficits in the "central executive"
component of working memory and the ability to handle novel 
tasks in intelligence tests (Drachman and Leavitt, 1974; 
Flicker et. al., 1987; Kopelman, 1986a; Rusted and
Warburton, 1988), However, it now seems clear that there 
are many dissimilarities. Scopolamine does not produce 
deficits in recall of remote memories (Troster et. al.,. 
1989), language functions such as object naming (Flicker 
et. al., 1990), intrusion errors in paired associate 
learning (Beatty et. al., 1986) and the recall of temporal 
context information (Kopelman and Corn, 1988). People with 
AD, in contrast, show impairment on all of these measures.
The present experiments illustrate further limitations of 
the scopolamine model. The drug does not effect higher-
order elaborate aspects of retrieval from semantic memory.
which become impaired in very early stages of AD (Martin 
and Fedio, 1983). In addition, the drug does not impair 
memory for modality, and it seems that scopolamine amnesia 
might not be usefully described as a contextual memory 
deficit. This contrasts with the severe loss of context
memory in AD, and observations that at least part of the AD 
amnesia may be directly attributable to a context memory 
deficit (Kopelman, 1989).
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(2) Limitations of single neurotransmitter models:
Psychopharmacology is undergoing rapid change. With the
of knowledge of the total number ofexpansion
neurotransmitters and neuropeptides, and the interactions
between them, it is becoming less viable to propose that
any systemically administered drug has a singular effect on
one neurotransmitter system (Decker and Gallagher, 1987). 
This, in turn, renders it unlikely that one type of drug
has a distinctive pattern of effects upon cognition. In
human studies, it has not been possible to reliably
distinguish the effects of scopolamine in healthy subjects
from diazepam, another amnestic drug (Frith et. al, 1984;
Preston et. al., 1989; Richardson et. al., 1984). The 
picture from animal experiments is much the same (Flood and
Gherkin, 1986).
One key problem for a specific hypothesis of cholinergic
function is that. when anticholinergic drugs are
administered, the cognitive effects often can be counter­
acted by both cholinergic and non-cholinergic drugs (Flood 
and Gherkin, 1986). In drug models of dementia, there is a 
need to delineate effects in cross-reversal experimental 
designs, where at least two classes of disruptive drugs are 
used, and attempts are then made to reverse these effects 
with two relevant agonists (see Preston et. al., 1989). 
Without these more complex designs, there is the danger of
duplication
hypotheses. For example, Nissen et. al. (1987) and Danion
of psychopharmacologicalunnecessary
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et. al. (1989) have used single, but different, drugs
(scopolamine and diazepam) to show dissociations between
explicit and implicit memory. As well. Crow (1979) and 
Mewaldt et. al. (1983) used these separate drugs to show a
selective impairment to the transfer of information from
short to long term memory. While the data are of general
interest, it is obviously not possible to argue that the
neurochemical systems affected by the drugs are specific
substrates of these aspects of cognition.
This lack of specificity is also true for the idea that
scopolamine selectively impairs effortful cognitive
processes, since, as mentioned earlier, the same hypothesis
has been put forward for levodopa (Newman et. al., 1984).
It has been apparent for some time that single drug models.
and therefore single neurotransmitter hypotheses, of
Alzheimer's Dementia are inadequate, since many other
neurotransmitters are altered in this disease. In Chapter 
One, it was argued that dysfunction occurs in cholinergic 
systems to a greater degree in early AD than is found in
cholinergic
pathology is the only type which has reliably been found to 
correlate with cognitive impairment in AD. It is tempting 
to speculate that a distinct pattern of loss is caused by 
cholinergic deficiency, and that other aspects of cognitive 
impairment (such as a deficit in remote memory), are
other neurotransmitter systems. Further,
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associated with (later) changes to other neurotransmitter 
systems. This, however, is a very tenuous proposition. 
First, although it may be possible to ascribe specific
cognitive functions to particular neurochemical systems in
healthy animals and humans (Warburton, 1987), it is another 
issue altogether to say that a specific dysfunction is
caused by particular neurochemical disturbance (Flood and 
Gherkin, 1986). Clinical neuropsychology is, at present, 
not sufficiently precise to "map" cognitive changes onto 
stages of degradation in particular neurochemical systems 
(as might be indicated in CSF analysis or ante-mortem 
biopsy). There is far too much variability in all the
relevant measures.
In summary, it is clear that the scopolamine model of 
Alzheimer's Dementia has serious limitations. The present 
series of experiments further support this view. As 
knowledge of brain-behaviour relationships has expanded, it 
has become increasingly obvious that single drug models of 
AD are just too simple to account for the rich and varied 
data.
7.4. Weaknesses and strengths of this thesis
The are several weaknesses in this thesis which should be
critically discussed. First, no attempt was made to 
establish dose-response effects. Multiple dose studies are 
becoming the norm for several important reasons. They can 
identify whether null effects on particular tasks are
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meaningful, rather than the result of low drug sensitivity.
and they can establish whether some tasks are differentially
sensitive to drug dose (Broks et. al.. 1988). Studies of
scopolamine generally find, for example, that free recall
is affected by lower doses than is attention (Broks et. al., 
1988; Kopelman, 1986a; Parrott, 1986), which suggests that
recall deficits should not be attributed to impaired
attention.
i
In the present series, it would have been useful if
automatic and controlled processes in memory were examined
at multiple doses. It may be that non-conscious processes
such as semantic priming are affected by scopolamine, but
not until higher doses (e.g. 1.2mg oral) are used. Such an
observation would have given support to the central theory
of this thesis.
Five of the experiments used 0.9mg oral, which is within a
low to moderate range in comparison to published
experiments, but is the maximum dose recommended
commercially for general use. A single dose was chosen 
because test administration and scoring was very labour 
intensive (especially experiments 3 to 6). In retrospect, 
however, multiple dose testing of the same subjects would 
have allowed sufficient experimental power to reduce the 
sample size.
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Despite the acknowledged weakness of the decision to employ
a single dose, it is important to justify why this dose
(0.9mg oral), and not any other, was chosen. As discussed
in chapter four, 0.9mg oral scopolamine has considerably
less potency than a similar dose administered parenterally 
(Bowman et. al., 1968; Safer and Allen, 1971), and this dose
is lower than that chosen by many other scopolamine
experiments. Clearly, the consequent pattern of effects may
be due to low drug sensitivity.
/
However, it is arguable that the purpose of this thesis
would have been lost if a higher dose of scopolamine had
been used. The aim was to examine similarities between
subtle effects of anticholinergic blockade and patterns of
cognitive deficits observed in the early stages of
Alzheimer's Disease.
If a higher effective dose (such as l.Omg subcutaneous 
(Drachman and Leavitt, 1974), or 0.8mg intramuscular 
(Troster et. al., 1989) had been used, then it is possible, 
on the basis of published studies, that subjects' 
performance would have deteriorated in most cognitive tasks. 
At such high doses, the drug significantly decreases general 
arousal (Kopelman, 1986; Preston et. al., 1988) and it is 
likely that many cognitive deficits are secondary to 
impairments in arousal (Kopelman and Corn, 1988; Lines et.
al., 1991).
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Such a generalised pattern of impairment at high doses
produces many interpretative problems, particularly when
cognitive tasks are designed to examine subtle aspects of
conscious control over information processing. If subjects
are impaired on every measure, then how can we distinguish
poor recall due to problems with effortful, organisational
processes from poor recall due to impaired automatic memory
processes? Clearly, in order to demonstrate, as this thesis
set out to do, that a drug selectively impairs some
cognitive operations and not others, then a dose must be
chosen which does not compromise a subject's ability to
complete all elements of the tasks.
This is particularly important when comparisons are drawn
to problems in mild Alzheimer's dementia. There is little
point in comparing gross impairment by anticholinergics with 
gross cognitive loss in the latter stages of dementia. As
was argued in chapter one, the selectivity of cholinergic 
loss is only a feature of early AD. In later stages many 
other neurotransmitter systems are dysfunctional. As well, 
high doses of scopolamine (or any centrally acting drug) may 
alter activity in numerous interacting neurochemical systems 
(c.f. Introini-Collison and McGaugh, 1988; Panksepp, 1986) 
and therefore any gross behavioural changes may not be 
directly attributable to cholinergic blockade.
The primary aim of this thesis was to compare subtle 
effects of scopolamine with subtle changes in AD that may
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be attributable to cholinergic depletion in dementia. It is
arguable that this aim would not have been achieved had high
doses of the drug been given to subjects.
Apart from these interpretative issues, there is a danger
that high dose scopolamine may not be tolerated by some
subjects, as was documented by Troster et. al. (1989) who
found that one of their thirteen subjects experienced acute
delirium following 0.8mg IM scopolamine. That subject
exhibited incoherent speech, was disoriented to both time
i
and place. and was unable to produce even a single word
beginning with the letter F after four attempts. It is worth
noting that the present author self-administered l.Smg oral
on one occasion (at mid-day) and fell asleep for two hours.
In sum, while these experiments could have been improved by
establishing dose-response effects, it is probable that the
actual choice of dose is not a weakness. The studies
generated a profile of subtle effects of 0.9mg oral
scopolamine, and this allowed a meaningful comparison with
the subtle changes that occur in early Alzheimer's dementia.
As Lines et. al. (1991) suggest, drug effects at low to
moderate doses are not 'clouded' by problems which accrue
from impaired arousal at higher doses. It is likely, then, 
that some of the variation in attention and learning found 
in these experiments can be attributed to the central
effects of scopolamine. More specifically, this thesis has
shown that the magnitude and direction of these effects
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appear to be equivalent for both effortful and more
automatic cognitive processes.
A second limitation of these studies is that the
experimenter exerted only limited control over factors which
influence drug absorption from the gut. In any study 
employing oral administration it is necessary to control and 
equate food and beverage intake prior to, and during, drug 
absorption (Julien, 1985). In the present experiments,
subjects were asked to avoid food and caffeine-containing
/
beverages for two hours prior to testing and until after the 
end of each session. This requirement was not, however, 
under strict moment-to-moment control, and therefore some 
of the "error" variability in drug response may be due to
potentially preventable absorption differences between and
within subjects. It is worth noting that of ten publications 
reporting experimental procedures with oral scopolamine.
none mentioned control over food intake and only five 
described instructions to limit alcohol, tea and coffee
intake prior to testing. It is therefore unknown whether
other researchers took precautions to control food intake
as a source of variability.
A third limitation of this thesis is evident in experiments 
three and four. These studies would have been stronger if 
some brief tests of recall or paired-associate learning had 
been included to establish that the drug was having 
predictable effects on these functions, but not upon
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semantic memory retrieval. In experiment four, in
particular, it may have been useful to include a test of
memory for the answers to number series problems. If this
had been done, and scopolamine impaired recall of the
answers, then this would have established a dissociation
between drug effects on access to arithmetic knowledge and 
episodic memory for the products of this knowledge.
A fourth limitation is evident in experiment five. A pilot
study should have been done to establish whether word list
/
semantic relatedness did have an effect on subjects' ability 
to cluster words on the basis of sensory modality. In 
addition, this experiment attempted to embed too many 
variables within the recall and recognition word lists. As
a result. it was not possible to develop lists in which
there was adequate control over stimulus characteristics.
such as imagery and frequency, which are known to effect
recall. This additional "noise" may have introduced high
error variance.
One of the strengths of this series of experiments is that 
it examined three cognitive functions in more depth than is 
found in most work with scopolamine. This approach helped 
to illuminate the processing which occurs when selective 
attention is impaired, the qualitative aspects of semantic 
memory search and the effects of conscious organisation of 
material during learning.
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A second positive element is that this thesis drew together 
information from a diverse range of research areas, and
placed them within a single conceptual frame. Neuro­
pathology research in AD was examined to see whether
neurochemical loss could be linked to alterations in
cognitive function, and to energetical systems (See Hockey
et. al., 1986; Wens et al., 1989). Data from neuro­
psychology were evaluated, and it was found that clinical
studies of cognitive loss in AD can, despite the mass of
information, be usefully interpreted in terms of a declines
/
in controlled cognitive processes. In addition, a body of
pure research in cognitive psychology was considered. It was
from here that the automaticity metaphor and most elements
of the tasks were adopted.
Some other fields of research were also examined in early
stages. Electrophysiological studies have found some
interesting links in the puzzle. example.For
anticholinergic drugs alter the P300 component of 'limbic
and cortical event-related potentials (ERPs), P300 has been
described as an indicator of cognitive effort (McCarthy and 
Donchin, 1981; Mulder, 1986), and is found to be altered in 
AD (Meador et. al., 1987, 1988). However, it appears to be 
the case that the P300 component of the ERP has been 
proposed as a marker for most brain disorders, including 
alcoholism, schizophrenia, parkinsonism, anorexia and 
attention-deficit disorder. Given this poor specificity, 
this line of evidence was excluded from detailed review.
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Another broad field of research not discussed in detail is
that concerned with delineating differences between
cognitive function in normal and pathological aging. It
should be acknowledged that controlled processing is thought
to be selectively impaired in normal aging as well as AD
(Cohen and Faulkner, 1983; Craik and Byrd, 1982; Rabbitt,
1979, 1982; Salthouse and Somberg, 1982). Despite this, some
important differences between controlled processing in aging
and mild AD have been described (Nebes and Madden, 1988;
Nebes et. al., 1986). There is also some evidence that non-
demented elderly subjects are affected by scopolamine more
than young normals (see Sunderland et. al., 1987) and this
can be added to some observations of declining cholinergic
neurotransmission in normal aging (Decker, 1987). Clearly,
these data could have been brought in to discussions of the
cholinergic hypothesis of memory. However, this information
is too voluminous and conflicting to include without the
thesis becoming too diffuse.
Some of the more reflective review papers in this field (see 
Kopelman, 1985, 1986a, Sahakian, 1988) state that meaningful 
questions cannot be asked unless theory is based on 
information from inter-connected fields of inquiry. The 
trick, however, is to do this and produce theory which has 
explanatory power. The idea that cholinergic systems and 
drugs modulate controlled processing does appear to be 
suggested by a lot of data. When the narrowly focussed 
experiments here failed to support this (admittedly very
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general) hypothesis, one is left to wonder about a suitable
replacement.
Rusted and Warburton (1988) suggested that working memory
is a useful framework, and described similarities between
scopolamine's effects on the 'central executive' and similar
impairment in AD. However, as Rusted and Warburton
acknowledged, it also appears that the slave systems of the
central executive (the articulatory loop and visuo-spatial 
scratchpad) may be impaired in AD and this distinguishes AD 
from scopolamine. One further limitation to this 'model' is
that the working memory model does not capture a wide range 
of cognitive functions that are impaired in AD. Where 
similarities between AD and scopolamine are found (i.e.
impaired central executive function) this observation may 
simply be re-phrased by saying that the drug and disease 
state both impair conscious control of information in
memory, while the more 'automatic' components (such as
articulatory rehearsal) are relatively preserved (see Morris
and Kopelman, 1986).
Warburton (1986, 1987) has proposed a functional state
model' to understand relationships between human information 
processing and neurochemical systems. In this view, observed 
cognitive performance is seen as a cross-product of the 
transient state of the brain (ie. cortical arousal) and the 
energetic requirements of the cognitive task. Warburton 
(1986) reviewed electrophysiological evidence which shows
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that some cognitive processes require a high state of
arousal (e.g. vigilance, selective attention) while others
seem to operate best at low states of arousal (such as
creative thinking). A key point to this model is it explains
why centrally acting drugs (such as cholinergic antagonists
which reduce cortical arousal) might impair some cognitive
functions but not others.
The role of attention in cognition is a good example. It is
well known that scopolamine reduces target detection in
laboratory tasks which require high arousal and focussed
attention (Dunne and Hartley, 1985; Experiment two; Wesnes
and Warburton, 1984). This can be viewed as a "dysfunction"
or "deficit". However, it is also the case that some tasks.
such as creative thinking, are done best when attention is
broadened, and the "mind is free to wander". These two types
of tasks are two end points of a continuum. Most complex
cognitive operations, such as learning and rehearsal of new
information, require both high and low arousal at various
stages. The capture of information into longer term memory
depends on high arousal, whereas elaboration and integration
of this information within broader semantic networks benefit
from low arousal. Findings that scopolamine impairs
information acquisition but not conscious organisation and
elaboration might suggest that the drug caused a cortical
arousal state which was suboptimal for the former, but
optimal for the latter.
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The functional state model has application beyond the
laboratory. Observations that cigarette smoking is increased
during periods of intense work (Wesnes and Warburton, 1983b)
may be due to the fact that nicotine helps to maintain a
high state of cortical arousal during tasks that benefit
from high arousal. On the other hand, drugs which decrease
cortical arousal, such as cannabis and alcohol, may be
chosen because they induce broadened attention and divergent 
thinking, and this state is optimal for situations in which
the drugs are used.
As Warburton (1986) suggested, further verification of the
functional state model requires multivariate research
designs which examine effects of multiple doses of drugs 
upon tasks for which different brain states are optimal. 
Some of the suggestions for further research outlined below
may go some way toward this goal.
7.3. Suggestions for further research
Research into the cognitive effects of anticholinergic drugs 
has been very fruitful in the past. The scopolamine model 
of dementia, for example, has produced some important 
insights into the effects of drugs and disease upon 
cognitive function. Most importantly, it has focussed 
attention in clinical pharmacology upon the development of 
cholinergic agonists for the treatment of dementia.
While a number of studies have found that these agents (and
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well as dietary acetylcholine precursors, such as choline)
do not improve cognitive function in either demented
patients or normal people (Chatellier and Lacomblez, 1990;
Christie et. al., 1979; Harris et. al., 1983; C. Smith et.
al., 1978, 1986; Stern et. al., 1987; Thai et. al., 1982a;
Wettstein, 1983), there have been enough positive outcomes
to stimulate further drug developments (Agnoli et. al..
1983; Becker et. al., 1988; Beller et. al., 1985; Davis and
Mohs, 1982; Sahakian et. al., 1989; Schwartz and Kohlstaedt,
1986; Sitaram et. al., 1978; Summers et. al., 1986; Thai et.
al., 1982b). At present, a useful strategy may be to use 
cholinergic agonists in combination with other memory
enhancing drugs to see whether there are any positive
interactions (Sahakian, 1988).
Research into the effects of scopolamine upon cognition in
healthy subjects is likely to continue for some time.
although the recent growth in papers documenting limitations
to the scopolamine model of dementia should subside soon.
It is, of course, not necessary that the drug accurately
models a chronic disease state for research to be
productive.
The work in this thesis suggests several lines of future
research. One approach, alluded to earlier, would be to
examine sustained retrieval from semantic memory under
different doses of both scopolamine and clonidine. This
experiment should also include episodic memory tasks of
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equivalent difficulty, such as multi-trial learning of long
lists of words. Following Frith et. al. (1985), it would be
very interesting to see, in a double dissociation design, 
whether clonidine impaired qualitative aspects of semantic
memory retrieval, but not learning, while scopolamine
impaired learning but not semantic memory retrieval. Such
a result would be an important development in research into
the specificity of action of different centrally acting
drugs.
Another approach is suggested by the task used in experiment 
six and some insights from Deutsch’s (1971) early 
experiments. In experiment six, recall was poorer when input 
modality varied across trials. This may be partially due to 
the fact that the memory traces for these words were weaker.
because on successive trials there was incomplete
reinforcement. This idea of weaker memory traces is strongly 
suggested by the fact that, in long term recall of material 
learned before the drug, words from variable trials were
recalled significantly less often than words from consistent
modality trials (although some of this effect may be due to 
the intrusive effects of the requirement to cluster words
by modality).
With careful development and pilot study, a task could be 
created in which several points on a continuum of input 
modality consistency were set (from completely consistent, 
partially consistent to completely inconsistent across
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trials). Hence we could have a sliding scale' of trace
strength. In this task, subjects would not be required to
actively cluster words.
According to Deutsch's studies, and several other animal
experiments (se Sahakian, 1988, for a review), cholinergic 
agonists and antagonists have differential effects depending 
on the strength of the memory trace. It would be very
interesting to see whether scopolamine and cholinergic 
agonists such as nicotine or physostigmine had opposite 
effects on recall of these words, and particularly whether 
there were interactions between the drugs and the degree of 
'trace strength'.
Another issue which remains unresolved in this field is
whether scopolamine impairs retrieval from episodic memory. 
This issue could be examined in the following way. Non- 
drugged subjects could be trained to criterion on various
tests of verbal and non-verbal memory, using highly
memorable material. They could then be given scopolamine 
soon after learning, and again on perhaps six occasions 
(from days, weeks to months after). In each drug session, 
they could be given brief tests of new learning of similar 
material and of attention and arousal, to assess drug 
sensitivity. They would also be asked to recall the material
from time one.
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Clearly, forgetting of the original material would occur
over time, and it would be interesting to see whether
retrieval differed between drug and placebo. In addition.
it would be possible to correlate the level of time one
information recall with the current session's memory scores.
If sessional drug impairment correlated highly with time one
retrieval problems, then a global effect on cognitive 
efficiency would be suggested. A second possibility, of 
course, is that the drug may not impair retrieval of time
one information, but only effect new learning. Regardless
i
of outcome, such an experiment could give an answer to one 
of the more persistent unresolved questions in this field.
A fourth avenue for research with scopolamine is to use the
drug in pharmacological challenge designs with people 
suspected to be in the early stages of dementing diseases 
(Freedman and Cohen, 1985). Recently, Dubois et. al., (1987) 
compared the effects of low dose (0.25mg s.c.) scopolamine
on groups of non-cognitively impaired parkinsonian patients
and matched controls. The patients showed a selective
vulnerability to the drug, while the controls were not 
impaired at all. A similar approach has been taken by 
Sunderland et. al. (1987) with people with mild AD, who show 
impairment at very low doses, while matched elderly only 
become effected at higher doses. This author (Raphael, 
Dunne, et. al., 1990) is currently using the Dubois et al 
design to examine whether asymptomatic men with(1987)
Human Immuno-deficiency Virus (HIV) infection are
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selectively vulnerable to low dose (0.43mg s.c. )
scopolamine.
In clinical challenge studies with scopolamine, it is not
necessary to speculate that a pathological state is caused
by a selective loss of cholinergic neurons for the study to
be meaningful. It is sufficient if, in diseases which can
produce dementia, dysfunction in central cholinergic systems
is present, along with the many other changes that are
occurring. As Dubois et. al. (1987) demonstrated,
scopolamine can aid the detection of global brain pathology
at a very early stage. Throughout the next decade, this drug 
will continue to be a useful exploratory tool in both
clinical and experimental research into brain function.
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Appendix 5.1. Part 1: Notes on the calculation of ARC 
values for experiments 5 and 6, with annotated examples.
The Adjusted Ratio of Clustering (ARC) was developed to 
measure the degree of clustering, or grouping, of words in 
verbal free recall. According to Roenker et. al. (1971), 
ARC scores provide a measure of clustering which is 
independent of list length and the number of grouping 
variables. It gives a score between 0 (nil clustering) and 
1.0 (maximum clustering). This measure was used in 
Nilsson's (1973) analysis of verbal free recall protocols, 
and more recently in Calev et. al.'s (1987) analysis of 
clustering in verbal and non-verbal recall by schizophrenic 
patients and normal controls.





R = total number of observed category repetitions (i.e. 
the number of times a category item follows an item 
from the same category)
maxR = Maximum possible number of category repetitions 
E(R) = expected (chance) number of category repetitions
It should be noted that
maxR = N - k
where N = total number of items recalled and, 
k = number of categories in the protocol




where ni = number of items recalled from category i and N is 
as before (from Roenker et. al., 1971).
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The following examples from two 
protocols in experiment 
scores in measuring clustering 
modality. Note that 
modality respectively.
subjects' recall 
6 illustrate the derivation of ARC 
on the basis of input 
"A" and "V" signify Auditory and Visual
Example 1: Example 2:







Words in : Link 
order
A V





















maxR = 7-2=5 




Therefore, R = 8
maxR = 12-2=10 
E (R) = 72 + 52ARC = 1 - (-1.571)
-1
12





Note: item repetition and intrusions were ignored in the 
ARC calculations.
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N.B: A = auditory presentation, V = Visual presentation
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Recognition test, experiment five
Note: A separate list of words, which did not contain any 
items from the recall lists, was presented. Following this, 
subjects completed a recognition test, where they were asked 
to indicate whether each word was "old" or "new", and to 
indicate the modality of presentation of the words. 14 of the 
words were from the original recognition list, 14 were 
semantically related distractors, and 14 were new, unrelated 
distractors. Words in the recognition test are shown below.










































Note: Subjects were asked to complete the following word 
stems with "the first word that comes to mind". Half of the 
stems were new, while the other half derive from all of the 
words in the list which was presented prior to the 
recognition test.
The stems were;
TRA CLI INF BIS DEL
SLE MAG FLA PLA DRA
GRI GRO POS SWE WRI
SEN CHA MOT EXP ATT
INS HEL LIN EFF SER
VOL WAL GIRREV PRI
BEA DEP SEL RES NUM
SPE COR HUM FOR CAN
BLO COA SHO PAN GAN
GAR EST CLO EVE PAR
PLU REA LAN PAS BUS
SCA
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Appendix 6.1: Word lists and response booklets, experiment 6.

























































































































































































































































































32.0 Mean 3.77 33.6




































































































(2) Recognition test words.
Test booklets included all words presented in 
lists condition (consistent modality lists only), 
equal number of unrelated distractor words. 
required to





indicate whether they recognised the words, and
was seen or heard in the
The recognition test items were;
FORM A FORM B FORM C
(practice lists)
decree
hint
concept
essence
crisis
inch
quest
demon
circuit
greed
hide
nephew
fault
mercy
shock
pact
author
charter
tribute
tenure
malice
joke
heaven
spread
claim
charm
drama
vision
proxy
disease
anger
judge
deluge
impulse
truce
belief
satire
excuse
reflex
maker
item
lunch
dream
impact
mood
array
noon
hunger
humour
wind
glow
venom
speech
grief
welfare
royal
session
fortune
owner
silence
assault
virtue
pride
flow
encore
friction
shame
preview
madness
code
balance
hardship
namesake
deed
soul
mark
crime
instance
contract
outcome
mileage
honour
vacuum
duty
pleasure
grace
chaos
feline
nonsense
rating
patent
figment
spree
fate
upkeep
style
